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This thesis provides evidence for the presence of multiple RNAs in the axons and
growth cones of developing thalamic cells, particularly the mRNA for the cell adhesion
and Wnt-signalling-related molecule β-catenin.
After many decades of effort, mRNAs have been shown to be present in the axons
of many different systems in recent years. Furthermore, these mRNAs have been
shown to be locally translated at the growth cone, and this local translation is required
for axons to turn in response to multiple guidance cues. As studies accumulate, it is
becoming clear that different axonal systems contain different complements of mRNAs
and have different requirements for local translation.
One axonal system which has not been investigated to date is the thalamocortical
tract. The nuclei of the thalamus are connected to the areas of the cortex via bundles
of axons which travel from the thalamus to the cortex via the ventral telencephalon
during embyronic development. These axons make a number of turns and are guided
by many cues and other axonal tracts before innervating their cortical target.
In this thesis, a quantitative real-time polymerase chain reaction (qRT-PCR)
approach is developed to isolate multiple mRNAs from developing thalamic axons in
vitro, including β-catenin mRNA, β-actin mRNA, 18S ribosomal RNA and ten other
mRNAs. The method used should be suitable for use with other axonal systems and
also for testing the effect of guidance cues on mRNA expression in axons.
The qRT-PCR results for β-catenin, β-actin and 18S have been validated using in
situ hybridisation. Analysis of in situ hybridisation results indicates that β-catenin and
18S, but not β-actin, are upregulated in the growth cone compared to the axon.
As β-catenin has been shown to be involved in axon guidance via Slit and
ephrin guidance cues in other axonal systems, and these guidance cues act upon
thalamocortical axons, the identification of β-catenin mRNA in thalamic axons is an
important step towards a full understanding of the thalamocortical system.
The results presented here indicate that local protein synthesis is likely to occur in
thalamic axons as it does in other axonal systems, and that local translation is likely to
be important for thalamic axonal responses to guidance cues and other axonal tracts.
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This thesis provides evidence for the existence of many mRNAs in developing thalamic
axons, in particular the mRNA for β-catenin, a molecule with key roles in cell adhesion
behaviour and the Wnt signalling pathway. The majority of the results presented here
derive from quantitative real time polymerase chain reaction (qRT-PCR) experiments
and in situ hybridisation experiments intended to assess the presence or absence of
mRNAs in developing thalamic axons. In this opening section, the context and
motivation for this work is presented, beginning by placing the work in its overarching
biological context and presenting an overview of the argument of the rest of the chapter.
While great variety can be seen in the body plans of bilateral animals, the genes
which underlie the development of these body plans are highly conserved, with
common genetic regulatory networks determining the overall structure of the embryo
and the position of various body parts (Davidson and Erwin, 2006). For example,
the design of the eye varies considerably across different species, but the position
and initial development of the eye is driven by the same small number of genes in
many species. The Drosophila eye does not develop in the absence of seven critical
genes, the homologues of which are also involved in the development of the mouse
and human eye (Fernald, 2006). The study of development has been greatly enriched
by the ability to link observations from many different species to the same gene or
gene network. For example, McGlinn and Tabin (2006) explore the morphogen Sonic
hedgehog’s role in limb development by discussing studies in human, mouse, chick and
Drosophila; similarly, Olson (2006) describes a gene regulatory network underlying
the development of the heart that is common to simple chordates, reptiles, birds and
1
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mammals.
The development of the brain has also been linked to genes which are common
throughout organisms with nervous systems. The gross divisions of the brain into
forebrain, midbrain and hindbrain are determined by the expression of homeobox
genes such as Otx, Hox and Pax-2/5/8 (Reichert, 2005) and the further differentiation
of each of these divisions also depends on genetic mechanisms. For example, the
rhombomeres of the hindbrain are subdivided by the differential expression of a series
of Hox genes (Kiecker and Lumsden, 2005). Other homeobox genes are crucial for
the development of the forebrain; for example, Emx1 is essential for the development
of the corpus collosum, Lhx5 is required for hippocampal progenitors to differentiate
and the ventral forebrain is not correctly established in the absence of Nkx2-1 (Wigle
and Eisenstat, 2008).
The development of the neocortex (hereafter the cortex) is of particular interest in
this context (see Northcutt and Kaas (1995); Molnár et al. (2006); Abdel-Mannan et al.
(2008) for reviews). The cortex can be divided into areas according to the organisation
and behaviour of neural networks in different parts of the cortex. The differentiation
of these areas requires the patterned expression of developmental genes such as Pax6,
Emx2 and Sp8 (O’Leary and Sahara, 2008; Rash and Grove, 2005). Areas of the
cortex are intimately connected to other organs; for example, the cells of the retina
are connected to the visual cortex via a series of axonal relays, and the visual cortex
is mapped to reflect the topographical organisation of the retina. Therefore, it will
be particularly interesting to compare the gene regulatory networks underlying the
arealisation of the cortex with those underlying the development of related organs of
the body, as it might be expected that their co-development will place constraints on
the evolution of these systems.
For example, Pax6 is one of the critical genes required for the initiation of eye
development (Fernald, 2006) but it is also expressed in a gradient across the cortex
during early brain development, and this gradient is required for the visual areas
of the brain (among other areas) to form correctly (Bishop et al., 2000; Bayatti
et al., 2008). This suggests that the evolution of the eye and visual cortex and the
connections between the two could be investigated by comparing the evolution of
Pax6 with changes in the structure and function of these systems. Therefore the
study of the molecules underlying the development of the cortex and the connections
between the organs of the body and regions of the brain, in addition to its considerable
intrinsic appeal, may have profound implications concerning the function of the brain
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throughout evolution.
The study of the thalamus is significant to this project both due to the central
role of the thalamus in the overall functioning of the brain and due to the internal
patterning of the thalamus itself, which requires explanation from a developmental
perspective. In particular, the bundles of axons which grow from the thalamus to the
cortex, collectively known as the thalamocortical tract, are of critical importance to
understanding the thalamus and brain development in general, because they connect
the cortex to sensory and motor organs via the thalamus and their correct organisation
is crucial to the function of these organs and the organism as a whole.
The particular focus of this thesis is on RNAs in thalamocortical axons. The
existence and functional importance of many RNAs in various axonal systems, while
a controversial subject for many years, is now well established (Alvarez et al., 2000;
Piper and Holt, 2004), although the precise purpose of these locally translated RNAs is
still an open question. It appears that one reason why RNAs were not discovered earlier
in axons is that protein synthesis at the tip of the growth cone is a feature of developing,
but not mature, axons. This makes the thalamocortical tract an ideal system for the
investigation of axonal RNA, as its development has a number of striking features
where the existence of local protein synthesis appears to provide an advantage.
Firstly, the axons of the thalamocortical tract must navigate long distances from
the thalamus to the cortex, responding to the presence of many molecular guidance
cues during their journey. These guidance cues elicit rapid turning responses from the
growth cones of thalamocortical axons, which suggest that the growth cones have some
internal ability to alter their behaviour, which the local translation of intermittently
required RNAs might explain.
Secondly, while all thalamocortical axons follow the same gross path from
thalamus to cortex, when the axons reach the cortex they innervate different cortical
areas according to the thalamic nucleus from which they originated. This indicates that
thalamocortical axons are not all uniform and that growth cones develop and maintain
different identities which enables them to find their various targets. The presence of
different complements of RNAs in these growth cones might explain this behaviour.
However, to date, there has been no investigation of RNAs in thalamocortical
axons. Before the function of RNAs in thalamocortical axons can be investigated,
their presence must be established. This is the core finding which is presented in this
thesis.
The development of the thalamocortical tract will be described in detail in this
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chapter, following the growth of the axons from the thalamus to the cortex, and
presenting the environment which these axons must navigate to reach their targets.
Once this is established, the internal mechanics of growth cones will be explored, in an
attempt to explain their behaviour during brain development. However, before these
core topics can be addressed, they must be put into context. In the next section, some
principles of development are established which are repeatedly referred to in what
follows, including the regulation of transcription and translation, the use of molecular
gradients in development and axon guidance and the mechanisms of cell adhesion.
Following this, the structure, function and development of the thalamus and cortex
will be outlined. At the end of the chapter, the aims and structure of the thesis will be
described in full.
1.2 Principles of development
The development of the thalamocortical tract depends upon some basic mechanisms
common to many aspects of development. In this section, the mechanisms involved
in the control of gene expression and the application of these mechanisms both
to the specification of body parts and the guidance of axons will be introduced.
These mechanisms will be explored in more depth during the later discussions of
the development of the cortex, thalamus and thalamocortical tract and the function
of axonal growth cones.
1.2.1 The control of differential gene expression
Each of the vast number of cells in a eukaryotic organism contains a set of DNA
molecules in its nucleus which comprise the entire genome for that organism.
However, each of the cells expresses only a specific subset of all the proteins which
could be produced from this genome, a subset which differs from cell to cell and which
changes over time as each cell’s environment changes. The production of the right
proteins at the right time is regulated at each stage of the process of transcribing DNA
into RNA and translating RNA into protein.
The protein for a gene is translated from a messenger RNA (mRNA) molecule,
which in turn is transcribed from genomic DNA. The genomic DNA sequence for
a protein-coding gene contains not only the sequence which will be transcribed into
RNA, but also a control region upstream of the mRNA sequence (see Figure 1.1a). This




Figure 1.1: a) Genes contain many regulatory regions which must be bound by a number of proteins,
including transcription factors and RNA polymerase II, in order for transcription to proceed. These
gene control regions govern the spatial and temporal expression of the mRNA for the gene. b)
Nuclear RNA can be spliced into mRNA via four main mechanisms: exons can be skipped entirely,
individual exons can be spliced at alternative 5’ (donor) or 3’ (acceptor) sites, and introns can be
retained. These mechanisms are responsible for roughly two thirds of alternative splicing events;
the remaining third involve more complex mechanisms such as alternative transcription start sites and
multiple polyadenylation sites. c) mRNAs contain 5’ caps, 3’ poly-A tails, open reading frames (ORF)
which are translated into protein, upstream oRFs (uORFs) which normally repress translation, 5’ and 3’
UTRs around the ORF which can bind regulatory proteins and other RNAs such as microRNAs (green
ovals), IRES sites which can be used to initiate cap-independent translation, and secondary structure
elements such as hairpins which affect the mRNA’s protein-binding capabilities. a) taken from Alberts
et al. (2004); b) taken from Kim et al. (2008); c) taken from Gebauer and Hentze (2004).
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control region contains several subregions known as promoter and enhancer regions.
The core promoter region contains a TATA box, a site where several proteins known
as basal transcription factors will bind, which enables the synthesis protein RNA
polymerase II to bind to the DNA and begin transcription of mRNA (Kornberg, 2007).
Other promoter and enhancer regions can be bound by other transcription factors,
which act as switches to turn transcription of the mRNA on or off (Kadonaga, 2004).
This means that the transcription of the downstream sequence requires the binding
of particular transcription factors to the promoter regions. For example, the Homeobox
(or Hox) genes are a set of transcription factors which contain a homeodomain, an
amino-acid motif which binds to DNA at specific promoter sites and can activate
or repress transcription of the genes downstream of the promoter sites (Svingen and
Tonissen, 2006). This mechanism enables the complex regulation of DNA transcrip-
tion. Many genes can be regulated by a single transcription factor, providing all the
genes contain the appropriate binding site for that transcription factor. Alternatively,
a single gene can require binding by many transcription factors, which can enable
very subtle spatial and temporal control of the expression of this gene. Examples of
these methods of regulation will be seen in the rest of this chapter. Many transcription
factors interact during development in complex gene regulatory networks which are
involved in the determination of cell fate and therefore the specification of different
tissues (de Leon and Davidson, 2007).
RNA is initially transcribed in the nucleus of the cell. This nuclear RNA (nRNA)
is not the same as the mRNA which will be translated into protein in the cytoplasm
of the cell. It contains long sequences which are spliced out of the RNA before it is
transported out of the nucleus (see Figure 1.1b). These sequences are known as introns,
because they remain in the nucleus, as opposed to the sequences that form part of the
mRNA, which are known as exons. When the introns in the nRNA are spliced out to
produce mRNA, it is also possible for some selection of exons to take place, which
means many different proteins containing different groups of exons can be produced
from the same genomic DNA (see Kim et al. (2008) for a recent review).
The initiation of most translation in the cell is dependent on the presence of a
cap at the 5’ end of the target mRNA, which is added in the nucleus. This cap is
bound by eukaryotic initiation factor 4E (eIF4E), which is required for translation to
begin (Goodfellow and Roberts, 2008). The 3’ end of mRNA is also modified in the
nucleus, with a poly(A) tail being added which must be bound by PABPC (Poly-A
Binding Protein, Cytoplasm) for the initiation of translation to take place (Kühn and
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Wahle, 2004). Translation initiation can be regulated by interfering with the binding
of eukaryotic initiation factors and poly-A binding proteins.
Around 95-97% of mRNAs are translated via the cap-dependent pathway (Merrick,
2004), while the remainder are translated via sequences within the mRNA that can
be translated directly, which are called internal ribosome entry sites (IRESs) (Komar
and Hatzoglou, 2005). The translation of IRESs requires many of the same proteins
required for cap-dependent translation, but not the cap itself, and so the absence of
eIF4E does not affect this cap-independent translation (see Figure 1.2a).
After splicing and the addition of the cap and poly-A-tail, mRNA is transported
into the cytoplasm where it can be translated by ribosomes, complexes of protein
and RNA which assemble free amino acids into proteins according to the sequence
of the mRNA (Kapp and Lorsch, 2004). An mRNA contains a protein-coding region
as well as regions which are not translated at either end of the molecule, labelled the
5’UTR and 3’UTR (for Un-Translated Region; see Figure 1.1c). These UTRs contain
regulatory sequences which can be bound by proteins and other RNAs such as the
small regulatory RNAs known as microRNAs (Kuersten and Goodwin, 2003; Wu and
Belasco, 2008). These sequences can act in a similar way to promoter regions in DNA,
with multiple microRNAs regulating multiple mRNAs, enabling complex regulation
of mRNA translation to occur.
In particular, the 3’UTR is involved in the localisation of an mRNA to particular
places in a cell, contributing to cell polarity and functional compartmentalisation of the
cell. mRNAs can be packaged in ribonucleoprotein complexes (RNPs) which can be
transported along tracks in the cytoskeleton. The mRNAs are bound by translational
repressors which usually bind to the 3’UTR of the mRNA. When the RNP reaches
a source of protein which can remove the translational repressor, the mRNA can be
translated at this location (see Besse and Ephrussi (2008); see Figure 1.2c/d).
Once an mRNA has been translated into protein, the protein can be modified in
many ways which affect its behaviour and which can deactivate it completely. For
example, proteins can be phosphorylated by protein kinases, which add phosphate
groups to residues in the target protein, causing a conformational change in the
protein which may alter its ability to bind to other proteins; this process can be
reversed by protein phosphatases, which dephosphorylate the target protein (Hunter,
1995). Particular classes of kinases can phosphorylate particular residues; for example,
tyrosine kinases add phosphate groups to tyrosine residues (Hunter, 1998).
Phosphorylation is involved in many cellular processes, and translation is no
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exception (see Figure 1.2b). For example, translation is usually repressed because
eIF4E is bound by unphosphorylated 4EBP, the binding protein for eIF4E. When
4EBP is phosphorylated, it releases eIF4E, which can then initiate translation of capped
mRNAs (Gingras et al., 1999). 4EBP is phosphorylated by a molecule called mTOR,
or mammalian target of rapamycin. In turn, as its name suggests, the phosphorylation
of mTOR is prevented by rapamycin (Hay and Sonenberg, 2004). Unphosphorylated
mTOR cannot phosphorylate 4EBP, which in turn does not release eIF4E, and so cap-
dependent translation is prevented by rapamycin treatment.
In summary, there are multiple mechanisms for controlling the differential expres-
sion of genes which can be used to explain the processes of development. In particular,
the processing and localisation of RNA during transcription and translation is essential
to the selective expression of genes and compartmentalisation of cell function which
therefore makes RNA of particular relevance to the study of developmental problems.
1.2.2 Molecular gradients are involved in many aspects of devel-
opment including axon guidance
A central problem in development is how cells acquire positional information in order
to differentiate correctly. For example, the vertebrate hindbrain is divided into a
series of eight rhombomeres, each with the same underlying structure but also with
different features; for example, different sensory and motor cranial nerves emerge from
different rhombomeres (Lumsden, 1990). What positional information is available
to the neurons in these rhombomeres which causes them to develop the appropriate
nerves?
One major mechanism for identifying positional information is the use of molec-
ular gradients. For example, retinoic acid is expressed posterior to the hindbrain
and diffuses anteriorly, creating a high concentration of retinoic acid in the posterior
hindbrain and a low concentration in the anterior hindbrain (Glover et al., 2006). This
gradient is required for the rhombomeres to differentiate appropriately. In the absence
of retinoic acid, only the anterior rhombomeres (r1-4) develop, spreading out across
the whole length of the hindbrain; as retinoic acid concentration gradually increases,
the remaining posterior rhombomeres gradually differentiate (Gavalas, 2002).
This gradient of retinoic acid is at least in part responsible for the expression of
a series of Hox transcription factors across the hindbrain in an overlapping pattern,
which defines the positions of the rhombomeres (Wilkinson et al., 1989; Fraser et al.,
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1990). For example, HOXB2 is expressed in rhombomeres 2-8, whereas HOXA1
is expressed in rhombomeres 4-6 and HOXB1 is expressed in rhombomere 4 alone
(Kiecker and Lumsden, 2005); cumulatively the combinations of different Hox genes
across the hindbrain confer unique identities on each rhombomere (see Figure 1.3b).
This is an example of a common process in development, shown in Figure 1.3c,
whereby genes are expressed from organiser regions (often at boundaries between
other regions), which creates a signalling gradient across a previously uniform sheet
of cells. This gradient regulates expression of mutually repulsive transcription factors,
causing the cells to take on different identities in different parts of the region. These
regional identities are then sharpened by cell sorting activities. This enables formal
boundary phenotypes to emerge, and these new boundaries can in turn act as organiser
regions.
Genes which induce the formation of patterns, often through graded expression,
are known as morphogens, examples of which include the Hedgehog and Wnt
families, each of which have complex downstream signalling pathways (Kornberg and
Guha, 2007). Many of the proteins in the functioning Hedgehog signalling pathway
are phosphorylated, indicating a role for protein kinases in the regulation of this
pathway (Aikin et al., 2008). In fact, there can be multiple pathways downstream
of these molecules; Wnt proteins act through at least three major pathways, known
as the canonical pathway, the planar cell polarity pathway and the calcium pathway
(Huelsken and Behrens, 2002) and several variants of these pathways have been
discovered (see, for example, Salinas (2007)).
Molecular gradients are also crucial for the guidance of axons to their destinations
during development. As axons grow, they are attracted or repelled by molecular
cues in their environment, which cause them to turn towards or away from the cue.
Classically, there are four families of axon guidance cue molecules: ephrins (Flanagan
and Vanderhaeghen, 1998), netrins (Barallobre et al., 2005), semaphorins (Roth et al.,
2009) and Slits (Hohenester, 2008). While the details of their behaviours differ, the
overall model of their function is the same. The guidance cue is distributed in a gradient
across the growth cones of axons, which causes the axon to turn towards or away from
the source of the cue, or causes the growth cone to collapse completely.
This behaviour is dependent on the presence in the membrane of the growth cone
of an appropriate receptor for the guidance cue. Netrins bind to their receptors DCC
or Unc-5, Slits bind to Robos, semaphorins bind to a range of different molecules
including plexins and neuropilins, and ephrins bind to Ephs (Dickson, 2002). When a
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guidance cue binds to one of its receptors, it triggers downstream activity within the
growth cone, which causes the growth cone to turn or collapse.
The molecular gradient, rather than just the presence of a molecule, is crucial
for these guidance behaviours. For example, axons of cortical explants grow
towards increasing gradients of semaphorin-3C but not towards similar gradients of
semaphorin-3A, and the semaphorin receptors neuropilin-1 and neuropilin-2 must
be expressed in cortical axons for these turning responses to occur (Bagnard et al.,
1998). However, in the presence of uniform distributions or decreasing gradients
of semaphorins, as opposed to increasing gradients, these axons do not respond
differently to the two guidance cues (Bagnard et al., 2000). The responses to
increasing gradients of semaphorin-3C and semaphorin-3A are resilient to changes
in both the absolute concentration of the semaphorins and in the slope of the gradient,
indicating that the growth cones are detecting any increase in semaphorin concentration
regardless of the actual quantity of semaphorin present (Bagnard et al., 2000).
Each guidance cue family contains many members which operate in many different
systems. For example, the ephrins are divided into two subclasses, A and B, and their
receptors, the Eph molecules, are divided into the same two subclasses, to represent
their affinity with the ephrins (Flanagan and Vanderhaeghen, 1998). The Eph receptors
are receptor tyrosine kinases which span the cell surface membrane and are activated
when they are bound by ephrins (Schlessinger, 2000). For example, EphA2, a receptor
for ephrinA signalling molecules, is known to have a role in the development of the
tectal topographic map and in the guidance of spinal commissural axons (Wilkinson,
2001). EphrinA ligands are expressed in a caudal-to-rostral gradient in the tectum and
repulse temporal retinal axons which express EphA receptors. The effects of ephrins
can be widespread; Zhang et al. (2008) identify over 200 proteins in cell cultures whose
expression is significantly changed after stimulation with ephrin-B1. Similarly, over
140 transcripts are differentially expressed in somatosensory cortex in wild-type and
ephrin-A5-deficient mice (Peuckert et al., 2008).
In addition to the classical guidance cue families, many other molecules have
been implicated in axon guidance, including several morphogens such as Hedgehogs
and Wnts (Endo and Rubin, 2007; Sánchez-Camacho et al., 2005; Charron and
Tessier-Lavigne, 2005) and cell adhesion molecules such as N-cadherin and NCAM
(Kiryushko et al. (2004); see below). For example, Wnt4 mRNA is expressed in the
floor plate of the mammalian spinal cord in a decreasing anterior-to-posterior gradient
which attracts commissural axons (Lyuksyutova et al., 2003; Killeen and Sybingco,
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2008), and retinal ganglion cells require Sonic hedgehog signalling both intrinsically
and from the midline to navigate out of the retina in the correct topographical
organisation (Sánchez-Camacho and Bovolenta, 2008).
As morphogens are implicated in axon guidance, so guidance cues are involved
in patterning and compartment formation; for example, ephrins are involved in the
sharpening of boundaries between rhombomeres in the hindbrain (Cooke and Moens,
2002) and in similar cell sorting behaviour in the intestinal epithelium, disruptions
of which can lead to colorectal cancer (Clevers and Batlle, 2006). Therefore the
morphogen and guidance cue labels should perhaps be considered as historical markers
of the first discovered role of a molecule, rather than indicators of a molecule’s entire
range of behaviours. In what follows, many more examples of these behaviours will
be seen to be involved in the development of thalamocortical axons, and the pathways
which are downstream of these molecules will also be described.
1.2.3 Cell adhesion mechanisms are involved in the development
of axons
Axons grow not only in response to molecular gradients but also by adhering to
other cells and axons in their environment. This adhesion appears to operate using
standard cell adhesion mechanisms, which will now be introduced. The involvement
of various cell adhesion molecules in the development of the thalamocortical tract will
be described in Section 1.4.1 and the details of how the cytoskeleton of the growth
cone interacts with cell adhesion molecules will be considered in Section 1.6.2.
Broadly speaking, there are two different ways a cell can anchor itself. It can
bind to another cell or it can attach itself to the extracellular matrix. Cell-cell
adhesion is primarily mediated by molecules called cadherins, whereas cell-matrix
adhesion is mediated by integrins (Shapiro et al., 2007). Cadherins have extracellular,
transmembrane and intracellular domains. The extracellular domains of cadherins
anchored in different cells bind together, forming adherens junctions which connect
the cells. The intracellular domains bind to molecules called catenins, which in turn
bind to the cytoskeletons of the cells. This means that intracellular changes in one
cell can have effects on the cytoskeletons of other cells through their cadherin-based
connections (Redies, 2000).
Cadherins are usually homophilic, which means that they will only bind to
cadherins of the same type and not to different types (Stemmler, 2008). This has clear
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significance for regional specification. If the cadherins being expressed in a group of
cells are the same, they will bind together. If they are different, they will segregate,
forming a divide between different groups. The quantity of cadherin expressed on the
cell surface also has an adhesive effect. Cells expressing more of a certain cadherin on
their surface bind together before cells expressing less of the same cadherin (Duguay
et al., 2003).
These mechanisms are involved in the growth of neurites (Kiryushko et al., 2004).
For example, if N-cadherin is inhibited in vivo, growth of retinal axons is severely
impaired (Riehl et al., 1996); also, in vitro assays on cerebellar neurons show that
neurite length increases with N-cadherin concentration (Doherty et al., 1991). As
noted above, the specific functions of cell adhesion molecules in the development of
thalamocortical axons will be returned to in later sections.
With these basic concepts established, it is now possible to turn to their application
in the development of the cortex, the thalamus, and the thalamocortical tract.
1.3 The cortex and the thalamus
In this section, an interest in the development of the thalamocortical tract will be
justified by considering the structure and function of the cortex and the thalamus, the
relationships between them, and their importance to the overall function of vertebrate
organisms (see Figure 1.4 for an overview). The development of both thalamus and
cortex will also be reviewed, so that the development of the thalamocortical tract can
be put into context.
1.3.1 The structure and function of the cortex
Much of the processing required for mammals to detect and respond to features of
their environments is carried out by the cerebral cortex. The cortex can be divided into
areas and layers on anatomical grounds by staining of patterns of cells and fibres (see,
for example, Caviness Jr. (1975) for a description of the architectonic map of mouse
cortex). These divisions correlate with differences in function, which can be identified
by, for example, ablating particular cortical areas and observing functional defects
(see Phillips et al. (1984) for a history) or by using imaging techniques to correlate
behaviour with activity in cortical areas (see Op de Beeck et al. (2008) for review).
The cortex is segregated into frontal, temporal, parietal and occipital lobes, each of
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Figure 1.4: Sensory organs map their output to the cortex via the thalamus. A) The output of different
modalities is transmitted to modality-specific nuclei of the thalamus and to areas of the cortex via
axonal tracts. B) In the mouse, there are separate cortical areas for the initial processing of visual
(V1, V2), auditory (A1), somatosensory (S1, S2) and motor (M1, M2) information. C, D) Cortical
areas contain mappings of their input, which can vary greatly between modalities. Areas can be mapped
topographically, as the whiskers of the mouse are topographically mapped in somatosensory cortex (C),
or by feature, as the photoreceptors of the retina are mapped in ocular dominance columns in V1 (D),
reflecting input from ipsilateral and contralateral eyes. E) The dorsal lateral geniculate nucleus (dLGN)
projects axons to layer IV of V1 (blue), whereas the ventrobasal nuclei (VB) project axons to S1 (red).
These axons also project branches into layer VI of the cortex and the thalamic reticular nucleus (TRN).
Corticofugal axons project from layer VI to the thalamus (purple) and from layer V to the cerebral
peduncle (CP, green). wm, white matter; CPU, caudate putamen; GP, globus pallidus; IC, internal
capsule. a,b,e) taken from López-Bendito and Molnár (2003); c,d) taken from Lübke and Feldmeyer
(2007).
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which contains several functional areas. There are a number of primary areas which
are functionally related to the processing of sensory and motor information (see Figure
1.4). For example, there is a topographic mapping of the pattern of the photoreceptors
in the retina within an area of cortex in the occipital lobe which is labelled V1, and
this area responds to changes in visual input (Huberman et al., 2008). Similarly, the
whiskers on the face of a mouse are each connected to groups of neurons shaped into
barrel-like structures, which are topographically organised to match the pattern of the
whiskers. These barrels are required for the processing of somatosensory information
from the whiskers (Lübke and Feldmeyer, 2007). These cortical areas have been
conserved throughout mammalian evolution, although their topographic organisations
are different depending on the particular sensory apparatus of each species (Krubitzer,
1995).
There are also a number of secondary areas which do not process sensory
information directly but which primarily receive inputs from other cortical areas.
Primates and, in particular, humans have much larger prefrontal and temporal lobes
than other mammals, and these lobes are mostly involved in secondary processing
(Kaas, 2005). These regions can be restricted to complex processing of one sensory
modality; for example, the output of V1 is processed by many other areas of the brain
which focus on particular features of visual information such as colour or direction
of motion (see Wandell et al. (2007) for a review of human visual areas). However,
there are also many association areas, particularly in the frontal cortex, which integrate
information from many other cortical areas and have been linked to behaviours such
as abstract thought and action selection (see Badre (2008) for review).
The cortex does not appear to be split into repeating segmented modules across
its surface as the rhombomeres in the hindbrain are (Wilkinson et al., 1989; Fraser
et al., 1990). The cortex is much more diverse, with areas of varying sizes, with much
less well defined cell lineage restriction boundaries and many very different patterns
within each cortical area, such as barrels in mouse somatosensory cortex and ocular
dominance columns in visual cortex (Larsen et al., 2001; Chambers and Fishell, 2006).
However, the same basic mechanisms appear to operate in the cortex as are found in
other areas during development (see Figure 1.3 and Kiecker and Lumsden (2005)),
with the expression of molecular gradients leading to the differentiation of cortical
areas. Specific examples of gradients acting to form areas of thalamus and cortex will
be discussed in Sections 1.3.3 and 1.3.4.
Chapter 1. Introduction 17
1.3.2 The structure and function of the thalamus
The thalamus is a region of the diencephalon which is central to the functioning of the
brain as a whole system and as a series of specialised subsystems, and therefore the
development of the thalamus itself and its connections with other areas of the brain is
of great interest. The thalamus has been classically divided into three main parts; the
dorsal thalamus, the ventral thalamus and the epithalamus (see Figure 3.2). The dorsal
thalamus in turn is a collection of nuclei, each of which has structural and functional
identifying marks (Jones (2007), Sections 3.1-3.4). Recently, it has been recommended
that the dorsal thalamus is renamed the thalamus and the ventral thalamus is renamed
the prethalamus (Puelles and Rubenstein, 2003). This convention will be followed
from this point onward.
There is a simple model of thalamic function which runs as follows. Almost all
input to the cortex first passes through the thalamus (Sherman and Guillery (2006),
Chapter 1). Sensory and motor systems of the body send afferent connections to
particular nuclei of the thalamus, which in turn sends connections to particular areas
of the cortex (see Figure 1.4e). For example, the retina projects axons which form
connections with the lateral geniculate nucleus, one of the nuclei of the thalamus,
which in turn forms connections with V1 and other visual areas of the cortex
(Huberman et al., 2008), whereas auditory information is passed to auditory cortex via
the medial geniculate nucleus (Winer and Lee, 2007), and somatosensory information
is passed to somatosensory cortex via the ventrobasal nuclei (Hand and Morrison,
1970; Inan and Crair, 2007). The thalamocortical tract is the collection of axons
which project from the thalamus and innervate the cortex. There is a corresponding
corticothalamic tract of axons which project from the cortex and innervate the
thalamus.
This simple model has been elaborated over the years as it has become possible to
investigate the anatomy of the thalamus, cortex and their connections in ever increasing
detail (Percheron et al., 1996). For example, Jones (1998) proposes that in primates,
many thalamic nuclei project diffuse connections to many different cortical areas,
based on a group of thalamic cells which are immunoreactive to calbindin and which
project to many areas of cortex, although this feature may be limited to primates
as these calbindin-reactive cells could not be detected in rat thalami. Also, some
single axons (but not all axons) from one nucleus can produce several branches which
innervate different cortical areas (see, for example, Birnbacher and Albus (1987)).
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Indeed, it increasingly appears that, although there are many connections between
cortical areas, the thalamus also has a role to play in communication from cortical
area to cortical area, with corticothalamic projections transmitting information to the
thalamus which is then transmitted by the thalamus to other cortical areas (see Cudeiro
and Sillito (2006) and Sherman and Guillery (2006) for full reviews).
These insights have led to a re-evaluation of the importance of the thalamus. In
terms of sheer quantity of connections, it appears that the number of corticocortical
connections dwarfs the number of thalamocortical connections (for example, Essen
(2005) notes that in the primate visual system there is a 20-25-fold greater number
of connections between visual areas V1 and V2 than between the lateral geniculate
nucleus and V1). However, the fact that all sensory and motor systems project to the
thalamus and that the thalamus communicates with all cortical areas in both directions
has led to an increase in the study of the roles of thalamus in such general subjects
as attention (McAlonan et al., 2008), memory (Mitchell and Gaffan, 2008) and even
consciousness (Schiff, 2008).
Despite the complexity of the connections between thalamus and cortex, it remains
the case that the thalamus has an internal organisation which is related to cortical
organisation in a complex but reliable fashion. This raises a number of developmental
questions. Firstly, how are the thalamic nuclei and cortical areas defined? Are the
kind of genetic mechanisms which define cortical areas also the cause of thalamic
segregation? Secondly, how do the thalamocortical axons traverse the long distance
from the thalamus to the cortex, crossing several areas of the brain and requiring a
number of changes of direction? Thirdly, how do the axons from particular nuclei make
specific connections with related cortical areas? These questions will be addressed in
the following sections.
1.3.3 The development of the thalamus
The thalamus, cortex and thalamocortical pathway develop during overlapping periods
in mouse embryonic development; the neurons of the thalamus proliferate between
E10 and E16 (Angevine, 1970); the cortex forms between E11 and E19 (Dehay and
Kennedy, 2007) and the thalamocortical projection grows from the thalamus to the
cortex between E11 and E18 (Deng and Elberger, 2003). How does this overlap in
time bear on the developmental questions posed above? How interdependent are these
systems?
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The early brain is differentiated into the prosencephalon (forebrain), the mesen-
cephalon (midbrain) and the rhombencephalon (hindbrain); the thalamus and cortex
both develop from the prosencephalon (Kiecker and Lumsden, 2005). However,
before this occurs the prosencephalon is further differentiated into the telencephalon
and diencephalon (Puelles and Rubenstein, 2003). The cortex, basal ganglia and
hippocampus develop from the telencephalon whereas the thalamus, epithalamus and
pretectum develop from the diencephalon (Bertrand and Dahmane, 2006). Therefore
the cortex and thalamus develop separately in the period before they are connected by
the thalamocortical tract. These separate developmental processes are now described.
The developing diencephalon (reviewed by Lim and Golden (2007)) begins to
segregate into three prosomeres (p1-3) at E10.5 in the embryonic mouse (Wolf et al.,
2001); see Figure 1.3a). Prosomere p1 becomes the pretectum, p2 becomes the
thalamus and the epithalamus and p3 becomes the prethalamus and eminentia thalami
(Puelles and Rubenstein, 2003). Prosomeres p2 and p3 are separated by the appearance
of the zona limitans intrathalamica (ZLI), a region whose position is determined by
expression of Lrrn1 (Andreae et al., 2007), Otx1l and Otx2 (Scholpp et al., 2007)
and which requires the secretion of the morphogen Sonic hedgehog (Shh) from the
basal plate for its formation (Zeltser, 2005). The boundaries of the ZLI are defined
both anteriorly by fezl, a protein containing a zinc finger DNA-binding domain which
is expressed from the rostral diencephalon and is required for correct formation of
the prethalamus (Hirata et al., 2006; Jeong et al., 2007), and posteriorly by Irx1b
(Scholpp et al., 2007). Once formed, the ZLI expresses Shh independently of its basal
plate expression, and it is this source of Shh which causes p2 and p3 to differentiate
into thalamus and prethalamus (Vieira and Martinez, 2006). For Shh to induce the
formation of thalamus and prethalamus the transcription factor Irx3 must be expressed
in both of these regions (Kiecker and Lumsden, 2004).
The progenitor cells which give rise to the thalamus can be identified at E10.5-
E11.5 by expression of Olig3, Ngn1 and Ngn2 (Vue et al., 2007). The homeodomain
transcription factors Hoxa1, Hoxd2 and Pax6 are also expressed in p2 and p3 at this
time (Wolf et al., 2001). Vue et al. (2007) show that there are opposing gradients
of Dbx1 and Olig2 throughout the same cells at this time, which indicate that these
cells are already heterogenous before the thalamus differentiates into nuclei. Angevine
(1970) shows that thalamic cells are generated between E10.5 and E16.5 but that
the cells of different nuclei proliferate at different times; for example, the cells of
the lateral geniculate nucleus proliferate between E10.5 and E14.5. Postmitotic cells
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Figure 1.5: a) The mRNAs for Lhx2 (A-C), Lhx9 (D-F), Gbx2 (G-I) and Ngn2 (J-L) are differentially
expressed in dorsal thalamus (dTh) at E14.5, along both medial to lateral and rostral to caudal axes.
(A,D,G,J) The cross, asterisk and double-headed arrow in J indicate medial strips of differential
expression. The arrows show expression of Lhx9 and Ngn2 but not Lhx2 and Gbx2 at the site
of the laterodorsal nucleus. (B,E,H,K) Differential expression of the four mRNAs can be seen at
the sites of the lateral posterior nucleus (arrows), dorsal lateral geniculate nucleus (asterisks) and
ventroposterior nucleus (VP). (C,F,I,L) Differential expression can also be seen in the peripeduncular
nucleus (arrowheads) and the ventral medial geniculate nucleus (asterisks). Scale bar, 200µm. b)
Gradients of Emx2 and Pax6 are expressed across the cortex during development. In Emx2 and Pax6
loss-of-function mutants, the area organisation of the cortex is shifted caudally in the case of Emx2
and rostrally in the case of Pax6. c) Cortical layers develop from E11 to P8 in the mouse. Cortical
neurons migrate from the ventricular zone (VZ) and subventricular zone (SVZ) into the preplate (PP)
from E11. The preplate differentiates into the marginal zone (MZ), cortical plate (CP), subplate (SP) and
intermediate zone (IZ). The layers of the cortical plate then form inside out, from layer VI to layers II/III.
Thalamocortical axons innervate the cortex from E15 onwards, pausing in the subplate for several days
and then forming synapses with neurons in layer IV postnatally. a) taken from Nakagawa and O’Leary
(2001); b) taken from O’Leary and Nakagawa (2002); c) taken from López-Bendito and Molnár (2003).
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initially form into clusters known as pronuclei; the final segregation of nuclei into
fully functional units is not complete until the first few days after birth (Jones (2007),
Section 6.4).
It may be that the differential expression of genes in the early thalamus is sufficient
to determine all the thalamic nuclei. Nakagawa and O’Leary (2001) shows that
Lhx2, Lhx9, Gbx2 and Ngn2 are expressed in distinct but overlapping patterns in the
thalamus which match the locations of several thalamic nuclei (see Figure 1.5a), and
that these genes are expressed from the time progenitor cells become post-mitotic until
the nuclei are fully differentiated (although the role of Lhx2 has been questioned; see
Section 1.4.2).
For example, the transcription factor Pax6 is involved in the development of the
thalamus and the growth of the thalamocortical tract. In Small eye mice, in which
Pax6 is non-functional, the thalamus forms but does not differentiate correctly, as
expression of region-specific genes such as Nkx2.2 and Lim1/Lhx1 is disrupted (Pratt
et al., 2000). There is also disruption of the expression of the cell adhesion molecule R-
cadherin, which is usually co-expressed with Pax6 (Stoykova et al., 1997). R-cadherin
can rescue the innervation of the thalamus by postoptic commissural axons (Nural and
Mastick, 2004), a behaviour which is abnormal in Pax6-/- knockout mice (Andrews
and Mastick, 2003).
Similarly, the neurotransmitter serotonin influences thalamic development, as its
presence enhances neurite outgrowth in E15.5 thalamic explants (Lotto et al., 1999;
Persico et al., 2006). There is differential expression of serotonin receptor variants
across the thalamus at this stage, with 5-HT1A and 5-HT1D being expressed across the
whole thalamus but 5-HT1A being more strongly expressed dorsally and 5-HT1F being
more strongly expressed ventrally (Bonnin et al., 2006).
It is not only the presence, but also the quantity, of gene expression that determines
the patterning of the thalamus. Gbx2, for example, is expressed throughout the
thalamus during development but shows higher levels of expression in some regions
than in others (Martinez-de-la-Torre et al., 2002). This effect can also be seen after the
nuclei have differentiated; for example, the cadherins R-cadherin and N-cadherin are
expressed across the thalamus at P1 but with varying levels of expression in different
nuclei (Obst-Pernberg et al., 2001). As noted in Section 1.2.3, this causes the cadherins
with similar quantities of expression to bind together, closely associating cells within
nuclei while separating cells from different nuclei. In addition, there are areas where
the mRNA for one of these cadherins is present but the protein is not; both R-cadherin
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and N-cadherin mRNA can be found in the lateral geniculate nucleus but the translated
proteins are not (Obst-Pernberg et al., 2001), indicating that the expression of protein
is regulated post-transcriptionally in the postnatal thalamus.
Differential gene expression in the thalamus is required for thalamic afferents to
form appropriate topographic mappings with thalamic nuclei. For example, there are
gradients of ephrin-A2 and ephrin-A5 mRNA and protein across the lateral geniculate
nucleus, which, if removed, cause retinal afferents to spread diffusely across the LGN
rather than forming a tight topographic mapping of the cells of the retina (Feldham
et al., 1998; Lyckman et al., 2001).
Other molecules including Fgf8 (Kataoka and Shimogori, 2008), Math4a, Dlx5
(González et al., 2002) and Frizzled5 (Liu et al., 2008) have been implicated in the
differentiation of nuclei and many more studies are required before a full account
of the formation of nuclei can be given. However, in principle there is no reason
why patterning of transcription factors and secreted morphogens could not completely
account for the segregation of thalamic nuclei. The patterning of the nuclei themselves
is another matter; for example, the lateral geniculate nucleus is separated into layers,
with retinal ganglion cells from each of the two eyes innervating alternate layers, and
this segregation requires spontaneous firing of retinal neurons (Shatz and Stryker,
1988). Such activity-driven refinements of thalamic cells may well influence the
behaviour thalamocortical axons; however, the innervation occurs late in embryonic
development (in animals such as cat and monkey) or postnatally (in mouse and ferret)
(Chalupa, 2007), by which time the thalamocortical axons have already reached the
cortex, and so innervation of the thalamus is unlikely to play a role in the growth of
thalamocortical axons to the cortex.
1.3.4 The development of the cortex
In the mouse, the cells of the cortex begin to proliferate from the ventricular zone
which lines the cerebral ventricles at E10.5, the same time as thalamic cells begin
to proliferate, and continue to proliferate from this region until E18.5 (Dehay and
Kennedy, 2007). From E18.5 onward, progenitor cells begin to develop into glial cells
rather than neurons (Levers et al., 2001). Between E11.5 and E13.5, the preplate and
subventricular zone form above the ventricular zone and the preplate is then split into
two regions, the marginal zone and the subplate, by cells which form the cortical plate.
The cortical plate, which will contain the six layers of the mature cortex, develops
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between E13.5 and the first week of birth (see Figure 1.5c).
The cortical layers develop outward from the ventricular zone and subventricular
zone, with layer VI cells proliferating from E11.5 and populating the cortical plate until
E16.5, layer V cells doing the same between E12.5 and E16.5, layer IV cells between
E14.5 and E17.5 and layer II/III cells between E15.5 and E18.5 (Polleux et al., 1997;
Kriegstein and Noctor, 2004). Cortical areas emerge as the cortical layers form. Early
cortical neuroblasts begin to take on areal identities as early as between E10.5 and
E12.5 and areas continue to be refined until at least E18.5 (Mallamaci and Stoykova,
2006).
Many genes have been implicated in the processes of cortical lamination and
arealisation. Molyneaux et al. (2007) summarises evidence of the expression of 66
genes during cortical lamination, with genes showing expression in a single layer
or multiple layers and expression changing over time. While far fewer genes have
been linked to arealisation than lamination so far, it appears the processes involved
are similar to those seen in the thalamus, where rather than one gene being expressed
for each area, overlapping domains of expression of individual genes create a pattern
of regions which express unique combinations of genes (Rash and Grove, 2005). As
development progresses, the behaviour of different regions of the cortex can be related
to graded and overlapping patterns of gene expression.
In the last decade, several secreted ligands, including several Fgfs, Bmps and
Wnts (Cholfin and Rubenstein, 2008; Grove and Fukuchi-Shimogori, 2003), and
transcription factors, including Emx1, Lhx2 and TBr1 (Donoghue and Rakic, 1999b),
Emx2 (Hamasaki et al., 2004), Pax6 (Stoykova et al., 1997), Foxg1 (Pratt et al., 2002),
COUP-TFI (Faedo et al., 2008) and Sp8 (Cholfin and Rubenstein, 2008) (see O’Leary
et al. (2007) for review), have been identified which are required for the main cortical
areas (V1, A1, S1 and M1) to form correctly (O’Leary and Sahara, 2008).
For example, the transcription factor Emx2 is expressed in a posterior-medial to
anterior-lateral gradient across the telencephalon throughout corticogenesis (see Figure
1.5b); overexpression of Emx2 causes the posterior cortical area V1 to grow in size
whereas the anterior area M1 shrinks. In heterozygous Emx2 knockout mice, where
Emx2 is downregulated in the cortex, the reverse happens, with V1 shrinking in size
and M1 expanding (Bishop et al., 2000; Hamasaki et al., 2004). In homozygous
Emx2-/- knockout mice, a similar shift of areas is seen, with posterior-medial areas
reduced and anterior-lateral areas increased in size (Mallamaci et al., 2000). This
shows that the size of cortical areas can be regulated by the level of expression of
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transcription factors.
Similarly, in Pax6 conditional knockouts, where the expression of Pax6 in the
juvenile cortex is abolished but its expression elsewhere in the brain is normal, the
cortex is substantially reduced in size and areal markers such as Id2 and EphA7 show
that posterior areas of the brain are smaller but anterior areas are larger than in juvenile
wild-type animals (Piñon et al., 2008). However, although areas differ in size, they
form in their usual pattern. This indicates that Pax6 expression in the cortex does not
intrinsically affect cortical boundary formation or thalamocortical connectivity.
The differential graded expression of Emx2 and Pax6 and the cell adhesion
molecule Cadherin-6 (Cadh6) can be related to differences in cortical axon growth
behaviour. Bellion and Métin (2005) dissected a dorsal area of E12.5 mouse cortex
with strong Emx2 expression, weak Pax6 expression and no Cadh6 expression and
compared it to a lateral area of the cortex with weak Emx2 expression, strong
Pax6 expression and strong Cadh6 expression. The dorsal cortex projects long,
fasciculated corticofugal axons, whereas the lateral cortex projects shorter, more
diffuse corticofugal axons. This behaviour is not dependent on the position of
the cortical areas, because the same behaviour is observed when both tissues are
transplanted to the pallial-subpallial boundary, when the tissues are grown in culture,
and when dissocated dorsal or lateral cells are grown in culture (Bellion and Métin,
2005). This behaviour is therefore likely to be dependent on the expression of different
proteins in these tissues such as Emx2, Pax6 and Cadh6.
Genes are not only expressed in gradients across the cortex but also specifically
within individual cortical areas and layers, as can be shown by the Eph receptor
molecules, which are expressed selectively in cortical areas and layers in the macaque
(Donoghue and Rakic, 1999b,a). For example, EphA6 is restricted to layer VI of the
cortical plate in the visual system. This patterning appears to be tissue-autonomous,
as expression of the EphA receptors is the same in wild-type cortex, cortical explants
grown in vitro and in Mash-1 knockout mice, where no thalamocortical connections
are made (Yun et al., 2003). However, the expression of the Eph ligand ephrin-A5 did
change in cultured cells and Mash-1 knockout mice, suggesting that this ligand may
regulated by factors extrinsic to the cortex (Yun et al., 2003).
As with the development of the thalamus, although the precise mechanisms
and genes are so far poorly understood, there is no a priori reason why cortical
areas could not entirely be specified by genetic regulatory networks intrinsic to the
cortex. However, it will become clear in what follows that extrinsic factors, such as
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thalamocortical innervation, are involved in some aspects of cortical development.
1.4 The development of the thalamocortical tract
The thalamocortical tract is the fundamental pathway for the transmission of sensory
and motor information to the cortex. The axons within the tract form connections
between the nuclei of the thalamus and the areas of the cortex in complex patterns
which are not fully understood. In this section, the formation of this tract and its
relevance to brain development in general will be explored, demonstrating the variety
and complexity of the behaviour of thalamocortical axons during their development.
In what follows, the growth of thalamocortical axons from thalamus to cortex, the
topographical organisation of these axons as they grow, and the innervation of the
cortex by these axons will be discussed in detail.
1.4.1 The growth of the thalamocortical tract to the cortex
While the cells of the thalamus are proliferating and differentiating to form nuclei,
they begin to project axons which will grow towards and innervate the cortex. These
axons (which are projected from 80-85% of lateral geniculate nucleus cells and 99%
of the cells in the rest of the thalamus in rat and mouse (Arcelli et al., 1997)) have to
make several changes of direction and navigate a number of obstacles and intermediate
targets in order to reach their final destination in the cortex (see López-Bendito
and Molnár (2003) and Price et al. (2006) for reviews). The axons grow towards
the hypothalamus, turn laterally, cross the boundary between the diencephalon and
telencephalon, travel across the ventral telencephalon, and cross the boundary between
the subpallium and pallium, after which they innervate the cortex, forming synaptic
connections with neurons in layer IV of the cortex. This journey will now be described
in detail.
1.4.1.1 Growth of the thalamocortical tract from the thalamus to the diencephalic-
telencephalic boundary
At E12.5, thalamic cells begin to project axons out of the thalamus (see Figure
1.6). These axons grow to cross the thalamic reticular nucleus (TRN), which lies
ventral to the thalamus, projecting branches into the TRN as they cross (Pinault,
2004). The axons then proceed ventrally but turn laterally before reaching the
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Figure 1.6: a) Thalamocortical axons are guided away from the hypothalamus and towards the internal
capsule by expression of Slit1 and Slit2 in the hypothalamus and anterior preoptic area (POa), which
requires the axons to express Robo1 and Robo2 in their growth cones. Corticofugal axons grow to the
thalamus and the cerebral peduncle (cp). b) In addition to repulsive guidance cues in the hypothalamus
and attractive guidance cues in the ventral telencephalon, ventral telencephalon neurons project axons
to the thalamus which provide a scaffold for thalamocortical axons. c) At E12.5, the medial ganglionic
eminence (MGE) is not permissive to thalamocortical axons (purple shading); neurons from the lateral
ganglionic eminence (LGE) migrate to the MGE and provide a corridor for thalamocortical axons to
grow through from E13.5 onwards. This requires Nrg1-CRD expression (blue shading) and Nrg1-Ig
expression (green shading). NCx, neocortex; Str, striatum; dTh, dorsal thalamus; GP, globus pallidus.
a) taken from López-Bendito et al. (2007); b) taken from Braisted et al. (1999); c) taken from López-
Bendito et al. (2006).
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hypothalamus. At E13.5, the axons cross the boundary between the diencephalon
and telencephalon (diencephalic-telencephalic boundary, or DTB) and begin to cross
the ventral telencephalon through a region called the internal capsule (Molnár et al.,
2003). Why do thalamic axons destined for cortex turn and cross the DTB rather than
innervate the hypothalamus?
As indicated in Section 1.2.2, thalamocortical axons are attracted to and repelled
by molecular guidance cues, which are produced by nearby regions of the brain and are
usually expressed in gradients. The presence of these molecular signals can be inferred
because, for example, thalamocortical axons cultured in vitro fail to grow towards
explants of hypothalamus but do grow towards explants of ventral telencephalon,
indicating that some secreted molecule is influencing axon growth by repelling axons
away from the hypothalamus (Braisted et al., 1999).
It was subsequently shown that two molecules from the Slit guidance cue family,
Slit1 and Slit2, are expressed in the hypothalamus as the thalamocortical axons grow
and that in both Slit2-/- single knockout and Slit1/Slit2-/- double knockout mice
some thalamocortical axons are able to grow into the hypothalamus (Bagri et al.,
2002). This indicates that Slit1 and Slit2 are repulsive guidance cues, influencing
the thalamocortical axons to turn towards the ganglionic eminences. In addition, the
receptors for Slits, Robo1 and Robo2, have also been implicated in thalamocortical
axon guidance. Both Robo1 and Robo2 are expressed in thalamocortical axons, and
the thalamocortical axons in a Robo1/Robo2-/- double knockout exhibit the same
abnormal behaviour as the Slit1/Slit2-/- double knockout described above (López-
Bendito et al. (2007); see Figure 1.6a).
This indicates that both the expression of Slit from the hypothalamus and the
expression of Robo receptors in the thalamocortical axons is required for the axons
to grow correctly. In fact, it appears that Robo2 rather than Robo1 is essential for
correct growth, as axons in a Robo2-/- single knockout mouse behave the same as
the axons in both the Slit and the Robo double knockouts, whereas in two different
Robo1-/- knockouts (Andrews et al., 2006; López-Bendito et al., 2007) thalamocortical
axons appear to follow their normal route, although is appears that the thalamocortical
projection is further advanced into the cortex at E14.5 than in wild-type mice (Andrews
et al., 2006).
Thalamocortical axons therefore require a molecular guidance cue to turn away
from the hypothalamus, but it appears that they require the guidance of other axons
to cross the DTB. Developing axonal projections can be traced by injecting crystals
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of fluorescent carbocyanine dyes such as DiI, DiA and DiO. Crystals can be injected
at the point of axonal termination, where the dye will spread towards the projecting
cell (retrograde tracing) or at the projecting cell, where dye will spread along the axon
towards the growth cone (anterograde tracing) (Godement et al., 1987). When DiI was
injected into axon terminals in the thalamus of E14, E15 and E16 rat brains, the dye
retrogradely traced projections back to cells in the thalamic reticular nucleus and the
internal capsule (Molnár and Cordery, 1999), showing that these areas project axons
into the thalamus (see Figure 1.6b).
The region of the internal capsule which projects axons into the thalamus is
missing in Mash1-/- knockout mice, and thalamocortical axons are unable to cross
the DTB (Tuttle et al., 1999). Similarly, in Emx2-/- knockout mice, internal capsule
cells disperse and fail to project axons into the thalamus, causing thalamocortical
axons to project disparately into the ventral telencephalon (López-Bendito et al.,
2002). This indicates that internal capsule cells must project axons to the thalamus
for thalamocortical axons to enter the internal capsule. Also, netrin-1 is expressed
in the ventral telencephalon in wild-type animals, and in netrin-1-/- knockout mice
the internal capsule is abnormally narrow and the thalamocortical axon projection is
reduced (Braisted et al., 2000). Therefore it appears that molecular cues are required
for thalamocortical axons to cross the DTB correctly, at least in part because these
cues regulate cells of the internal capsule, which are required to project axons for
thalamocortical axons to fasciculate onto and grow along.
Wnt signalling factors (see Section 1.2.2) have been indirectly implicated in this
stage of thalamocortical development. Wnt ligands bind to the members of the Frizzled
receptor family (Bhanot et al., 1996), and Frizzled-3-/- knockout mice show a complete
loss of the thalamocortical and corticothalamic tracts (Wang et al., 2002). In these
mice, axons growing out of the thalamus are unable to enter the internal capsule and
instead grow posterior to the optic tract and enter the contralateral side of the thalamus
(Wang et al., 2006).
The complete lack of thalamocortical and corticothalamic connections is also seen
in mice without Celsr3, a molecule which is co-expressed with Frizzled-3 in the cortex,
thalamus and striatum during brain development (Tissir et al., 2005). In Celsr3-/-
knockout mice, thalamocortical connections cannot cross the DTB, and when Celsr3
is inactivated in Dlx5/6-expressing cells alone, which are found in the ganglionic
eminences, thalamocortical axons are unable to enter the internal capsule and instead
grow aberrantly into the basal telencephalon (Zhou et al., 2008).
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This is significant because Frizzled-3 and Celsr3 are the homologues of the
Drosophila genes frizzled and flamingo respectively, both of which are involved in the
planar cell polarity pathway (Goodrich, 2008), one of at least three pathways through
which Wnt signalling operates (Huelsken and Behrens, 2002). It may be that this in-
dicates the planar cell polarity pathway operates during thalamocortical development,
although other planar cell polarity genes such as members of the dishevelled (Dvl), van
gogh-like (Vangl) and prickle-like families are not co-expressed closely with Frizzled-
3 and Celsr3, with Vangl1 and Prickle1 having different expression patterns, Dvl1
having broad expression across the brain, and Dvl3 and Prickle2 having the closest
pattern of expression to Frizzled-3 and Celsr3 (Tissir and Goffinet, 2006).
1.4.1.2 Growth of the thalamocortical tract through the ventral telencephalon
Once the thalamocortical projection has entered the internal capsule in the ventral
telencephalon, the axons travel through the medial ganglionic eminence (MGE) via
a transitory permissive corridor of neurons which is derived from cells from the lateral
ganglionic eminence (LGE) (López-Bendito et al., 2006) and pause at E14.5 when
they reach the boundary between the subpallium and pallium (Molnár and Cordery,
1999). The ganglionic eminences act as an intermediate target for thalamocortical
axons, with cells in the MGE projecting axons to the thalamus which provide a scaffold
for thalamocortical axons as they grow into the internal capsule (Métin and Godement,
1996).
A number of genes have been implicated in the formation of the permissive corridor
of LGE cells (see Figure 1.6c). Two products of neuregulin-1, Nrg1-CRD and Nrg1-
Ig, are expressed in the LGE and cause the LGE and the corridor of LGE cells in the
MGE to be permissive to thalamocortical axons. When these neuregulin-1 isoforms
are absent from these LGE cells, most thalamocortical axons do not cross the MGE
and instead turn caudally towards the hypothalamus (López-Bendito et al., 2006).
In addition, the corridor does not form in the absence of the protocadherin OL-pc,
which is usually expressed in the striatum. The axons of wild-type striatal cells project
through the globus pallidus and cross the DTB, growing adjacent to thalamocortical
axons in the internal capsule. In OL-pc-deficient mice, striatal axons fail to grow
through the globus pallidus and across the diencephalic-telencephalic boundary, the
caudal globus pallidus fails to form and thalamocortical axons are unable to enter the
internal capsule (Uemura et al., 2007). Therefore, similar to the role of axons from
internal capsule cells described in the previous section, the growth of thalamocortical
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axons across the ventral telencephalon appears to require the presence of co-located
striatal axons.
Other molecules have been implicated in this stage of thalamocortical development.
Part of the thalamocortical projection in Sema6A-/- knockout mice does not reach
the cortex and instead grows aberrantly into the amygdala (Leighton et al., 2001).
Sema6A is usually expressed throughout the thalamus during the development of
the thalamocortical projection and so this may be a cell-autonomous effect, although
Sema6A is also expressed in the amygdala during the same period in wild-type animals
and so it may be that the lack of Sema6A in this region disrupts non-cell-autonomous
signalling in the internal capsule (Leighton et al., 2001).
In Pax6-/- knockout mice, many thalamocortical axons do not cross the diencephalic-
telencephalic boundary and others are unable to reach the pallial-subpallial boundary
(Jones et al., 2002; Pratt et al., 2002); cells in the prethalamus and internal capsule
which are thought to project axons into the thalamus and guide thalamocortical axons
(see Section 1.4.1.1) disperse throughout the hypothalamus and ventral pallium, and
cells in the LGE which usually express Pax6 are greatly reduced in number. This lack
of Pax6-expressing cells and aberrant thalamocortical growth can also be seen in Small
eye mice, which have non-functional Pax6 (Kawano et al., 1999; Hevner et al., 2002).
The transient thalamic afferents which grow from the MGE are disrupted in Pax6-/-
knockout mice (Pratt et al., 2002), but this appears to be due to defects in the thalamus
rather than the ventral telencephalon, because the expression of ventral telencephalic
markers such as Mash1, Tbr1, Emx1 and Dlx1 is not affected in Pax6-/- or Small eye
mutants (Pratt et al., 2002; Stoykova et al., 2000), and Pax6 is not expressed in this
region while the transient afferents form (Stoykova et al., 1996). Also, there are other
thalamic afferents, such as the tract of the postoptic commissure, which grow at the
same time as the afferents from the ventral telencephalon and which do not innervate
the thalamus in Pax6 mutants (Nural and Mastick, 2004). This perhaps indicates that
although thalamocortical axons require these transient thalamic afferents as a scaffold
to grow along as they enter the internal capsule, these afferents in turn require signals
from the thalamus to form the appropriate scaffold.
1.4.1.3 Crossing the pallial-subpallial boundary: interaction with corticothala-
mic axons from the subplate
From E13.5 onwards (Auladell et al., 2000), thalamocortical axons reach the pallial-
subpallial boundary (PSPB), a region which is distinctively marked by the expression
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of several genes, Tbr1 and Emx1 expressed in the pallium and Dlx2 and Nkx2.1
expressed in the subpallium, patterns which are conserved in mouse and chick
(Puelles et al., 2000). When thalamocortical axons reach this target, their behaviour
changes. As the axons grow through the internal capsule, their growth cones are small
and simple, their growth is rapid and they spend approximately 80% of their time
advancing, 12% pausing and 8% retracting (Skaliora et al., 2000). In contrast, when the
axons reach the pallial-subpallial boundary, growth cones become large and complex,
the axons begin to project many exploratory side branches, the net growth rate is half of
what it was during internal capsule growth and the axons spend approximately 37.5%
of their time advancing, 37.5% pausing and 25% retracting (Skaliora et al., 2000).
This change in behaviour is most likely due to interactions with corticofugal
axons on the subpallial side of the PSPB (Molnár et al., 1998a). As thalamocortical
axons project to the cortex, so cortical axons are projected to the thalamus, with the
corticothalamic pathway pioneered by axons projected from the subplate (Allendoerfer
and Shatz, 1994). The cortex projects two major axonal tracts; the corticothalamic
projection, which originates in layer 6 and project exclusively to the thalamus,
and the pyramidal tract, which originates in layer 5 and innervates multiple targets
including the pons, superior colliculus and spinal cord (Martin, 2005). These two
projections grow concurrently through the ventral telencephalon and away from the
basal telencephalon (Canty and Murphy, 2008). However, their growth is differentially
regulated; in Nkx2-1-/- knockout mice, corticothalamic axons innervate the thalamus
as normal, but pyramidal axons grow aberrantly into the basal telencephalon, where
Nkx2-1 is normally expressed (Marı́n et al., 2002).
As the medial ganglionic eminence provides a scaffold for thalamocortical axons,
so the lateral ganglionic eminence sends axons towards the cortex and provides a
scaffold for corticofugal axons (Métin and Godement, 1996). This requires the
expression of netrin-1 at the PSPB, without which corticofugal axons are unable to
reach the LGE (Métin et al., 1997).
The development of thalamocortical axons and corticothalamic axons is closely
related, with both groups of axons pausing and intermingling at the PSPB before
progressing to the cortex and thalamus respectively (Molnár and Butler, 2002); see
Figure 1.7b). In the adult, the axons from the two systems form tight bundles which
are spatially ordered across the cortex (Molnár et al., 1998a). When subplate neurons
are ablated in fetal cats, thalamocortical axons from the lateral geniculate nucleus do
not innervate layer IV of the cortex, despite the presence of their target cells, but instead
Chapter 1. Introduction 32
grow through the entire cortical plate and into white matter at the surface of the brain
(Ghosh et al., 1990).
Several studies of gene expression also indicate the importance of the relationship
between subplate neurons and thalamocortical axons. For example, axons which
express the neural cell adhesion molecule L1 innervate areas of the cortex which
express neurocan, which binds L1 in vitro (Fukuda et al., 1997). At E16.5, neurocan
expression is limited to the subplate, and L1-expressing axons will only innervate the
subplate at this age without progressing to the cortical plate (Li et al., 2005). This
behaviour is also observed in the reeler mutant mouse, where the subplate becomes a
‘superplate’ which grows above the cortical plate. L1-expressing axons innervate the
superplate, which they preferentially innervate by growing through strips within the
cortical plate which also express neurocan in these mutants (Li et al., 2005).
Tbr1 is a transcription factor which is expressed in the developing subplate and
cortical layer 6, but not in the thalamus. In Tbr1-/- knockout mice, the development
of the subplate is disrupted and the corticothalamic axonal projection stalls in the
internal capsule and does not progress to the diencephalon (Hevner et al., 2001, 2002).
The thalamocortical projection in these mice enters the internal capsule but does not
cross the PSPB. The thalamocortical and corticothalamic projections intermingle as
in control mice, but they are unable to progress towards their targets (Hevner et al.,
2002). It may be that this misrouting is due to changes in molecular signalling from
the cortex but, as the thalamocortical projection begins to be diverted at the place
where it would usually interact with axons from the subplate, this further indicates that
the thalamocortical axons depend on cortical axonal projections to navigate to their
destinations correctly.
Similarly, in COUP-TFI-/- knockout mice, subplate neurons fail to differentiate
properly and die prematurely, and the majority of thalamocortical axons fail to cross the
PSPB (Zhou et al., 1999). Cortical layer IV is absent in these mice, which may indicate
that cell survival in these regions is dependent on the presence of thalamocortical axon
terminals (Windrem and Finlay, 1991). Axons from ventrobasal nuclei appear to grow
normally through the internal capsule, which suggests that the failure of these axons to
cross the PSPB is due to the lack of subplate neurons and not due to a cell-autonomous
effect in the thalamus. However, such an effect cannot be ruled out because COUP-TFI
is expressed in the developing thalamus as well as the subplate in wild-type animals.
Indeed, it appears that normal growth of the thalamocortical tract is required for
the corticothalamic tract to grow correctly. Gbx2 is a transcription factor which is
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Figure 1.7: a) Left, example of diffusion tractography images taken of human internal capsules at
two different points in the horizontal plane, in this case tracing fibres from the prefrontal cortex
(PFC). Right, segmentation map of images of cortical fibres in the internal capsule, averaged over 11
human individuals. Fibres found in cortical regions were traced back to the internal capsule, where
topographical organisation was evident. The majority of the connections were from the prefrontal cortex
(PFC), and there was considerable overlap between regions. PMC, premotor cortex; ppc, posterior
parietal cortex; Tmp, temporal lobe; Occ, occipital lobe. b) Thalamocortical axons labelled with a DiI
crystal (red) and corticothalamic axons labelled with a DiO crystal (green) in an E15.5 rat. F is a higher
magnification of the region in E marked with an arrow (Scale bars: E, 100µm; F, 10µm). Groups of
axons from each tract bundle together and grow alongside each other. a) taken from Zarei et al. (2007);
b) taken from Molnár et al. (1998a).
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expressed in the developing thalamus but not in the cortex (see Section 1.3.3). In
Gbx2-/- knockout mice, thalamocortical projections enter the internal capsule but fail
to cross the pallial-subpallial boundary; corticothalamic projections also stall in the
internal capsule (Hevner et al., 2002). This indicates that the thalamocortical projection
must form correctly for the corticothalamic projection to reach the thalamus.
1.4.2 Establishing the topography of thalamocortical axons
As discussed in Section 1.3.2, the thalamus is organised into nuclei and the cortex into
areas according to their function, and related thalamic nuclei and cortical areas are
connected via thalamocortical axons. The internal topographic mappings of thalamic
nucleus to cortical area are not simple, with some area mappings being mirror reversals
of their nuclear mappings and others being simple rotations (Adams et al., 1997). This
means that, in the mature brain, the bundle of thalamocortical axons is topographically
organised according to the origin and destination of different groups of axons. Where
and how does this organisation of axons occur? It has emerged over the last decade
that thalamocortical axons are organised when they leave the thalamus, but that they
require further organisation in the ventral telencephalon and by corticofugal axons to
innervate the correct cortical area. In this section, the organisation of axons as they
leave the thalamus and the influence of guidance cues, other axons and the cortex on
thalamocortical organisation will be considered.
1.4.2.1 Thalamocortical axons are topographically organised throughout their
journey
The thalamus must develop normally for thalamocortical projections to reach their
targets. For example, the Wnt coreceptor Lrp6 is essential for the formation of the
thalamus. In Lrp6-/- knockout mice, the zona limitans intrathalamica is disrupted and
thalamic cells do not proliferate correctly, leading to a significant reduction in the
size of the thalamus and a failure of thalamic nuclei to form, although prethalamus
development is normal (Zhou et al., 2004a). Very few thalamocortical axons project
out of the thalamus, as might be expected given the lack of thalamic cells; however,
those that do leave the thalamus terminate in the striatum, indicating that these axons
are able to turn at the diencephalic-telencephalic boundary but are unable to progress
to the pallial-subpallial boundary.
The cortex alone is not sufficient to organise thalamic axons. When dorsal lateral
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geniculate nucleus explants are cocultured with postnatal explants of either visual
cortex or motor cortex, they do not preferentially innervate the visual cortex as they
do in vivo but instead innervate both types of cortical explant (Molnár and Blakemore,
1991). This suggests that the cortex does not guide thalamocortical axons via area-
specific cues, but it may be that prenatal cortex does express such cues but postnatal
cortex does not. However, it may also be that cortical cues are present but that
thalamocortical axons require exposure to intermediate cues in order for them to
respond to cortical cues appropriately.
Indeed, in humans, the topography of thalamocortical axons is broadly preserved
from the time when the axons cross the ventral telencephalon to when they reach the
cortex. By using diffusion tractography to trace thalamocortical (and corticothalamic)
connections from the cortex to the internal capsule in human brains it can be shown that
the topographic organisation of connections in the internal capsule was the same as that
across the cortex, and that this organisation is remarkably consistent across different
individuals, strongly indicating genetic regulation of this organisation long before the
axons reach the cortex (Zarei et al., 2007); see Figure 1.7a). In the following sections,
evidence will be provided showing that there is also topographical organisation of
axons in the internal capsules of mice.
1.4.2.2 Topographical organisation of thalamocortical axons requires molecular
gradients
The topographical organisation of thalamocortical axons which can be observed in the
ventral telencephalon is established by molecular gradients in the thalamus and the
ventral telencephalon. Rostral, medial and caudal regions of thalamus project axons
which preferentially innervate respectively rostral, medial and caudal regions of the
ventral telencephalon both in vivo (observed by DiI tracing) and in vitro, in explant
co-cultures (Seibt et al., 2003). Several proteins have been shown to be required for
this preferential innervation to take place.
Some studies have indicated that the topography of thalamocortical axons is
determined by gene expression in the ventral telencephalon. For example, in Ebf1-/-
and Dlx1/2-/- knockout mice, which appear to have normally regionalised thalami and
cortices but which have abnormal ganglionic eminences, thalamocortical projections
are shifted medially in the cortex, which suggests that regionalisation of the thalamus
itself is not the only influence on the topographical organisation of the thalamus and
intermediate decision points such as the ganglionic eminences have a role to play in
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this organisation (Garel et al., 2002).
Conversely, other studies have claimed a cell-autonomous role for genes expressed
in the thalamus in organising the topography of thalamocortical axons. For example,
neurogenin-2 (Ngn2) is expressed in a high rostral to low caudal gradient in the
thalamus from E13.5 to E15.5, as thalamic axons are emerging and growing through
the ventral telencephalon (Seibt et al., 2003). When rostral thalamic slices from
Ngn2-deficient mice are cocultured with wild-type ventral telencephalon, their axons
innervate a more caudal region of ventral telencephalon than wild-type rostral thalamic
axons (Seibt et al., 2003). This indicates that Ngn2 regulates the topography of
thalamocortical axons in a cell-autonomous way by modulating the responsiveness
of these axons to existing intermediate cues in the ventral telencephalon.
In addition, the neural cell adhesion molecule Close Homolog of L1 (CHL1) is
expressed in a high rostral to low caudal gradient in the developing thalamus and is
also expressed in thalamocortical axons but not in the ganglionic eminences (Wright
et al., 2007). In CHL1-/- knockout mice, the projection of axons from the ventrobasal
nuclei is caudally shifted in the ventral telencephalon and in the cortex, where these
axons innervate visual rather than somatosensory cortex; DiI tracings show that axons
innervating V1 all originate in the lateral geniculate nucleus in wild type animals but, in
CHL1-/- knockouts, V1 is also innervated by axons from the ventroposterior lateral and
ventroposterior medial nuclei, which are among the ventrobasal nuclei (Wright et al.,
2007). Therefore it appears that expression of different genes in both the thalamus,
such as CHL1 and Ngn2, and the ventral telencephalon, such as Ebf1 and Dlx1/2, is
required for correct topographical organisation of thalamocortical axons to take place.
CHL1 forms a stable complex with neuropilin-1, a receptor for Semaphorin-3A.
Both CHL1 and neuropilin-1 are expressed in thalamic axons and Semaphorin-3A is
expressed in a low caudal to high rostral gradient across the ventral telencephalon.
Wright et al. (2007) show that thalamic axons grow abnormally across ventral
telencephalon in mice where neuropilin-1 cannot bind semaphorin-3A, and that CHL1
is required for semaphorin-3A to cause thalamic axons to collapse in culture. This
is further evidence that correct topographic organisation of thalamocortical axons
requires both cell-autonomous gene expression in thalamic axons and intermediate
cue expression in ventral telencephalon (see Garel and Rubenstein (2004) for review).
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1.4.2.3 Topographical organisation of thalamocortical axons requires classical
guidance cues
Corresponding gradients of guidance cues in ventral telencephalon and guidance cue
receptors in thalamus have been seen for members of the classical guidance cue
families the netrins and the ephrins. A high rostral to low caudal gradient of netrin-1
mRNA (de la Torre et al., 1997) has been demonstrated in E14.5 and E15.5 mouse
ganglionic eminences and the lack of this gradient causes those thalamocortical axons
which normally grow to rostral cortex in the wild-type to grow to all regions of the
cortex in netrin-1-/- knockout mice (Powell et al., 2008). This netrin-1 gradient in the
ventral telencephalon is matched by a high rostro-medial to low caudo-lateral gradient
of the netrin-1 receptor DCC in the thalamus, which indicates that thalamocortical
growth cones also express graded quantities of DCC receptors in their membranes.
These results are supported by demonstrations that different parts of the thalamus
have different responses to exposure to netrin-1 (see Figure 1.8). Axons from rostral
regions of the thalamus, with high levels of DCC expression, are repelled by netrin-1,
whereas axons from caudal thalamus, with low levels of DCC expression, are attracted
by netrin-1 (Bonnin et al., 2007). This behaviour is modulated by serotonin receptors
5-HT1B and 5-HT1D (see Section 1.3.3), which have patterns of expression which
overlap with DCC and another netrin-1 receptor, Unc5c. When treated with serotonin,
axons from caudal thalamus are repulsed by netrin-1, rather than attracted, but this
change in behaviour fails to occur when receptor 5-HT1D is blocked by an antagonist
(Bonnin et al., 2007). This study demonstrates not only that axonal responses are in
part determined by the gene expression of their originating cells but also that these
responses can be reversed via expression of other genes.
Dufour et al. (2003) show that at E13.5-E14.5, before the thalamic nuclei can be
identified, a high rostral to low caudal gradient of the RNA for the guidance cue ephrin-
A5 can be found in the ventral telencephalon and a high rostro-medial to low caudo-
lateral gradient of the RNA of the ephrin-A5 receptor EphA4, as well as RNAs for
EphA3 and EphA7 (see Figure 1.8f). In ephrin-A5/EphA4 double knockout mice,
thalamocortical axons grow in a considerably more caudal direction when compared
to wild-type mice, which indicates that the gradients of ephrin-A5 in the ventral
telencephalon and EphA4 in the thalamus influence the topographic organisation of
thalamocortical axons.
Furthermore, thalamocortical axons bind to soluble ephrin-A5 protein (introduced
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in situ), with highest binding activity in rostral regions of the ventral telencephalon,
indicating that not only do the thalamocortical axons contain ephrin-A5 binding
receptors but also that these receptors are differentially expressed in a pattern which
corresponds with gradients of receptors found in the thalamus (Dufour et al., 2003).
This suggests that the organisation of thalamocortical axons is influenced not only by
gradients of guidance cues in the ventral telencephalon but also by the complements
of receptors present in the growth cones of the axons, because different groups of
axons show different binding responses to ephrin-A5 protein and so will have varying
sensitivities to gradients of the protein.
Eph receptors do not simply operate due to their binding of ephrin ligands, causing
activation of kinase signalling, but also because the receptors cluster together, and
that these two behaviours have different functions. Normally, EphA4 kinase receptor
is activated by the binding of ephrin ligands. Egea et al. (2005) show that mouse
mutants which have EphA4 receptors that are kinase active without the presence of
ephrin ligands have defects in thalamocortical axon growth but not in other EphA4-
related behaviours such as midline axon pathfinding across the spinal cord. Also,
when cortical axons from these mice are grown in vitro, their growth cones collapse in
response to ephrin-B3, as do the growth cones of wild-type animals. However, when
the EphA4 receptors in these mutant axons are prevented from clustering together by
blocking the globular domains of the receptors, the mutant growth cones no longer
collapse in response to ephrin-B3 (Egea et al., 2005).
These results demonstrate two separate processes in which EphA4 receptors
mediate axon guidance behaviours, although the thalamocortical role of EphA4
receptors appears to be due to the binding of ephrinA ligands and not to receptor
clustering. Further evidence for the role of ligand binding is provided by Dufour
et al. (2006), who demonstrated that EphA4’s influence on topographic mapping of
thalamocortical axons is dependent on the presence of a tyrosine kinase domain in
EphA4, but not PDZ-binding motif or Sterile-α motif domains, two other non-catalytic
domains with poorly understood functions. Selective mutations of EphA4 with any
one of these domains removed can still be expressed in a gradient across the thalamus,
but only the tyrosine kinase domain mutant mouse has disrupted thalamocortical axon
topography.
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1.4.2.4 Topographical organisation of thalamocortical axons involves interac-
tions with other axonal tracts
All of the above results indicate that gradients in the ventral telencephalon must
be matched by gradients in the thalamus for thalamocortical axons to be correctly
topographically organised. It appears that many of the molecules expressed in these
gradients operate directly by binding to the growth cones of thalamocortical axons
(eg netrin-1, semaphorin-3A). However, it may be that they also act indirectly by
influencing the development of pioneer axon tracts, which thalamocortical axons
fasciculate onto and grow along.
One prominent explanation for the topographical organisation of thalamocortical
axons is the ‘handshake’ hypothesis: as thalamocortical axons fasciculate onto
corticothalamic axons from the subplate and grow along these axons until they reach
the cortex (see Section 1.4.1.3), and as corticothalamic axons originate from different
cortical areas, perhaps thalamocortical axons from each thalamic nucleus fasciculate
onto the corticothalamic axons from the appropriate cortical area for this nucleus
(Molnár and Blakemore, 1995).
Indeed, DiI and DiA labelling of thalamocortical and corticothalamic axon tracts
demonstrates that when the projections meet at the lateral edge of the internal
capsule thalamocortical axons destined for a particular area bundle together with
corticothalamic axons from that area, rather than travel to the area independently
(Molnár et al., 1998a). This is the case even in reeler mice, where the entire cortical
plate forms below the subplate (now a ‘superplate’) and thalamocortical axons still
innervate the correct cortical areas. It appears that thalamocortical axons grow through
the developing cortical plate by following fascicles of ‘superplate’ axons which project
through the cortical plate, remain at the ‘superplate’ for several days and then grow
downward to innervate the cortical plate below the ‘superplate’ (Molnár et al., 1998b).
This supports the case that the corticothalamic projections from each cortical area are
required for thalamocortical axons to grow to their appropriate target area.
Further support for the handshake hypothesis comes from knockouts of the zinc
finger gene fez-like (fezl). In fezl-/- knockout mice, the number of mature subplate
neurons, and therefore the size of the corticofugal projection, is reduced (Hirata et al.,
2004). In addition, the corticofugal projections from the subplate neurons which do
develop are delayed, being unable to cross the pallial-subpallial boundary until E15.5
rather than crossing at E14.5 as they do in the wild-type (Komuta et al., 2007), and so
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failing to provide a scaffold for thalamocortical axons to grow upon.
The number of thalamocortical axons in these mice is reduced and those that do
grow connect with the cortex aberrantly. The aberrant growth of thalamocortical axons
appears to be due to the lack of the corticofugal projection rather than disruption
of gene expression, because the expression of many genes which are related to
thalamocortical axon growth such as Pax6, netrin-1, neuregulin-1, Emx1, Tbr1 and
Gsh2 is unchanged in fezl-/- knockouts (Komuta et al., 2007; Chen et al., 2005).
However, it cannot be ruled out that some other untested gene has been misexpressed
in these knockouts, or that the reduced number of thalamocortical axons has caused
the axon bundle to be disorganised from the time the axons begin to grow out of the
thalamus.
It may be that pioneer axons from internal capsule cells are also involved in
the topographical organisation of thalamocortical axons. The transcription factor
Lhx2 is expressed in the thalamus and cortex during development and influences the
parcellation of these regions into nuclei and areas, but it is also expressed in the
ventral telencephalon (Rétaux et al., 1999; Bulchand et al., 2001). Mice which do
not express Lhx2 have a substantial reduction in the number of internal capsule cells in
the ventral telencephalon near the diencephalic-telencephalic boundary (Lakhina et al.,
2007). As discussed in Section 1.4.1.1, these internal capsule cells project axons which
guide thalamocortical axons across the diencephalic-telencephalic boundary, and the
reduction in internal capsule cells therefore reduces the number of axons available to
guide thalamocortical axons.
The thalamus segregates normally in Lhx2-/- knockout mice according to a wide
range of markers, but the thalamic axons are unable to enter the ventral telencephalon.
in vitro, Lhx2-/- thalamus projects axons into wild-type ventral telencephalon and the
topography of these axons is normal. However, when wild-type thalamus projects
axons into Lhx2-/- ventral telencephalon, the axonal topography is aberrant, with
axons from caudal thalamus, which usually innervate caudal ventral telencephalon,
being shifted rostrally (Lakhina et al., 2007). This may indicate that internal capsule
axons influence the topography of thalamocortical axons and the reduction in number
of these axons in Lhx2-/- mice causes the thalamocortical axon topography to be
disrupted. However, it may be that Lhx2-expressing cells express some other guidance
cue which attracts thalamocortical axons, and that it is a reduction in guidance cue
expression which disrupts the growth of the axons. More studies are required to
determine if it is internal capsule axons, or simply internal capsule cells, which are
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required for correct topographical organisation of thalamocortical axons.
Given the many examples of gene expression in the thalamus and ventral telen-
cephalon influencing the topography of thalamocortical axons, it is consistent with the
evidence to claim that, while the corticofugal projection does appear to be necessary
for thalamocortical axons to innervate the cortex correctly, it is not sufficient for the
organisation of thalamocortical axons, and that the axons are already organised to some
extent when they reach the lateral edge of the internal capsule and interact with the
corticofugal projection.
1.4.3 Innervation of the cortex by thalamocortical axons
Thalamocortical axons innervate the cortex in a controlled fashion, with some groups
of axons spreading out across the whole cortex but others innervating a single
cortical area (Jones, 1998). As described in Sections 1.3.4 and 1.4.2, by the time
thalamocortical axons reach the cortex, the axons are topographically organised and the
cortex is arealised to some extent by the expression of guidance cues and transcription
factors (Sur and Rubenstein, 2005). In this section, the innervation of the cortex
by the thalamocortical projection will be discussed, considering the influence of
the thalamocortical projection on lamination, inter-areal patterning and intra-areal
patterning of the cortex and also the role of activity in these processes.
1.4.3.1 Lamination
Thalamocortical axons mostly innervate layer IV of the cortex, and it is in this layer
where topographic mappings such as barrels in somatosensory area S1 can be seen
(see Inan and Crair (2007) for review). This layer-specific innervation only occurs
when thalamocortical axons are presented with postnatal cortex. In explant cultures
of rat tissue, thalamic axons do not innervate cortical slices taken prior to E19. In
slices taken after E19 but before P2, axons will enter the cortex and project radially
throughout the slice. In slices taken after P2, the axons arborise and terminate in layer
4 of the cortex (Molnár and Blakemore, 1999). When presented with a choice between
E18-19 cortical tissue and P0-1 cortical tissue, thalamic axons prefer to grow on the
postnatal tissue, a choice which is mediated in part by higher levels of expression of the
neural cell adhesion molecules L1 and N-CAM in the postnatal cortical tissue (Tuttle
et al., 1995).
When cortical slices are taken at earlier ages and cultured for over 7 days, the
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innervation of these slices by thalamic axons is closer to that seen for the chronological
age of the slice, rather than the age at which it was dissected (Molnár and Blakemore,
1999). This indicates that not only do changes in the cortex regulate the behaviour
of thalamic axons as they innervate the cortex but also that these changes are at least
partly intrinsic to the cortex, because they persist in the absence of the rest of the brain.
Several genes have been identified which restrict thalamocortical axons to layer IV
of the cortex. For example, semaphorin-7A, ephrin-A5 and kit ligand are expressed in
the upper layers of the cortex and inhibit the growth of thalamocortical axons (Mann
et al., 2002; Maruyama et al., 2008). Similarly, N-cadherin is expressed in layer IV of
the cortex and if N-cadherin is blocked by inhibitory peptides, thalamocortical axons
grow to layer IV at the same rate as normal but then continue to extend to the outer
edge of the cortex (Poskanzer et al., 2003).
The neurotrophins, a family of chemoattractants which operate through two
receptor systems, Trk, which is upstream of PI-3 kinase, and p75, which is upstream
of RhoA (Chao, 2003), are also involved in thalamocortical innervation of the cortex.
Multiple neurotrophins are expressed in the cortex during development and stimulate
dendritic growth. Different neurotrophins regulate each other’s effects, with, for
example, neurotrophin-3 (NT-3) being expressed in layer 4 and inhibiting BDNF-
stimulated dendritic growth, and BDNF being expressed in layer 6 and inhibiting NT-3-
stimulated dendritic growth (McAllister et al., 1997). When expression of NT-3, which
operates through TrkC, is ablated in the cortex, thalamocortical axons which would
normally terminate in layer 4 in visual cortex fail to innervate the cortical plate, instead
accumulating in the subplate and eventually retracting (Ma et al., 2002). Also, the
tyrosine receptor kinase TrkB, which is bound by neurotrophin and BDNF, is required
for thalamocortical axons to be restricted to layer IV, because in its absence in TrkB-/-
knockout mice, thalamocortical axons also invade layer III of the cortex (Vitalis et al.,
2002).
1.4.3.2 Inter-areal patterning
As discussed in Section 1.3.4, the cortex is already divided into areas by the time it
is innervated by thalamocortical axons and it is not thought that the thalamocortical
projection has a significant influence on the arealisation of the cortex. For example,
in Gbx2-/- knockout mice, the thalamocortical projection does not cross the pallial-
subpallial boundary, but the cortex develops normally, with many area-specific genes
maintaining the patterns of expression seen in wild-type animals (Miyashita-Lin et al.,
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1999).
This area-specific gene expression is required for thalamocortical axons to inner-
vate the appropriate cortical areas. For example, Fgf8 is a signalling molecule which
is secreted in the developing forebrain and influences the arealisation of the cortex
(Grove and Fukuchi-Shimogori, 2003); see Figure 1.9a). Electroporating constructs
expressing excess Fgf8 into the anterior forebrain at E10.5/E11.5 causes cortical
somatosensory area S1 to develop posterior to its normal position, whereas blocking
Fgf8 causes S1 to develop anterior to its normal position (Fukuchi-Shimogori and
Grove, 2001). Fukuchi-Shimogori and Grove (2001) also show that electroporating
Fgf8-expressing constructs posteriorly causes a second S1 area to develop in the
posterior forebrain. Thalamocortical axons from the ventrobasal (VB) nucleus, which
innervates S1 in wild-type animals, also innverates S1 in these modified cortices, with
VB axons even branching when they reach the cortex to innervate both the anterior and
posterior S1 areas in the latter case (Shimogori and Grove, 2005).
Similarly, the membrane protein and neural cell adhesion molecule LAMP is
expressed in limbic regions such as the perirhinal cortex and attracts thalamocortical
axons from the lateral dorsal nucleus (Barbe and Levitt, 1992; Mann et al., 1998). If
LAMP-expressing cells are transplanted into developing somatosensory cortex, the lat-
eral dorsal thalamocortical axons innervate somatosensory cortex instead of perirhinal
cortex (Barbe and Levitt, 1992). These lateral dorsal axons are also influenced by the
expression of ephrin-A5, which is expressed in somatosensory cortex; in ephrin-A5
knockouts, they innervate both perirhinal cortex and somatosensory cortex, rather than
perirhinal cortex alone (although ventrobasal axonal connections to somatosensory
cortex are unaffected in these mutants) (Uziel et al., 2002). Therefore, as ephrin-A5
appears to inhibit growth of lateral dorsal axons and LAMP encourages growth, both
chemoattractive and chemorepulsive signals appear to be necessary for laterodorsal
axons to navigate to their destinations correctly.
These area-specific innervations require the expression of appropriate receptors
in thalamocortical axons. For example, as ephrin-A5 is expressed in somatosensory
cortex but not in perirhinal cortex or other limbic regions, so the ephrin-A5 receptor
Eph-A5 is expressed in limbic thalamic nuclei but not in somatosensory thalamic
nuclei (Gao et al., 1998). Axons which express Eph-A5, from the limbic nuclei, will
not innervate somatosensory cortex, indicating that the interaction between ephrin-A5
and Eph-A5 has a repulsive effect (Gao et al., 1998).
These gene-specific effects may be due to changes in corticofugal axon behaviour.
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Figure 1.9: a) Electroporation of Fgf8 causes barrel cortex to shift position. A,D,G) Layer IV of
flattened P6 mouse cortices stained with cytochrome oxidase to mark barrels. B,E,H) Magnifications
of A,D,G respectively. C,F,I) Schematics of experimental conditions in A,D,G respectively, with red
dots marking size and location of Fgf8 source and orange dots marking barrels. Electroporation with
alkaline phosphatase control (A,B,C; +AP) showed the whisker pad (Wp) and anterior snout (As) at
a central position at the midpoint between the anterior and posterior poles of the neocortex (white
arrows in A,D,G). Anterior electroporation of Fgf8 (D,E,F; +Fgf8) shifted the barrel cortex posteriorly,
compressing individual barrels; blocking Fgf8 with overexpression of a soluble FGF receptor sFgfr3
(G,H,I; +sFgfr3) shifted the barrel cortex anteriorly, elongated individual barrels (see white arrows in B
and H) and skewed and elongated the Wp subfield (compare asterisks in B and H). a, anterior; l, lateral.
Scale bar in B is 2.0mm for A,D,G and 0.7mm for B,D,H. b) Axons exposed to high EphA expression
in the ventrobasal nucleus (VB) innervate regions of S1 with low lateral ephrin-A5 expression, and vice
versa. VL, ventrolateral nucleus. a) taken from Fukuchi-Shimogori and Grove (2001); b) taken from
Vanderhaeghen and Polleux (2004).
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Subplate neurons express p75 neurotrophin receptors during the period where thalamo-
cortical axons innervate the cortex, in a high-caudal to low-rostral gradient (McQuillen
et al., 2002). In the absence of p75 receptors, subplate axons from visual cortex (where
p75 expression is usually high) grow ectopically and thalamocortical innervation of
visual cortex is reduced, but innervation of auditory and somatosensory cortex (where
p75 expression is usually low) is normal (McQuillen et al., 2002). This appears to be
due to a defect in subplate growth cone morphology; subplate neuron generation and
cell death are similar throughout development in wild-type and p75-/- knockout mice,
but the number of cytoskeletal actin filaments in subplate growth cones is substantially
reduced (McQuillen et al., 2002).
1.4.3.3 Intra-areal patterning
Once each group of thalamocortical axons has made its way to the correct area and
grown into layer IV, the axons within the group must organise themselves appropriately
to match the function of their originating nucleus and destination cortical area. While
thalamocortical innervation does not appear to be required for cortical areas to form,
it does have a role to play in the patterning of individual cortical areas. For example,
thalamocortical axons appear to cause various cadherins to be expressed in cortical
areas. N-cadherin is co-expressed with thalamocortical arbors in barrel cortex during
the first postnatal week, and this expression is due to the positioning of the axons
rather than intrinsic signalling because if the pattern of axonal innervation is disrupted
by lesioning the infraorbital nerve which connects the whiskers to the thalamus, the
pattern of N-cadherin expression is disrupted in the same way as the axons (Huntley
and Benson, 1999).
Cadherin-6, -8 and -10 are also expressed in barrel cortex, in partially overlapping
but distinct patterns throughout the cortical layers (Gil et al., 2002). Just as N-cadherin
is co-expressed with terminating ventrobasal axons in barrel cortex, so cadherin-8
protein and mRNA are co-expressed with terminating axons from the posterior nucleus
in barrel septa, and are not enriched in barrel cell somata. Cadherin-8 mRNA is
enriched in the posterior thalamic nucleus, which suggests that cadherin-8 may be
transported along the axons and expressed at the axon terminals in the cortex. However,
the ability of thalamocortical axons to affect cadherin expression appears to be limited
to intra-areal patterning. When expression of cadherins 6, 8 and 11 was tested in wild-
type mice and Mash1-/- knockout mice (in which the internal capsule does not form
and thalamocortical axons are unable to cross the diencephalic-telencephalic boundary
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and reach the cortex), the laminar, graded and inter-areal patterning of the cadherins
in the cortex was unaffected (Nakagawa et al., 1999); intra-areal patterning was not
examined in this study).
Molecular gradients have a role to play in intra-areal patterning. For example, just
as a gradient of ephrin-A5 across the whole cortex matches a complementary gradient
of EphA5 receptor in the thalamus during embyronic development (see Section
1.4.3.2), postnatally a gradient of ephrin-A5 can be found across somatosensory
cortical area S1 which complements a gradient of EphA receptors in the ventrobasal
thalamic nucleus (Bolz et al., 2004); see Figure 1.9b), and absence of this gradient
disrupted the topographic mapping of innervating ventrobasal axons (Vanderhaeghen
et al., 2000; Prakash et al., 2000). In addition, one of the ephrin-A5 receptors, EphA7,
has been shown to be required for the somatosensory cortex to form correctly, with S1
being reduced in size in EphA7-/- knockout mice compared to wild-type control mice,
and with the lateral region of S1 being significantly more reduced than the medial
region, an effect which was even more pronounced in ephrin-A5/EphA7-/- double
knockouts (Miller et al., 2006).
This indicates that ephrin-A5 and EphA7 are required for correct topographical
formation of somatosensory cortex, but EphA7 is expressed in gradients across the
thalamus and the cortex. Are both gradients required for correct formation of the
thalamocortical projection or only one? In fact, misexpressing EphA7 in the cortex
alone (using electroporation) disrupts the intra-areal, but not inter-areal, patterning
of corticothalamic axons at their thalamic nuclei targets (Torii and Levitt, 2005).
However, misexpressing EphA7 in the cortex does not interfere with the inter- or intra-
areal connectivity of the thalamocortical axons with the cortex (Torii and Levitt, 2005).
This suggests that the two gradients of EphA7 are independent of each other, with the
cortical EphA7 influencing corticothalamic axon innervation of the thalamus and the
thalamic EphA7 influencing thalamocortical axon innervation of the cortex.
Once thalamocortical axons reach the cortex, they are able to form synapses
with cortical cells and activity begins to play a role in development. Artificial
stimulation of thalamic cells in rats can cause propagation of excitation through
thalamocortical axons and into the cortex from E17, and by E19 there is fully
functional thalamocortical synaptic transmission to the subplate (Higashi et al., 2002),
which means it is quite possible for activity to operate during the time that intra-areal
patterns are forming. Activity may even be involved in inter-areal patterning, as there
is evidence to suggest that activity is required for thalamocortical axons to innervate
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the appropriate cortical areas correctly. Preventing action potentials in the cat brain by
blocking sodium channels with tetradotoxin during the time when lateral geniculate
nucleus axons innervate the cortex causes these axons to innervate not only the visual
cortex (their usual target) but also auditory cortex, and those axons which do innervate
visual cortex are not correctly topographically organised (Catalano and Shatz, 1998).
However, in the SNAP-25-/- knockout mouse, in which action potentials do not
evoke neurotransmitter release, although spontaneous neurotransmitter release can
still occur, the major features of prenatal thalamocortical development are unchanged,
with thalamocortical axons growing to and innervating the cortex with their normal
topography and also being able to send action potentials to cortex (Molnár et al., 2002).
This indicates that the role of activity is limited to postnatal, intra-areal patterning
behaviours such as the branching of axons after innervation of layer IV (Hayano
and Yamamoto, 2008). For example, the transcription factor NeuroD2 is expressed
in the early postnatal cortex and is required for thalamocortical synapses to form
correctly. In NeuroD2 null mice, synaptic transmission at thalamocortical synapses
is defective and total excitatory synaptic currents are reduced in layer IV. These mice
also exhibit defects in barrel cortex formation, with thalamocortical axon terminals
failing to segregate into barrel hollows, presumably because they are unable to form
synapses correctly (Ince-Dunn et al., 2006).
In summary, therefore, the growth cones of thalamocortical axons exhibit many
complex and closely regulated behaviours in order for these axons to make their way
to the cortex, become topographically organised, innervate the correct cortical areas
and form the appropriate patterns within each cortical area. Whether by regulation
by gene expression or by activity, the differentiation of these growth cones must be
reflected by the proteins that can be found within the growth cones themselves. With
this in mind, it is now possible to turn to the growth cone, its contents and its regulation.
1.5 A role for RNA in axonal growth cones
How do developing axons (including thalamocortical axons, as shown in the previous
section) navigate through their environment, extending themselves while responding
to the directional cues around them? Attempts to explain these behaviours focus on the
growth cone, the complex structure at the tip of each axon which detects and responds
to the axon’s environment (see Gordon-Weeks (2000) for comprehensive review). In
this section, the structure and function of the growth cone is explored, with a focus on
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the recently discovered role of locally translated mRNAs in axon guidance behaviour
(see Willis et al. (2007); Hengst and Jaffrey (2007); Lin and Holt (2008) for reviews).
There is a range of evidence indicating that locally translated mRNAs are required
for growth cones to respond to their environment, and therefore, as thalamocortical
axons exhibit the same behaviours as axons from other systems, there is good reason
to believe that thalamocortical axons contain mRNAs which are locally translated.
1.5.1 The structure and function of the growth cone
The axon cytoskeleton, which is composed of bundles of microtubules, microfilaments
and (in some systems) neurofilaments, is extended at the growth cone (Dent and
Gertler, 2003). The growth cone itself is also composed of microtubules and
microfilaments, although they are not bundled in the same way as in the trunk of
the axon. The microtubules, which are dimers of α-tubulin and β-tubulin isoforms,
diverge and extend singly into the growth cone, where they form the bulk of the
central (C)-domain of the growth cone (Gordon-Weeks, 1993). The microfilaments,
which are composed of β-actin and γ-actin isoforms, dominate the peripheral (P)-
domain of the growth cone, which extends and contracts in response to its environment
(Gallo and Letourneau, 2004). Neurofilaments do extend into the growth cones of
peripheral nervous system axons but instead of being incorporated into the growth
cone cytoskeleton, they return to the main body of the axon and form part of the axon
cytoskeleton (Uchida and Brown, 2004); they have not been found in vertebrate central
nervous system growth cones (Dent and Gertler, 2003) and will not be considered
further here.
The microfilaments of the P-domain are largely incorporated into two types of
processes, lamellipodia, which form a sheet-like mesh extending distally from the
C-domain, and filopodia, which are long, thin processes which are spaced among
the lamellipodia and protrode outward in all directions (Faix and Rottner, 2006).
The growth of the axon involves a standard, three-step procedure of protrusion,
engorgement and consolidation (see Figure 1.10a): filopodia protrude outward beyond
the existing perimeter of the growth cone and are supported by lamellipodia which
follow behind; microtubules engorge the extended P-domain using the lamellipodia as
a substrate; and the microtubules consolidate into bundles while the microfilaments
around them are depolymerised, leaving a cylindrical form which becomes the distal
part of the axon (Goldberg and Burmeister, 1986; Schaefer et al., 2008).
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The growth cone also contains a wide variety of organelles in its C-domain
including mitochondria, smooth endoplasmic reticulum and vesicles (Tennyson, 1970;
Yamada et al., 1971; Chada and Hollenbeck, 2003). In addition, microtubules and
microfilaments are regulated by many associated proteins. For example, microfil-
aments are polymerised by proteins such as Ena/VASP and N-WASP, with Arp2/3
being required for lamellipodia to be formed and fascin being required for filopodia to
be formed (Ishikawa and Kohama, 2007; Pak et al., 2008), whereas microtubules are
stabilised by microtubule-associated proteins including MAP1, MAP2 and MAP Tau
(Gordon-Weeks, 1993; Dehmelt and Halpain, 2004). Also, many receptors, channels
and cell adhesion molecules can be found in the membrane of the growth cone,
enabling it to integrate signals from its environment and turn appropriately (Wen and
Zheng, 2006).
Actin filaments grow outward by a process known as actin treadmilling (see Figure
1.10b; see Le Clainche and Carlier (2008) for review). Actin filaments are polarised,
with a barbed end and a pointed end, and grow in the direction of the barbed end.
A single filament is not translocated intact, as a whole; rather, new actin monomers
are incorporated onto the barbed end of the filament and removed from the pointed
end. Actin monomers form a complex with ATP which preferentially binds to the
barbed ends of actin filaments. 1-2 seconds after incorporation of the monomer into
the filament, ATP is hydrolysed into ADP and an inorganic phosphate ion Pi; several
minutes later Pi is released, leaving actin associated with ADP at the pointed end of
the filament. These actin-ADP complexes are depolymerised from the filament at the
pointed end, after which an ATP-ADP exchange enables the now actin-ATP complex
to be reincorporated at the barbed end of the filament.
Therefore actin monomers are continually recycled as the filaments move, and the
actin filament is polarised due to the position of the three different actin complexes
along its length. These different complexes are preferentially bound by different
proteins (see Figure 1.11a); for example, Ena/VASP proteins, which promote the
elongation of actin filaments and prevent the branching of filaments, bind preferentially
to ATP-actin and so associate with the barbed end of filaments (Drees and Gertler,
2008), whereas cofilin, which depolymerises actin filaments, preferentially binds ADP-
actin and so is found at the pointed end where actin monomers are removed from the
filament (Fass et al., 2004). Therefore the growth of actin filaments and the formation
of superstructures such as filopodia and lamellipodia can be regulated not only by
supplying or removing a source of actin monomers but also by interfering with the
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action of many actin-binding proteins at different stages of filament formation (Pak
et al., 2008).
Microtubules are polarised like actin filaments, but their kinetics are different (see
Figure 1.10c). They have a fast-growing ‘plus’ end and a slow-growing ‘minus’ end.
The plus end is capped by β-tubulin, whereas the minus end is capped by α-tubulin,
with both forms of tubulin being bound to GTP (Morrison, 2007). When capped
by GTP-bound β-tubulin, stable β-tubulin heterodimers can bind together at the plus
end of the microtubule, causing the microtubule to extend rapidly. When GTP is
hydrolysed to GDP, GDP-β-tubulin heterodimers separate, causing the microtubules to
retract. This frequent, repeated extension and retraction process is known as dynamic
instability (Gardner et al., 2008). In growth cones, the minus ends of microtubules
are anchored in the C-domain, whereas the plus ends probe the actin filament network
in the P-domain for signals from guidance cues via dynamic instability, until they are
stabilised with actin filaments once a direction of growth has been established (Gordon-
Weeks, 2004).
Actin filaments and microtubules can each be targeted directly by guidance cues;
for example, when mouse retinal growth cones are exposed to a gradient of Slit2,
there is an increase of the actin-depolymerising protein cofilin and a decrease in actin
filaments, causing the growth cones to collapse (Piper et al., 2006). Similarly, exposing
mouse dorsal root ganglion (DRG) cells to neurotrophin triggers an actin-independent
pathway involving phosphoinositide 3 kinase (PI-3 kinase) and glycogen synthase
kinase (GSK)-3β which causes the adenomatous polyposis coli (APC) protein to bind
to microtubule plus ends and promote microtubule assembly (Zhou and Cohan, 2004).
These pathways will be examined in more detail in the sections that follow.
Over the last decade, several lines of evidence have indicated that growth cone
behaviour requires the translation of mRNAs in the growth cone itself. In order to turn
and grow in response to their environment, growth cones synthesise protein from a
complement of local mRNAs, and this complement of mRNAs varies with changes in
the environment (Willis et al., 2005). In the remainder of this section, the behaviour of
growth cones will be further explored in the context of local protein regulation.
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Figure 1.11: a) Guidance cues modify actin filaments and microtubules by regulating growth cone
proteins. Attractive guidance cues such as netrin-1 (left) activate actin anti-capping proteins such as
Ena/VASP (yellow dots) and proteins such as APC on the plus end of dynamic microtubules (+TIP
proteins, green dots) which enable the elongation of actin filaments and microtubules in the direction of
the cue. Other actin capping proteins enable repulsive guidance cues such as Sema3A to cause growth
cones to collapse. b) A recent summary of currently known guidance cue pathways involving local
protein regulation. The red box indicates protein degradation; green circles indicate protein synthesis.
a) taken from Kalil and Dent (2005); b) taken from Farrar and Spencer (2008).
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1.5.2 Axonal responses to netrin-1 require local protein synthesis
and degradation
For each of the four classical guidance cue families, the netrins, ephrins, semaphorins
and Slits, in at least one species and axonal system, it has now been shown that
regulation of protein synthesis and degradation is required in the growth cone for the
guidance cues to cause growth cones to turn or collapse (Campbell and Holt, 2001;
Brittis et al., 2002; Wu et al., 2005; Piper et al., 2006); see Figure 1.11b for overview).
However, it is not yet certain whether this is the case for all species and all systems,
with at least one paper finding no requirement for protein synthesis in growth cone
turning behaviour (Roche et al., 2009). Evidence for and against a link between protein
regulation and guidance cues will now be described by example, beginning with netrin-
1.
Netrin-1 was among the first guidance cues to be identified and is involved in the
development of many neuronal and non-neuronal tissues (Barallobre et al., 2005).
It was discovered as a chemoattractant for spinal cord commissural axons and, as
discussed in Section 1.4.2, it is present in a gradient across the ventral telencephalon
and is involved in the topographical organisation of thalamocortical axons. In culture,
Xenopus retinal axons are attracted to, and turn towards, point sources of netrin-1 and
this attraction requires the presence of the netrin receptor DCC (de la Torre et al.,
1997).
Netrin-1 was also the first guidance cue to be linked to local protein synthesis,
via treatments of netrin-1-induced turning behaviour in developing Xenopus retinal
growth cones (Campbell and Holt, 2001). Growth cones were exposed to a gradient
of netrin-1, which was generated by focal application of netrin-1 by micropipette.
The protein synthesis inhibitors anisomycin and cycloheximide and the transcription
inhibitor α-amanitin were individually added to the culture medium. The turning
effects induced by netrin-1 were inhibited by anisomycin and cycloheximide but not
by α-amanitin, indicating that protein synthesis, but not transcription, is required for
these axons to turn in response to netrin-1. Most importantly, these effects were not
only seen in axons with cell bodies, but also in severed axons where cell bodies had
been removed. A similar study, exposing severed axons from cultured Xenopus spinal
neurons to a gradient of netrin-1, also found that anisomycin and cycloheximide, but
not the transcriptional inhibitor DRB, abolished the attractive reponse of the growth
cone (Ming et al., 2002). This indicates that protein synthesis is required for growth
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cone turning in at least two Xenopus axonal systems, and that the protein synthesis
required for axons to turn in response to netrin-1 occurs within the axon, rather than in
the cell bodies.
These results suggest that translation machinery must be present at the growth
cone and must be triggered by netrin-1, presumably by the cap-dependent translation
initiation pathway described in Section 1.2.1. To investigate this translation pathway,
Campbell and Holt (2001) applied antibodies for phosphorylated eIF-4E and 4EBP
to the same netrin-1 turning assays, because both of these proteins are required
for cap-dependent translation to take place. A rapid increase in eIF-4E and 4EBP
phosphorylation was seen shortly after netrin-1 treatment. This increase was abolished,
however, when growth cones were treated with rapamycin, which inhibits the 4EBP
phosphorylation molecule mTOR (Campbell and Holt, 2001); see Section 1.2.1.
A growth factor that has been linked to netrin-1-induced growth cone turning
(Guo-li Ming et al., 1999) and is upstream of mTOR (Hay and Sonenberg, 2004) is
PI-3 kinase. Treatment with the PI-3 kinase inhibitor wortmannin abolished netrin-
1-induced turning behaviour in axons with both cell bodies intact and with cell
bodies removed (Campbell and Holt, 2001). In summary, therefore, netrin-1, via
its receptor DCC, upregulates PI-3 kinase, which in turn upregulates mTOR. mTOR
phosphorylates 4EBP, which releases eIF4E and enables cap-dependent translation of
growth cone mRNAs to begin.
It has also been shown that degradation of proteins in Xenopus retinal growth cones
is required for netrin-1 to induce growth cone turning. Most proteins are degraded by
the 26S proteasome, a complex composed of a 20S core complex, a 19S regulatory
complex and an 11S regulatory complex, and are targeted to the proteasome when
they are tagged with ubiquitin via 4 regulatory enzymes, E1-E4 (see Tai and Schuman
(2008) for recent review). Campbell and Holt (2001) shown that the 20S core complex,
ubiquitin and E1 are all present in Xenopus retinal growth cones, and that when
proteasome inhibitors are added to the culture medium, retinal axons are no longer
attracted to gradients of netrin-1, thus demonstrating that axon guidance in this system
requires the regulation of protein synthesis and protein degradation.
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1.5.3 The localisation of EphA2 and tau mRNAs to the growth cone
requires an intact 3’UTR
Local protein synthesis has also been implicated in the function of Eph receptors. The
axons of spinal commissural neurons cross the midline via the floor plate and then grow
longitudinally on the contralateral side of the spinal cord to the neuron’s soma. EphA2
is synthesised locally in these axons, suggesting a regulatory role in this axon guidance
behaviour (Brittis et al., 2002); see Figure 1.12C). A reporter containing GFP and the
3’UTR of EphA2 was electroporated into commissural neurons and was shown to be
expressed in the soma and in the section of the axon which had crossed the midline,
both on emerging from the floor plate and after turning and growing longitudinally.
There was a section of axon between the soma and the growth cone where no GFP
was expressed, strongly suggesting local upregulation at the distal portion of the axon.
This upregulation was not seen in ipsilateral axons. This indicates that the 3’UTR of
the EphA2 mRNA is sufficient for the mRNA to be translated in axons and growth
cones, as the remainder of the mRNA was not present in the reporter.
Local translation in oocytes and dendrites is mediated by cytoplasmic polyadeny-
lation elements (CPEs) in the 3’UTR of relevant mRNAs. These CPEs are required to
activate poly(A)-tail lengthening of mRNAs, which can be required for translation
to take place (Wilkie et al., 2003). The CPE-binding protein CPEB, which must
be phosphorylated for poly(A)-tail lengthening to occur, is present in isolated axons
(Brittis et al., 2002). The upregulation of EphA2 in contralateral axon segments is also
dependent on a CPE sequence which is part of the EphA2 3’UTR. Electroporation of
a GFP-3’UTR EphA2 mutation which did not include the CPE sequence abolished
contralateral GFP expression but made no difference to expression in the soma,
indicating that expression of EphA2 mRNA in the cell body and in the axon is regulated
in different ways. Further mutations of the polyadenylation sequence abolished the
specific localisation of GFP to the distal portion of the axon and instead caused either
no or very low level expression along the entire axon. These results suggest that a
3’UTR which contains both the CPE and the polyadenylation sequence are essential
for EphA2 to be localised to contralateral axon segments.
Similarly, tau mRNA is transported to the axons of PC12 cells, where it can be
found to be colocalised with tau protein (Aronov et al., 2001). This localisation is
dependent on the tau 3’UTR; if the 3’UTR is removed, both tau mRNA and tau protein
are found only in the cell body. In addition, if the tau 3’UTR is replaced with the
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3’UTR for MAP2, a dendritic protein, then tau is localised to dendrites; if the MAP2
3’UTR is replaced with the tau 3’UTR, then MAP2 is localised to axons (Aronov
et al., 2001). This demonstrates that not only is the 3’UTR essential for localisation of
mRNAs, but also that specific 3’UTRs direct mRNAs to different parts of the neuron
and its neurites.
1.5.4 Sema3A causes translation of RhoA, which is required for
growth cone collapse
Sema3A is a member of the classical guidance cue family the semaphorins, which
causes Xenopus retinal axons to collapse, although many axons later recover from this
collapse and extend new branches, suggesting that Sema3A has a role as a branching
factor (Campbell et al., 2001). Sema3A-related growth cone collapse is not limited to
Xenopus but can also be seen in rat DRG neurons (Wu et al., 2005) and chick retinal
and DRG neurons (Roche et al., 2009).
Sema3A-induced behaviour in Xenopus retinal axons under the influence of
various inhibitors was examined (Campbell and Holt, 2001). Similarly to the results
acquired for netrin-1, collapse and turning behaviour of these axons were both
abolished by the translation inhibitors anisomycin and cycloheximide but not by
the transcription inhibitor α-amanitin. Both the collapse behaviour and the turning
behaviour triggered a rapid rise in phosphorylated eIF4E and 4EBP. Treatment with the
mTOR inhibitor rapamycin also abolished collapse behaviour, although, in contrast to
netrin-1 results, treatment with the PI-3 kinase inhibitor wortmannin did not. Also in
contrast to netrin-1 results, the inhibition of the proteasome had no effect on Sema3A-
induced collapse, indicating that protein degradation is not required for this behaviour.
These results demonstrate that Sema3A-induced growth cone behaviour in Xeno-
pus axons requires local protein synthesis, and that Sema3A triggers protein synthesis
through the mTOR - 4EBP - eIF4E pathway. However, Sema3A-induced growth cone
behaviour does not require PI-3 kinase, as netrin-1-induced effects do. Sema3A signals
through a complex of neuropilin and class A plexin receptors (Kruger et al., 2005). To
date, no link has been found between plexinAs or neuropilin and mTOR. However, a
recent study has identified a target of this protein synthesis pathway.
The small GTPase RhoA is a potential candidate for Sema3A regulation because it
has already been linked to growth cone collapse. Ephrin-A1 signalling via EphA4
receptors (which are involved in thalamocortical development; see Section 1.4.2)
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tyrosine phosphorylates the guanine exchange factor ephexin1, which activates RhoA
(Sahin et al., 2005). Ephexin1 activation via ephrin signalling causes the growth cones
of rat DRG cell axons to collapse (Shamah et al., 2001). This collapse is mediated by
the phosphorylation of RhoA by RhoA kinase (ROCK), which causes actin filaments
to bundle together and prevents further actin polymerisation (Gallo, 2006). Conversely,
netrin-1, via its receptor DCC, inactivates RhoA in E13 rat dorsal spinal cord axons,
which causes growth cones to turn towards the netrin-1 source (Moore et al., 2008),
presumably due to the prevention of actin regulation by RhoA.
Using fluorescent in situ hybridisations, RhoA mRNA can be found in E15-16 rat
DRG axons (see Figure 1.12A). Wu et al. (2005) demonstrated that this RhoA mRNA
was translated in the axon and that this axonal translation was triggered by Sema3A. A
GFP-expressing vector containing the RhoA 3’UTR was seen to be expressed in axons
and growth cones, an effect which was not due to diffusion because a separate vector
with a minimal 3’UTR was only expressed in the soma. The mRNA was seen in puncta
along the axons which increased in intensity with Sema3A treatment.
Wu et al. (2005) also demonstrated that this Sema3A-related translation of RhoA
mRNA was both necessary and sufficient for Sema3A-induced growth cone collapse.
All endogenous cap-dependent translation was abolished by treating axons with
rapamycin; following this, a vector containing an IRES, EGFP and RhoA was
transfected into these axons. This vector, expressed via cap-independent translation,
rescued growth cone collapse caused by treatment with Sema3A, indicating that axonal
RhoA translation is sufficient for Sema3A-induced growth cone collapse to occur.
However, this does not appear to be the case in all systems and in all conditions.
Roche et al. (2009) examined the role of local protein synthesis in E7 chick DRG axons
and could find no difference in Sema3A-induced growth cone collapse when axons
were treated with cycloheximide or anisomycin. While both phosphorylated 4EBP and
protein synthesis could be detected in axons when they were treated with Sema3A, and
protein synthesis was no longer detected in the presence of cycloheximide, the collapse
response was robustly maintained in the presence and absence of cycloheximide or
anisomycin. In addition, no significant variation in RhoA expression in the presence
of Sema3A, cycloheximide, or Sema3A plus cycloheximide.
It may be that E7 chick DRG axons simply do not require protein synthesis for
axon guidance behaviour, whereas DRG axons at later developmental stages or in other
systems behave differently. However, Roche et al. (2009) also failed to abolish the
Sema3A-induced collapse response in the presence of cycloheximide or anisomycin in
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E13 chick DRG axons and E15 mouse DRG axons (although they did not test E15-
16 rat DRG axons, as Wu et al. (2005) did, or stage 35/36 Xenopus retinal axons,
as Campbell and Holt (2001) did). The differences may also be due to variations in
protocol, as Roche et al. (2009) used different culture medium, substrates and exposure
times to both protein synthesis inhibitors and guidance cues than Wu et al. (2005) and
Campbell and Holt (2001). Therefore, while the differences in the studies may reflect
genuine differences in the behaviour of axonal systems, more consistent studies are
required before general conclusions can be reached.
In summary, it is now known that netrin-1 and Sema3A contact causes Xenopus
axons to phosphorylate mTOR, which triggers axonal protein translation via 4EBP
and eIF4E. In rat DRG axon cultures, RhoA is translated in axons on contact with
Sema3A, and this RhoA translation is necessary and sufficient for growth cone
collapse. However, this pathway may not operate in all axonal systems, in all species,
at all points in development, and more studies are required to fully discover what
exactly is the requirement for local protein synthesis in axon guidance.
1.5.5 β-actin mRNA is asymmetrically upregulated in growth cones
exposed to guidance cue gradients
The results described above indicate that local protein regulation is required for axons
to be guided in some species and axonal systems. But why should an axon turn in
response to an expression gradient of a guidance cue? This requires the cytoskeleton
to grow in one direction but not another, which implies that the guidance cue causes
the contents of the growth cone to differ from one side of the growth cone to the other.
How does this differentiation occur?
Microfilaments are composed of many β-actin and γ-actin molecules, and so in
order for the growth cone to be extended new actin molecules must be available in the
growth cone. These molecules could be transported or synthesised locally. Bassell
et al. (1998) showed that, while γ-actin protein is uniformly distributed across the
neuron and neurites, β-actin protein is enriched in growth cones and filopodia. Bassell
et al. (1998) also showed that γ-actin mRNA is absent from E19 rat cortical axons and
growth cones but that β-actin mRNA is present at the growth cone and is associated
with microtubules and polyribosomes.
Application of neurotrophin-3 to chick hippocampal and cortical cultured neurons
stimulated the localisation of both β-actin mRNA and β-actin protein to the growth




Figure 1.12: A) Rat DRG axons stained with riboprobes for a) β-actin, c) RhoA, e) ROCK1 and g) Rac1
mRNAs in situ (green); axons also immunostained for GAP-43 protein (b,d,f,h; red). All four riboprobes
were present in cell bodies (insets, also stained blue with cell marker DAPI) but only β-actin and RhoA
were detected in axons. Scale bar, 10µm. B) When exposed to a gradient of engrailed-2 (shown in blue),
temporal retinal axons turn away from the gradient, but nasal retinal axons turn towards the gradient
(left). Results for many axons shown on the right, with most axons tested turning in the same manner.
C) A commissural axon crossing a flattened spinal cord at the midline (ML) and treated with an axonal
marker (RFP-pA in red) and a GFP reporter attached to the 3’UTR of EphA2 (green). GFP staining
can be seen in the cell body (filled arrowhead) and the growth cone (arrow, and magnification on the
right) but not in the axon shaft (hollow arrowhead). D) Xenopus retinal growth cones immunostained
for β-actin and pseudocoloured according to fluorescent intensity (see scale in a)). a) Control growth
cone; b-e) growth cones treated with netrin-1 gradient (source shown by white arrowheads). b) There
is upregulation of β-actin where netrin-1 expression is highest. This asymmetric response is abolished
when the growth cone is treated with c) protein synthesis inhibitor cycloheximide (CHX) or d) β-actin
antisense morpholino oligonucleotide (AMO), and when axons are grown on a laminin substrate (e).
Scale bar, 10µm. f) Fluorescence ratios of the growth cone side near to the netrin-1 source compared
to the side far from the netrin-1 source are close to 1, except for netrin-1 treatment alone. **P=0.003,
***P<0.001, Kruskal-Wallis test. Error bars are standard error of the mean. A) taken from Wu et al.
(2005); B) taken from Brunet et al. (2005); C) taken from Brittis et al. (2002); D) taken from Leung
et al. (2006).
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cone (Zhang et al., 1999). This localisation has been linked to a region of the β-actin
mRNA 3’UTR known as the zipcode, which is bound by a protein called Zipcode
Binding Protein-1 (ZBP1) (Ross et al., 1997). ZBP1 is associated with β-actin mRNA
shortly after transcription via a second zipcode binding protein, ZBP2, whose absence
prevents ZBP1-associated β-actin transport and inhibits neurite outgrowth (Pan et al.,
2007). Once transported to the growth cone, the translation of β-actin is controlled by
Src, a protein kinase which phosphorylates a tyrosine residue of ZBP1 that is required
for ZBP1 to bind to mRNA, and so releases β-actin mRNA from ZBP1 which enables
it to be translated (Hüttelmaier et al., 2005).
If antisense oligonucleotides for the zipcode sequence are introduced into the axon,
intended to prevent binding of the zipcode by ZBP1, β-actin mRNA is not localised to
growth cones in the presence of neurotrophin-3, but it is localised to growth cones
in the presence of neurotrophin-3 when the axons are treated with control reverse
antisense oligonucleotides (Zhang et al., 2001). Expression of the mRNA in cells is the
same in all conditions, indicating that the antisense oligonucleotides specifically affect
localisation via the zipcode. Zhang et al. (2001) also show that an EGFP construct
containing the β-actin 3’UTR is upregulated in neurotrophin-3-treated cultured growth
cones, indicating that, as appeared to be the case with EphA2 (Brittis et al., 2002),
MAP2 and tau (Aronov et al., 2001), the β-actin 3’UTR is both necessary and sufficient
for β-actin mRNA and protein to be transported to the growth cone.
The same increase in transport of β-actin mRNA and synthesis of β-actin protein
at the growth cone can be seen in Xenopus retinal growth cones in response to netrin-1
signalling (Leung et al., 2006); see Figure 1.12D), and Xenopus spinal growth cones
in response to neurotrophin-3 and calcium signalling (Yao et al., 2006). These studies
show an asymmetric growth cone response to molecular gradients. Leung et al. (2006)
show that, when Xenopus retinal axons are exposed to a gradient of netrin-1, β-actin
protein, the eIF4E-binding protein 4EBP and the Xenopus ZBP1 homologue Vg1RBP
are all upregulated on the side of the growth cone with high netrin-1 expression. This
asymmetric response does not occur in the presence of the protein synthesis inhibitor
cycloheximide or a morpholino designed to bind to the start codon of β-actin mRNA,
indicating that the asymmetry depends on the presence and translation of β-actin
mRNA.
The neurotrophin BDNF causes Xenopus spinal axons to turn, a response which
is dependent on the presence of calcium in the growth cone (Song et al., 1997). Yao
et al. (2006) show that this response is blocked by the protein synthesis inhibitors
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cycloheximide and anisomycin and by antisense oligos which block the zipcode of
β-actin mRNA. They also show that, when growth cones are exposed to a gradient
of BDNF, both ZBP1 and β-actin mRNA particles are more dense on the side of the
growth cone with high BDNF expression. This indicates that growth cone turning
behaviour in Xenopus requires not only local protein translation but also the targeting
of β-actin mRNA to the region of growth cone expansion.
However, the involvement of β-actin in guidance cue responses may not hold for
all systems and species. Roche et al. (2009) found no difference in β-actin protein
expression in E7 chick DRG axons after treatment with a different neurotrophin,
NGF, and could also find no difference in expression in the presence of the protein
synthesis inhibitor cycloheximide, with NGF treatment or without. As discussed in
Section 1.5.4, this may be because local protein synthesis is not required at early
developmental stages, but it may also be because NGF, unlike BDNF and neurotrophin-
3, does not upregulate β-actin mRNA or protein. This appears to be the case in chick
forebrain axons, where stimulation with NT-3 and BDNF causes β-actin to localise
to growth cones, whereas NGF does not (Zhang et al., 1999); also, NGF, BDNF
and neurotrophin-3 have been shown to have differing effects on rat embryonic DRG
axons (Paves and Saarma, 1997). More systematic studies of the effects of the various
neurotrophins on a single system are required before the issue can be resolved.
1.5.6 Nasal and temporal retinal axons respond differently when
exposed to the transcription factor Engrailed-2
As discussed in Section 1.2.2, molecules which were first identified as classical
morphogens and transcription factors have been implicated in axon guidance. The
transcription factor Engrailed-2 is among this group of molecules, and its involvement
relies on the presence of locally translated RNA.
Using similar retinal axon turning assays to the previously described experiments
with netrin-1 and Sema3A (Campbell and Holt, 2001), it can be shown that a gradient
of Engrailed-2 molecule repels temporal retinal axons and attracts nasal retinal axons
(Brunet et al., 2005); see Figure 1.12B). This provides evidence that axons from
different sources can differ in their reaction to their environment, and therefore must
contain different proteins which cause these differences in behaviour. Both intact and
isolated growth cones produce the same turning effects, which are also not affected
by the presence of the transcription inhibitor α-amanitin. However, they are abolished
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by the protein synthesis inhibitor anisomycin, indicating that, as with netrin-1 and
Sema3A, local protein synthesis is required for Engrailed-2-induced turning to occur.
A mutation of Engrailed-2 which can not be internalised has no effect on treated growth
cones, suggesting that the internalisation is essential to the turning behaviour and that
Engrailed-2 does not operate by cell surface interactions.
Once internalised, Engrailed-2 binds directly to eIF4E, in common with many other
homeodomain proteins. When Engrailed-2 with a mutated eIF4E binding region is
presented to axons, it is internalised but no turning occurs. The internalisation of
Engrailed-2 also causes upregulation of the phosphorylated forms of both eIF4E and
4EBP, suggesting that it is involved in the same protein synthesis pathway in which
netrin-1 and Sema3A are involved (Brunet et al., 2005).
1.5.7 The RNA complement of growth cones
The above studies show that β-actin, RhoA, EphA2 and tau mRNAs are all present in
the growth cone and also suggest that their translation at the growth cone is required
for axons of some systems to be guided by external cues. However, many other RNAs
have been discovered in developing vertebrate axons (see Piper and Holt (2004) for
list), such as EphB2 (Brittis et al., 2002), neurofilament (Sotelo-Silveira et al., 2000)
and β-tubulin (Eng et al., 1999) and including more which have been implicated in
axon guidance such as CREB (Cox et al., 2008) and cofilin (Leung et al., 2006). It is
unclear how many more RNAs are present in growth cones, how many of them will
be involved in guidance behaviour and how consistent this behaviour will be across
different species and systems.
Two recent papers indicate that, in fact, hundreds of RNAs appear to be present in
growth cones. Hengst and Jaffrey (2007) refers to the generation of a cDNA library
from developing rat DRG axons, as yet unpublished, which contained around 100
RNAs. Willis et al. (2007) have published a similar survey showing the presence of
over 200 different mRNAs in regenerating rat DRG axons. This survey was performed
by treating cDNA arrays containing over 4,000 rat cDNAs with amplified cDNAs
prepared from isolated axonal rat DRG RNA. This confirms that the growth cone
contains a fraction of all RNAs that are expressed in cells, although this fraction is
much larger than had previously been shown.
Willis et al. (2007) go on to show that the expression of many of these RNAs is
modified in response to guidance cues such as BDNF, NT3 and Sema3A by quantifying
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RNA expression using qRT-PCR in the presence or absence of guidance cues. They
show that the response of RNAs differs to guidance cues in a complex fashion. For
example, the chemoattractants BDNF and NT-3 increase β-actin mRNA and ribosomal
protein RP-L22 mRNA expression but Sema3A, which causes axons to collapse,
decreases their expression. However, other RNAs such as Hsp90 were downregulated
in response to NT-3 and upregulated in response to Sema3A, and other RNAs such as
Vimentin were upregulated by both guidance cues.
This complexity may result from differential regulation of mRNAs via their
3’UTRs. The zipcode sequence found in the 3’UTR of β-actin mRNA, which is
required for β-actin mRNA to be transported to growth cones and locally translated,
is not present in any of the mRNAs found by Willis et al. (2007), nor is it present in
another axonal mRNA, cofilin (Leung et al., 2006). This suggests other regulatory
elements are present in the 3’UTRs of other axonal mRNAs which are yet to be
discovered.
The RNAs discovered by Willis et al. (2007) include many ribosomal proteins, a
translation elongation factor, ATP synthases and RNA polymerase II. Combined with
the known presence of mRNAs for cytoskeletal proteins such as β-actin and β-tubulin
and guidance cue receptor or pathway proteins such as EphA2 and RhoA, it is clear
that axonal RNA has a role to play in many different aspects of growth cone behaviour
and is important for axon guidance in many different axonal systems.
1.6 RNAs in thalamic axons
The above sections clearly show that locally translated mRNAs have many important
roles in axon guidance and that, as thalamocortical axons exhibit the same guidance
behaviours as axons from other systems, it is reasonable to investigate which mRNAs,
if any, are present in thalamocortical axons. In this section, the construction and
contents of a library of thalamocortical growth cone mRNAs is discussed, focussing
on one particular mRNA which was identified in this library, β-catenin. Finally, the
rationale for the work presented in the following chapters and the structure of the thesis
is given.
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1.6.1 A library of thalamic axonal mRNAs
A library of thalamic axonal growth cone mRNAs was constructed (T.Pratt, unpub-
lished). Thalamic axons were cultured and severed from cell bodies following Brittis
et al. (2002) and the mRNA from these axons was then cloned and sequenced with
the differential display technique (Liang and Pardee, 1992) with modifications for
increased efficiency and improved validation of results (Miele et al., 1998, 1999). In
this method, random 10mers and oligo-dT primers are used to reverse transcribe and
amplify as many mRNAs (which have poly-A tails) as possible using polymerase chain
reaction (Saiki et al., 1988). Because a limited set of random 10mers were used, this
library will not provide an exhaustive catalogue of axonal mRNAs. However, a number
of mRNAs were retrieved using this method. The mRNAs retrieved and the number of
times they were cloned are shown in Figure 1.13.
While this table shows that a wide variety of mRNAs was present in these thalamic
axon samples, it is striking that the only axonal mRNA identified in the literature which
appears in the library is β-actin, and that none of the other mRNAs in the library have
previously been found in axons. This could reflect differences in sensitivity of methods
used, or differences in axons from different parts of the nervous system. It should be
noted that Willis et al. (2007) also failed to find several known growth cone mRNAs
such as RhoA and EphA2 in their cDNA microarray study. In the case of EphA2
mRNA, this may be because, as it was shown to be present in spinal cord axons, it is
not present in the DRG axons that Willis et al. (2007) surveyed, but this explanation
does not hold for RhoA, which was previously discovered in DRG axons via in situ
hybridisation (Wu et al., 2005). Therefore it appears that there is variability in the
axonal complements of different systems and that some difficulty remains in accurately
and consistently identifying axonal mRNAs.
The library contains several mRNAs which are already linked to axonal function.
RPS3 (Lee et al., 2006) is a ribosomal protein, similar to the many ribosomal proteins
identified by Willis et al. (2007), further indicating that ribosomes are present in axons
and are apparently also constructed there via local protein synthesis. Reticulon-1 is one
of a family of reticulon proteins which are associated with the endoplasmic reticulum,
which is present in axons (Droz et al., 1975; Alvarez et al., 2000). Reticulon-1 has
been identified in hippocampal axons (Steiner et al., 2004) and interacts with spastin, a
protein which is mutated in hereditary spastic paraplegias, disorders which are believed
to be due to disruptions in axonal transport (Mannan et al., 2006).
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Small EDRK-rich factor 1 Coding and 3’UTR 3
Neurexin-1" Intron 2
Phosphogluconate dehydrogenase 5’UTR 2
RalA Coding 2






DNA polymerase ! Intron 1
EnTpD 1 3’UTR 1





tripartite motif-containing 59 Coding 1
Ubiquilin-1 5’UTR 1
Ubiquitin associated protein 2-like Intron 1
Nucleolar complex protein 14 Coding 1
Figure 1.13: A library of mRNAs isolated from samples of thalamic axons and identified by reverse
transcribing the mRNAs into cDNAs, then cloning and sequencing the cDNAs. The table shows the
names of the mRNAs identified with the number of times they were cloned.
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Synaptotagmin-1 is enriched in growth cones and is involved in calcium signalling
via vesicle trafficking (Kabayama et al., 1999); Synaptotagmin-13, which was found
in the thalamic axonal mRNA library, has a different structure to synaptotagmin-1 and
does not appear to be involved in calcium signalling but is still believed to have a
role in vesicle trafficking (Fukuda and Mikoshiba, 2001). The synaptotagmins also
interact with neurexin 1α, which was also found in the thalamic axonal mRNA library
(Fukuda and Mikoshiba, 2001). RalA, which is a small GTPase like RhoA (Lundquist
(2006), see Section 1.5.4), promotes neurite branching in cortical neurons (Lalli and
Hall, 2005) by acting via GAP-43, another protein whose mRNA is present in growth
cones (Smith et al., 2004).
One mRNA in the library, β-catenin, is of particular interest and has been chosen
as a focus for study in this thesis. The reasons for considering this a good candidate
for investigation are now discussed.
1.6.2 Potential roles for β-catenin in thalamic axonal development
β-catenin protein is expressed in the growth cones of DRG axons (Zhou et al., 2004b),
hippocampal axons and PC12 cell axons (Votin et al., 2005) as well as thalamic axons
(T. Pratt, unpublished data). It was the second most-cloned mRNA in the growth cone
library, with the ribosomal protein S3 being the most cloned and β-actin being the third
most-cloned (see Figure 1.13). This suggests that β-catenin has an important role, or
roles, to play in the growth of axons, which is beginning to be borne out by various
lines of evidence. β-catenin has critical roles in cell adhesion and Wnt signalling.
Indeed, there is considerable debate at present regarding the interactions between these
two processes, and it appears that β-catenin is one of the key protagonists in these
interactions (Nelson and Nusse, 2004; Bienz, 2005; Brembeck et al., 2006).
β-catenin is a member of the armadillo protein family, each of which contains
a central domain containing twelve ‘arm repeats’, which are 42-amino-acid motifs
which cluster together to form a positively-charged groove that binds to many different
negatively-charged ligands (Huber and Weis, 2001). The N-terminal and C-terminal
domains of the protein are less stable, with the exception of a highly conserved α-
helix at the N-terminal region of the C-terminal domain (Xing et al., 2008). These
ends are important for the recruitment of binding partners to the central domain,
and phosphorylation and dephosphorylation of these ends changes the protein-binding
capabilities of β-catenin (Daugherty and Gottardi, 2007).
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Figure 1.14a shows β-catenin (green circles) playing a critical role in cell adhesion,
forming a bridge between E-cadherin (grey bars) and α-catenin (black dots), which
connects to actin filaments in the cytoskeleton (black lines). The figure also shows how
Wnts, a class of morphogens which regulate many aspects of the embryonic body plan,
initiate transcription of target genes. In the absence of Wnts, a complex containing
Axin, CK1, APC and GSK3β phosphorylate β-catenin, causing it to be recognised
by the ubiquitin ligase subunit β-Trep, which targets β-catenin for ubiquitination and
degradation (Huang and He, 2008). Wnts bind to the cell surface receptors Frizzled
and Lrp6 and cytoplasmic protein Dishevelled, causing the phosphorylation of several
PPPSPxS (P, proline, S, serine, x, any residue) motifs in Lrp6. This phosphorylated
Lrp6 recruits a complex of Axin and GSK3β which inhibits GSK3β (Piao et al., 2008).
This prevents GSK3β from phosphorylating β-catenin and targeting it for degradation.
In the absence of phosphorylation, β-catenin is targeted to the nucleus by Pygopus
(Pygo) and Legless/BCL9-2 (Lgs). Here it binds to TCF transcription factors, which
stimulate the transcription of target genes.
The potential roles of cadherin-based adhesion and Wnt signalling in growth
cones will now be considered, with a focus on the involvement of β-catenin in these
processes.
1.6.2.1 Cadherin-based adhesion is involved in thalamocortical development
Growth cones must adhere both to the extracellular matrix via the class of adhesion
molecules known as integrins and sometimes to other cells or axons via the cadherins
in order to grow (see Section 1.2.3). These behaviours require a pool of β-catenin
which can be incorporated into adherens junctions, which suggests a role for local
translation of β-catenin mRNA.
β-catenin has been linked to axon guidance molecules via the adhesion pathway.
Rhee et al. (2002) demonstrate that Slit, via its receptor Robo, inactivates N-cadherin-
mediated adhesion in chick retinal axons by activating the tyrosine kinase Abl, which
phosphorylates β-catenin, causing it to dissociate from N-cadherins (see Figure 1.14b).
This causes the local retraction of parts of the growth cone while still allowing
other parts to continue to grow. The phosphorylated β-catenin is transported to the
nucleus and triggers transcription via TCF/Lef, although it is unclear which genes are
transcribed (Rhee et al., 2007). This strongly suggests that β-catenin is required at
thalamocortical growth cones, as thalamocortical axons are repelled by Slit expression
in the hippocampus (see Section 1.4.1.1).
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Figure 1.14: a) β-catenin (green circles) connects E-cadherin (grey bars) to actin filaments (black lines)
via α-catenin (black circles). In the absence of Wnt (left), β-catenin is phosphorylated by a complex
of Axin, CKI, APC and GSK (orange ovals). In the presence of Wnt (right), the complex is inhibited,
allowing β-catenin to be targeted to the nucleus by Legless (Lgs) and Pygopus (Pygo), where it binds to
TCF transcription factors and stimulates the transcription of target genes. b) Slit causes N-cadherin and
β-catenin to disassociate. On the left, Robo receptors bind to Abl, while N-cadherin connects to actin
filaments (red lines) via β-catenin and α-catenin (blue circle). On the right, Slit binding to Robo causes
Abl to bind to Cables (grey circle), which tyrosine phosphorylates β-catenin at Y489, causing β-catenin
to disassociate from N-cadherin. a) taken from Bienz (2005); b) taken from Rhee et al. (2002).
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In addition to this direct link between cell adhesion, β-catenin and axon guidance
molecules, there are a number of other links between β-catenin and molecules known
either to be present in, or to interact with, the growth cone, which have been discovered
in other cell-cell interactions.
As seen in earlier sections, the guidance cue ephrin-A5 is involved in many
stages of thalamic development; it is expressed in the thalamus, where it regulates
the topography of innervating retinal axons (see Section 1.3.3), it is expressed in the
ventral telencephalon, where it regulates the topography of growing thalamocortical
axons (see Section 1.4.2) and it is expressed in the cortex, where it is involved in inter-
and intra-areal patterning, lamination and thalamocortical innervation (see Section
1.4.3). Ephrin-A5 has also recently been shown to regulate the formation of adherens
junctions in the lens of the eye (Cooper et al., 2008). In ephrin-A5-/- knockout
mice, the shapes of lens cells are highly irregular, neighbouring lens cells are often
separated from each other by extracellular vacuoles (suggesting the lack of adherens
junctions) and N-cadherin, which is normally localised to lens cell membranes, is
instead distributed across the cytoplasm of lens cells.
The ephrin-A5 receptor EphA2 is co-expressed with β-catenin at lens cell mem-
branes in wild type and ephrin-A5-/- knockout mice, indicating that ephrin-A5 is not
required for β-catenin to associate with the EphA2 receptor. However, stimulation
with ephrin-A5 and EphA2 both independently increased N-cadherin and β-catenin
association (shown by immunoprecipitation for N-cadherin followed by Western blot
for β-catenin; Cooper et al. (2008)). This suggests that ephrin-A5 stimulation causes
cadherin-catenin complexes to form via EphA2. EphA2 appears to operate through
both the Src kinase and RhoA, phosphorylated by its kinase ROCK (Fang et al., 2008).
To date, expression of EphA2 protein in thalamocortical axons has not been
investigated, and EphA2 was not found in embryonic or postnatal cortex in a study
of EphA family expression (Yun et al., 2003). As seen in the earlier sections noted
above, ephrin-A5 in the brain appears to operate through EphA4, EphA5 and EphA7,
and so it may not regulate cadherin-catenin complexes in the brain as it does in the
retina via EphA2. However, as EphA4 has been shown to regulate both the formation
of adherens junctions and the level of actin filaments in Xenopus blastomeres (Winning
et al., 2001), and is also known to operate through ROCK to cause the collapse of rat
DRG axons (see Section 1.5.4), a link between EphA4 and β-catenin in thalamocortical
axons is certainly worthy of investigation.
In addition, ephrin-A5 has been shown to cause both the collapse of retinal growth
Chapter 1. Introduction 71
cones via ROCK and also the initial withdrawal of lamellipodia before collapse, which
is mediated through Abl (Harbott and Nobes, 2005). As Abl mediates Slit function
by phosphorylating β-catenin, it seems likely that ephrin-A5 also phosphorylates β-
catenin via Abl, thus preventing it from binding to cadherins and perhaps therefore
preventing the anchoring of lamellipodia, enabling their withdrawal. Similarly, Src
has been shown to phosphorylate β-catenin at tyrosine residue 654, which decreases
β-catenin binding to E-cadherin (Piedra et al., 2003); Src also phosphorylates N-
cadherin, which reduces its binding to β-catenin (Qi et al., 2006). Given Src’s known
role in EphA2 signalling (see above) and in initiating β-actin mRNA translation in
growth cones (see Section 1.5.5), it may be that Src is also linked to β-catenin function
in growth cones.
Finally, PI-3 kinase, which is required in growth cones for netrin-1 to induce
turning behaviour (see Section 1.5.2), has been shown to interact with β-catenin in
epidermal cells (Espada et al., 1999). β-catenin can be bound to PI-3 kinase, preventing
β-catenin from being phosphorylated. This increases the amount of β-catenin in the
cytoplasm and nucleus and therefore makes more β-catenin available for incorporation
into cadherin-catenin complexes. As with Abl and ephrin-A5, PI-3 kinase appears to
mediate lamellipodial extension specifically, and is not involved in the formation of
adherens junctions; this coincides with a strong co-expression of β-catenin with actin
filaments in lamellipodia (Gavard et al., 2004).
In summary, there is direct evidence that β-catenin is involved in axonal responses
to Slit and several reasons to believe that ephrin-A5 signalling involves β-catenin, and
both Slit and ephrin-A5 operate in thalamocortical axon guidance. In addition, several
proteins including Src, Abl and PI-3 kinase, which have been implicated in growth
cone function, are known to directly interact with β-catenin, increasing the likelihood
that the involvement of β-catenin in cell adhesion has a role to play in thalamocortical
development.
1.6.2.2 An alternative canonical Wnt signalling pathway is involved in axon
guidance
Given the strong evidence for β-catenin’s involvement in adhesion-related behaviours
in thalamocortical growth cones, does Wnt signalling involving β-catenin also have a
role in the development of thalamocortical axons? As has been discussed in Section
1.4.1.1, Wnts have been indirectly linked to thalamocortical axon guidance. Wnts
can act as guidance cues for axons, because vertebrate commissural axons have been
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Figure 1.15: a) A recent summary of the major Wnt signalling pathways: the canonical, β-catenin
pathway, the planar cell polarity (PCP) pathway and the calcium pathway. b) Wnt4 is expressed at the
midline of the spinal cord and influences the growth of commissural axons. FP, floor plate; A, anterior; P,
posterior. c) In addition to their roles in Wnt signalling, GSK3 and APC are also involved in microtubule
assembly via a neurotrophin (NGF)-PI3K pathway. PI3K also directly regulates actin polymerisation.
a) taken from Endo and Rubin (2007); b) taken from Charron and Tessier-Lavigne (2005); c) taken from
Arévalo and Chao (2005).
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shown to ignore Wnt4 as they approach the midline and become attracted to them
after midline crossing, causing them to turn anteriorly (see Figure 1.15b), whereas
Drosophila ventral nerve cord axons are repelled by DWnt5 (Zou, 2004). In addition,
Wnts are known to be expressed in the cortex during embryonic development and are
involved in cortical arealisation (Grove and Fukuchi-Shimogori, 2003), which may
mean they are involved in thalamocortical innervation of the cortex. There are also
several Wnt-related proteins including Lrp6, Frizzled-3 and Celsr-3 that have been
linked to thalamocortical development (see Sections 1.4.1.1 and 1.4.2).
However, to date Wnts have not been shown to directly influence thalamocortical
development and, in the cases noted above, it is unlikely that β-catenin is involved.
Wnt activity is mediated through several different pathways, the most well-understood
of which are canonical Wnt signalling, planar cell polarity (PCP) and Wnt/Calcium
signalling (see Figure 1.15a). β-catenin is only involved in canonical Wnt signalling,
which stabilises cell-cell adherens junctions and also causes transcription of many
target genes.
So far there is little evidence that the full canonical pathway is involved in axon
guidance. For example, Lrp6, which is required for the canonical pathway to function,
does not appear to be involved in the development of commissural axons, which
grow normally in Lrp6’s absence (Lyuksyutova et al., 2003); in addition, the lack
of thalamocortical axons in Lrp6 mutants appears to be due to severe defects in the
thalamus rather than changes in growth cone behaviour (Zhou et al., 2004a). It is most
likely that the PCP pathway (or a PCP-like pathway) is responsible for Wnt signalling
behaviour in axons (Zou, 2004; Price et al., 2006), as the lack of the PCP protein
Celsr-3 prevents thalamocortical axons from entering the internal capsule (see Section
1.4.1.1). The PCP pathway is also a more likely candidate for growth cone regulation
because it interacts with the cytoskeleton rather than initiates transcription (Goodrich,
2008) and is known to interact with Rho GTPases such as RhoA (see Section 1.5.4 and
Figure 1.15a).
However, in recent years it has been shown that a variant of the canonical Wnt
signalling pathway is involved in the regulation of microtubules (Salinas (2007); see
Figure 1.15c). As discussed in Section 1.5.1, both GSK-3β and APC, core components
of the β-catenin degradation complex in the canonical Wnt signalling pathway, are
involved in the regulation of microtubule growth and stabilisation. This pathway
has been shown to act in mouse DRG axons, not through Wnt, but through the
neurotrophin NGF (Zhou et al., 2004a). In these axons, NGF causes GSK-3β to be
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phosphorylated via PI-3 kinase. This phosphorylation prevents GSK-3β from binding
to APC, allowing APC to bind to the plus end of microtubules and stabilise them,
resulting in growth of the axon.
In canonical Wnt signalling, inactivating GSK-3β and APC in this way should
prevent the phosphorylation of β-catenin and enable the accumulation of β-catenin in
the cytoplasm, and indeed inhibiting either NGF or PI-3 kinase caused a decrease in
β-catenin levels in growth cones (Zhou et al., 2004b). However, it is unclear whether
this regulation of β-catenin by GSK-3β and APC has an effect on axon growth. Ciani
et al. (2004) show that Dishevelled, which is downstream of Wnt and Frizzled, is found
associated with axonal microtubules in the axons of cultured NB2a neurons, and also
inhibits GSK-3β via Axin, another member of the complex which targets β-catenin
for degradation in the canonical Wnt signalling pathway. This inhibition of GSK-
3β leads to an increase in β-catenin, but this increase is not required for Dishevelled
to stablise microtubules, and neither is β-catenin-driven, TCF-related transcriptional
activity (Ciani et al., 2004). Similarly, Orme et al. (2003) show that Axin and GSK-3β
are required for neurite outgrowth in neuroblastoma cells, but β-catenin/TCF-related
transcription and stablised β-catenin are not. However, in contrast, Votin et al. (2005)
show that not only are APC and β-catenin co-localised in the neurites of PC12 cells,
but also that there is a dose-dependent relationship between the quantity of stabilised
β-catenin in the neurites and neurite length, with higher levels of stabilised β-catenin
causing correspondingly greater inhibition of neurite growth.
It is not clear how these studies can be reconciled; it is possible that PC12 cells act
differently to COS-7 and neuroblastoma cells. It may also be due to different methods
of stabilisation of β-catenin; Orme et al. (2003) stabilise β-catenin by treatment with
Wnt3 or by expressing β-catenin attached to the phospholipid-binding domain of
AKAP79, and both approaches may prevent β-catenin from interacting with its usual
partners because of interference by Wnt3 or the AKAP79 domain. In contrast, Votin
et al. (2005) stabilised β-catenin by specifically removing its GSK-3β binding sites and
transcriptional transactivation domain, which may have more successfully preserved
β-catenin’s other binding abilities and enabled it to interact with neurite outgrowth-
regulating proteins.
Even if it proves that β-catenin is not required for neurite outgrowth, one coherent
interpretation of these results would be that β-catenin is upregulated in tandem with the
stablisation of microtubules, and this upregulation increases the formation of cadherin-
catenin complexes and therefore the stablisation of the actin cytoskeleton. The lack of
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β-catenin may not impede neurite outgrowth, but it does appear to affect axon guidance
via regulation of the actin cytoskeleton (see Section 1.6.2.1), and so it may be that β-
catenin is a crucial bridge between the action of microtubules and actin filaments.
In summary, the case for β-catenin’s involvement in variants of the Wnt signalling
pathway in thalamocortical axons is less clear than its role in adhesive behaviours in
these axons, and further studies are required to fully determine its behaviour in this
context. However, it is clear that β-catenin is present in growth cones, that a constant
supply of β-catenin is required to form cadherin-catenin complexes as the axon grows,
and that β-catenin accumulates when GSK-3β is inhibited. This suggests that β-catenin
is a strong candidate as a locally translated growth cone mRNA, and therefore the
presence of β-catenin mRNA in thalamocortical growth cones has been investigated in
detail in what follows.
1.6.3 Thesis rationale and structure
The library presented in Section 1.6.1 indicates that many mRNAs are present in
thalamic axons. However, the library requires validation from other sources of
evidence in order to be confident that the mRNAs in question really are present in
thalamic axons. Firstly, controls were not performed to test for the presence of cells in
the axonal samples. Secondly, the mRNAs were cloned using random primers rather
than gene-specific primers, and it is desirable to show that each mRNA is present using
specific probes or primers in order to be confident that the mRNA has been identified
correctly.
Therefore, this thesis describes the design and implementation of several methods
intended to validate this mRNA library by confirming the presence of these mRNAs
in thalamic axons. There are two major strands to this work: a series of quantitative
real time PCR (qRT-PCR) experiments on many mRNAs, and a number of in situ
hybridisation experiments primarily intended to identify β-catenin mRNA in thalamic
axons.
qRT-PCR, where gene-specific primers are used to exponentially amplify a par-
ticular cDNA sequence and measurements taken during amplification can be used to
quantify the amount of cDNA, has been chosen for use here due to its high sensitivity
and specificity. While qRT-PCR does not have the breadth of microarrays or SAGE
(serial analysis of gene expression), which can test for the expressions of thousands
of genes at a time, it is more specific and sensitive than either of these methods. Low
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abundance transcripts are often not detected using microarrays (Evans et al., 2003)
and SAGE does not detect specific genes but relies on amplification at restriction
enzyme sites and alignment of amplified sequences to reference sequences for gene
identification (Ding and Cantor, 2004); in this respect it is similar to the method used
to generate the library of thalamic mRNAs). qRT-PCR is capable of detecting single-
copy numbers of RNA molecules (Rameckers et al., 1997) and can be used with gene-
specific primers. Therefore it has been used to validate the library of thalamic axons
presented above.
The experiments carried out to identify mRNAs in samples of thalamic axons using
qRT-PCR are presented in Chapters 3 and 4 of the thesis, following the description
of a number of standard materials and methods in Chapter 2. Chapter 3 describes
the approach taken to harvest samples of uncontaminated axonal RNA from thalamic
axons for use in qRT-PCR experiments. Chapter 4 reports and analyses the results of
two sets of qRT-PCR experiments, testing for the presence of a subset of mRNAs from
the library described above in samples of thalamic axons harvested according to the
method described in Chapter 3.
While qRT-PCR is a very good method for confirming the presence of mRNAs in a
sample of tissue, it does not specify the location of mRNAs within the tissue. This is of
great interest with axonal mRNAs, because mRNAs are located in granules along the
axon and are also located in different parts of the growth cone (see Sections 1.5.4 and
1.5.5 for discussion). As it has not yet been possible to isolate growth cones away from
axons for quantification, it is necessary to use a method which can visualise mRNA in
intact growth cones and axons to observe axonal mRNA distribution. Therefore, in
situ hybridisation, where a probe which is specific for the mRNA of interest is bound
to mRNA in a tissue sample and detected using fluorescent antibodies or colorimetric
stains, has been used here to detect several mRNAs, in particular β-catenin.
The in situ hybridisation experiments carried out for this thesis are presented
in Chapters 5 and 6. Chapter 5 presents a number of in situ hybridisations on
cultured thalamic axons, primarily for β-catenin but also for β-actin and the ribosomal
RNA 18S. Chapter 6 presents a series of in situ hybridisations on coronal sections
of embyronic mouse brains, showing the thalamus and internal capsule during
thalamocortical development, in an attempt to identify β-catenin, β-actin, 18S and
RPS3 in these areas.





This chapter contains the protocols for all of the standard materials and methods used
to carry out the work described in this thesis. This includes tissue culture, molecular
biology, immunohistochemistry, reverse transcription polymerase chain reaction (RT-
PCR) and data analysis methods. Non-standard methods or methods which are
discussed within the following chapters are presented in the chapters where they are
relevant.
2.2 Tissue Culture
This section contains information about the animals and media used for the primary
thalamic cell cultures described in Chapters 3, 4 and 5.
2.2.1 Animals
All mice were housed and cared for under Home Office regulations.
2.2.2 Culture medium
Serum-free culture medium was prepared by mixing the following reagents together
under sterile conditions and stored for not more than two weeks at 4◦C until use.
Medium was warmed and equilibriated in a 37◦C humidified incubator containing 5%
CO2 for at least one hour prior to use.
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• 100ml F12, Hams (Sigma, Catalogue Number N4888)
• 100ml Dulbecco’s modified Eagles’ medium (DMEM) (Sigma, Catalogue
Number D5671)
• 1mg insulin (Sigma, Catalogue Number I6634), final concentration 5µg/ml
• 2mg apo-transferrin (Sigma, Catalogue Number T1147), final concentration
10µg/ml
• 3ml HEPES buffer (Sigma, Catalogue Number H0887)
• 0.24g Na2HCO3 (Sigma, Catalogue Number S5761), final concentration 0.12mg/ml
• 3ml antibiotics stock: 100mg gentamycin (Sigma, Catalogue Number G1264)
and 200mg kanamycin (Sigma, Catalogue Number K1377) added to 20ml sterile
double deionised water, filter-sterilised and stored at −20◦C .
• 2ml putrescene stock: 100µM stock, 161.1mg/100ml in sterile double deionised
water, filter-sterilised and stored at −70◦C (Sigma, Catalogue Number P5780),
final concentration 16.11µg/ml
• 20ul progesterone stock: 20µM stock, 6.29mg/100ml ethanol stored at −70◦C
(Sigma, Catalogue Number P8783), final concentration 6.29ng/ml
• 20ul Na2SeO3 stock: 30µM stock, 5.2mg/100ml in sterile double deionised
water, filter-sterilised and stored at −70◦C (Sigma, Catalogue Number S5261),
final concentration 5.2ng/ml
• 2ml L-glutamine stock: 0.2M stock, 6.344g/100ml in sterile double deionised
water, filter-sterilised and stored at −70◦C (Sigma, Catalogue Number G2128),
final concentration 25µg/ml
2.2.3 EBSS
Earle’s Balanced Salt Solution (EBSS) was prepared by mixing the following reagents
together under sterile conditions and stored for not more than two weeks at 4◦C until
use.
• 100ml Earle’s balanced salt solution 10X (Sigma, Catalogue Number E-7510)
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• 0.22g Na2HCO3 (Sigma, Catalogue Number S5761), final concentration 22mg/ml
• 0.065g glucose (Sigma, Catalogue Number G-7021), final concentration 6.5mg/ml
• 900ml double deionised water
EBSS was oxygenated by bubbling with 95% O2 and chilled on ice prior to use.
2.3 Molecular biology
This section contains details of the standard molecular biology techniques used to test
for the presence and quality of RNA in Figures 3.8, 4.7b and4.12b and used to generate
in situ hybridisation probes for the experiments presented in Chapters 5 and 6.
2.3.1 Gel electrophoresis
DNA and RNA samples were tested for size and purity using the following method.
1. Prepare an agarose (Sigma) solution of 1% agarose: 0.5g agarose in 50ml
1xTBE.
2. Microwave on medium power for 2 minutes, replacing evaporation losses with
ddH2O.
3. Add 1ul SYBRSafe (Invitrogen) and mix gently.
4. Pour into a gel casting tray and immediately insert comb.
5. Allow to set for 30 minutes.
6. Prepare sample DNA/RNA by adding 1µl 6X loading buffer per 5µl sample.
7. Load 6µl sample per well.
8. Run gels at 80V for 30 minutes or until bands have resolved.
9. Visualise by exposure to UV light.
1xTBE was diluted from a 10xTBE solution (108g Tris Base, 55g Boric Acid,
20mL 0.5M EDTA, with Water up to 1L).
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2.3.2 Templates
As described in Chapter 5, two long β-catenin probes were constructed and used for in
situ hybridisation experiments. The β-catenin clones used to make these probes were
inserted into a vector and amplified. The clones were then cut out of the vectors to
produce cDNA templates for each probe. The cDNA templates were then transcribed
into RNA probes. These methods used to produce the RNA probes are now described.
For details of vectors, restriction enzymes, promoters and RNA polymerases used, see
Section 5.2.1.
2.3.2.1 Insertion of clone into vector
Clones were inserted into new vectors by cutting the clones from their existing vectors
with the appropriate restriction enzymes. The strands were separated on a gel. To
confirm that the DNA had been cut successfully and to identify the required strands of
DNA, a 1Kb DNA ladder was run alongside three controls for each vector; a vector cut
with the first restriction enzyme only, a vector cut with the second restriction enzyme
only and an uncut vector. The clone sequence and the vector were cut out of the gel and
the DNA extracted from the agarose gel using a QIAquick Gel Extraction Kit (Qiagen,
Catalogue Number 28704) following manufacturer’s instructions. The elutions from
the kit were run on a gel to confirm the presence of both DNA strands. The strands were
then ligated overnight at 4◦C using T4 ligase (Roche, Catalogue Number 481220). The
successful incorporation of the template into the vector was confirmed by sequencing.
2.3.2.2 Transformation of vectors into bacteria
The ligated vector produced above, containing a clone within a vector, was transformed
into bacteria for amplification as follows.
1. Add 2µL of ligation reaction and 50µL of JM109 Competent Cells (Stratagene,
Catalogue Number 200235) to a 10 mL sterile tube.
2. Mix gently and leave tubes on ice for 20 minutes.
3. Heat shock cells in waterbath for 45-50s at 42◦C.
4. Put tubes on ice for 2 minutes.
5. Add 950µL of room temperature SOC medium (Sigma, Catalogue Number
S1797).
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6. Incubate for 1-1.5 hours at 37◦C, shaking at 200rpm.
7. Plate cells on agar plates (see below for protocol) and leave to dry for half an
hour.
8. Incubate plates at 37◦C overnight.
A single bacterial colony was taken from an incubated plate and incubated
overnight in LB broth (see below for protocol). The DNA from these liquid cultures
was purified using a QIAprep Spin Miniprep Kit (Qiagen, Catalogue Number 27104).
The DNA was then tested by cutting with the appropriate restriction enzymes and
running on a gel to confirm that both the clone sequence and vector were present. The
DNA was then sent for sequencing by MWG Biotech to confirm the presence of the
expected clone sequence.
Agar plates for this protocol were prepared as follows:
1. Stir 17.5g of LB Agar powder (Sigma, Catalogue Number L2897) in 500mL
ddH2O in 1L conical flask.
2. Autoclave flask and keep at 50◦C in water bath until ready to pour.
3. Add 500 µL of 100mg/mL ampicillin (Sigma, Catalogue Number A5354) and
mix gently.
4. Pour molten solution into petri dishes in flow hood.
5. Leave to set for 1 hour and store upside down at 4◦C until ready to use.
LB Broth for this protocol was prepared as follows:
1. Add 1 LB tablet (Sigma, Catalogue Number L7275) for each 50mL of water.
2. Autoclave to dissolve tablet and cool to room temperature.
3. Add ampicillin at 100µg/mL.
2.3.2.3 Amplification and isolation of cDNA templates
Having created and tested a vector containing the required clone, this vector could
be amplified and cut to create Antisense and Sense templates. The amplification was
carried out as follows.
Chapter 2. Materials and Methods 82
1. Prepare a starter culture by incubating a single bacterium in 3mL LB Broth
containing 3µL ampicillin for 8 hours.
2. Make 150mL LB Broth and add 150µL ampicillin and 300µL of the above starter
culture.
3. Incubate overnight at 37◦C, shaking at 200rpm.
4. Purify DNA from liquid culture using a Qiagen Plasmid Maxi Kit (Qiagen,
Catalogue Number 12162).
5. Quantify purified DNA using a mass spectrometer.
Antisense and Sense cDNA templates were cut from the vector prepared above
by incubating the vector overnight at 37◦C in ddH2O with the appropriate restriction
enzymes for each strand, in both cases adding Buffer H (provided with restriction
enzymes).
2.3.3 In vitro transcription of labelled probes from cDNA templates
The cDNA templates produced above were used to transcribe Antisense and Sense
RNA probes, labelled with digoxigenin, as follows:
1. Mix 1µg of linearised cDNA template with 2µL DIG RNA Labeling Mix (Roche,
Catalogue Number 11277073910), 2µL of the appropriate RNA Polymerase,
2µL 10xTranscription buffer (provided with RNA Polymerases) and sterile
RNase free ddH2O, to 20µL.
2. Centrifuge briefly and incubate for 2 hours at 37◦C.
3. Add 2µL DNase I, RNase free (Roche, Catalogue Number 10776785001) and
incubate for 15 minutes at 37◦C.
4. Stop the reaction by adding 2µL 0.2M EDTA (pH 8.0).
5. Add 2.5µL 4M LiCl and 75µL prechilled ethanol and mix well.
6. Leave for 2 hours at −20◦C and centrifuge for 5 minutes at 13000xg.
7. Decant the ethanol and dry the pellet.
8. Dissolve pellet in 50µL sterile RNase free ddH2O.
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2.4 Immunohistochemistry and In Situ Hybridisation
Standard protocols and solutions for immunohistochemistry and in situ hybridisation
follow. Specific in situ hybridisation protocols are presented in Chapters 5 and 6.
2.4.1 Immunohistochemistry
Immunohistochemical staining of thalamic explants with axonal growth, presented
in Chapter 3, was carried out as follows. All treatments were performed at room
temperature unless otherwise stated.
1. Fix explants in 4% PFA for 30 minutes.
2. Permeabilise for 15 minutes in 1% Triton-X/1xPBS.
3. Pre-treat with blocking solution for 30 minutes.
4. Treat with primary antibody (neurofilament (Biomol, Catalogue Number NA1297-
0100), 1:150 in antibody blocking solution) overnight at 4◦C.
5. Rinse with 1xPBS for 5 minutes.
6. Treat with secondary antibody (Alexa Fluor 488 anti-rabbit (Invitrogen (Molec-
ular Probes), Catalogue Number A11008), 1:200 in antibody blocking solution)
for 2 hours.
7. Apply nuclear counterstain (propidium iodide) for 10 minutes.
8. Wash three times with 1xPBS for five minutes each.
9. Mount using Mowiol and store in the dark at 4◦C until ready to view.
2.4.2 Solutions
In this section, protocols and recipes are presented for the solutions required for the
immunohistochemical and in situ hybridisation protocols described in Chapters 3, 5
and 6.
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2.4.2.1 DEPC Water
All solutions used prior to and including hybridisation of in situ probes were made
with DEPC water, which was prepared as follows. Bottles and stirrers were baked
at 150◦C for 4 hours before use. Bottle tops were autoclaved. 2mL DEPC (Diethyl
pyrocarbonate, Sigma, Catalogue number D5758) was added for every 1L of ddH2O
and stirred overnight. After stirring, bottles were heated at 60◦C for 1 hour and
autoclaved.
2.4.2.2 4% PFA
4g of paraformaldehyde was added for every 100mL of 1xPBS. 50µL 10M NaOH
was added and the solution was heated to 55◦C and shaken in a waterbath. After the
paraformaldehyde had completely dissolved, the solution was cooled to room temper-
ature. Finally, the solution was adjusted to the appropriate pH (7.5 unless otherwise
stated), tested using pH indicator sticks (Fisher, Catalogue Number FB33003).
2.4.2.3 Immunohistochemistry






– DEPC-treated water up to 250mL
• Antibody blocking solution
– 0.06g BSA
– 0.2mL Goat Serum
– 0.2mL Tween-20
– 1xPBS up to 20mL
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2.4.2.4 Fluorescent axonal in situ hybridisation
The following solutions were used for the fluorescent axonal in situ hybridisation
protocol described in Section 5.2.3.2. See previous section for other solutions.
• 10xTBS buffer
– 87.66g NaCl
– 24.228g Tris Base
– pH to 7.5
• 20xSSC
– 87.66g NaCl
– 44.12g Trisodium citrate
– ddH2O to 500mL
– pH to 7.5
• Acetylation solution
– 10mL 100mM HEPES (Sigma, Catalogue Number H4034), pH 8.0
– 25µL Acetic anhydride
• Hybridisation buffer
– 40% Formamide
– 10% Dextran sulphate
– 4xSSC
– 20mM Ribonucleoside vanadyl complex (New England Biolabs, Catalogue
Number S1402S)
– 10mM DL-Dithiothreitol (Sigma, Catalogue Number 43819)
– 1mg/ml yeast tRNA (Roche, Catalogue Number 10109495001)
– 1mg/ml salmon sperm DNA (Sigma, D7656)
• Antibody blocking solution
– 100mM Tris Base, pH 7.5




– 2.5% Goat Serum
– 2.5% Horse Serum
2.4.2.5 Colorimetric axonal in situ hybridisation
The following solutions were used for the colorimetric axonal in situ hybridisation
protocol described in Section 5.2.3.2. See previous sections for other solutions.
• 1xPBT
– 0.1% Tween-20 in 1xPBS
• Buffer 3
– 12.1g Tris Base
– 5.8g NaCl
– ddH2O to 1L
– pH to 9.5
– Add 10.15g Mg2Cl2
• Hybridisation buffer
– 5mL Formamide
– 2.5mL 20xSSC pH 4.5
– 100mg B-Block
– 2mL DEPC Water
– Dissolve in water bath at 65◦C
– 100µL 0.5M EDTA
– 100µL Tween-20
– 100µL CHAPS, 10% in H2O
– 4µL 50mg/mL Heparin
– 200µL 50mg/mL yeast tRNA, pre-denatured at 95◦C for 5 minutes
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2.4.2.6 Wax section in situ hybridisation
The following solution was used for the wax section in situ hybridisation protocol
described in Section 5.2.3.1. See previous sections for other solutions.
• 10xTEA
– 133mL Triethanolamine, pH 8
– Add ddH2O to 1L
2.4.2.7 Vibratome section in situ hybridisation
The following solutions were used for the vibratome section in situ hybridisation








– 62.5ml 1M Tris-HCl, pH 7.5




– ddH2O to 500mL
• NTMT
– 10mL 5M NaCl
– 50mL 1M Tris-HCl, pH 9.5
– 25 mL 1M MgCl2
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– 5 mL Tween-20
– ddH2O to 500mL
• Solution 1
– 500mL Formamide
– 250mL 20xSSC, pH 4.5
– 10g SDS
– ddH2O to 1L
• Solution 3
– 500mL Formamide
– 100mL 20xSSC, pH 4.5
– ddH2O to 1L
• Hybridisation buffer
– 25mL Formamide
– 12.5 mL 20xSSC, pH 4.5
– 0.25mL tRNA (10mg/mL)
– 0.5g SDS
– 0.25mL 10mg/mL Heparin
– DEPC Water to 50mL
2.4.2.8 Mowiol mounting medium
Mowiol mounting medium solidifies once used and allows direct mounting of the
coverslips onto glass slides. Once mounted, the coverslips can be viewed with
immersion lenses as the coverslips will not move. The coverslips are also removeable
by gently sliding off the side of the slide, using tweezers. The Mowiol can be removed
by immersing the coverslips in ddH2O for a few minutes.
1. Add 2.4g Mowiol (Calbiochem Catalogue Number 475904) to 6g of Glycerol
(Glycerol density = 1.26g/ml - for 6g = 6/1.26 = 4.76 mls) in a 50ml conical
flask.
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2. Stir with a pipette to mix.
3. Add 12ml dH2O and leave stirring for several hours or overnight at room
temperature.
4. Add 12ml 0.2M Tris (pH8.5) and heat to 50◦C for 1-2hr or until Mowiol is
completely dissolved. Vortex occasionally. (1M Tris = 121.14 g/l, 100nM =
12.114g/l, 200nM = 24.228g/l or 2.423g/100ml)
5. Centrifuge at 2000rpm for 15 minutes.
6. Add 1,4-diazobicyclooctane (DABCO) Sigma (Antifade) to 2.5% (=0.72g)
Aliquot and store at −20◦C.
7. Centrifuge before use to pull down any bubbles.
2.5 Extraction and amplification of RNA for RT-PCR
and qRT-PCR
In this section, the protocols and programs used for cDNA synthesis, RT-PCR and
qRT-PCR are described.
2.5.1 cDNA synthesis
cDNA synthesis was carried out using SuperScript III First-Strand Synthesis SuperMix
kits (Invitrogen, Catalogue Number 18080400) on a PTC-225 thermal cycler (MJ
Research).
1. Mix RNA with 1µL random hexamers, 1µL annealing buffer and RNase/DNase-
free water to 8µL. For the qRT-PCR experiments described in Chapter 4, 1µL of
Cells RNA was used to 5µL of water, whereas 4µL of Axons, Blank Near and
Blank Far RNA was used to 2µL of water, to improve the amplification of these
samples.
2. Incubate in a thermal cycler at 65◦C for 5 minutes.
3. Place tubes on ice for at least 1 minute and centrifuge briefly.
4. Add 10µL of 2xFirst-Strand Reaction Mix and 2µL of SuperScript III/RNase-
OUT Enzyme Mix, mix by pipetting and centrifuge briefly.
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5. Incubate in a thermal cycler at 25◦C for 10 minutes, 50◦C for 50 minutes and
85◦C for 5 minutes.
6. Chill tubes on ice and store at −20◦C.
2.5.2 Standard RT-PCR
The standard RT-PCR program used to produce the results for Figure 3.8 ran as follows
on a DNA Engine Dyad thermal cycler (MJ Research):
1. 94◦C for 5 minutes
2. Cycle 30 times:
(a) 94◦C for 1 minute (strand denaturation)
(b) 55◦C for 1 minute (primer annealing)
(c) 72◦C for 1 minute (strand elongation)
3. 70◦C for 10 minutes
2.5.3 Quantitative RT-PCR
Quantitative RT-PCR experiments were carried out using Quantitect Sybr Green
PCR Kits (Qiagen, 204143). All tubes were prepared and kept on ice throughout.
Primer mixes containing left and right primers were prepared with 12.5µL left primer,
12.5µL right primer and 75µL sterile RNase-free water. Master mixes were prepared
containing 12.5µL SYBR Green, 1µL primer mix and 10.5µL RNase-free water for
every tube required in the reaction. Each tube was prepared with 1µL cDNA and 24µL
master mix. Tubes were mixed by pipetting and centrifuged briefly. 24µL from each
tube was added to 8-tube strips with clear caps (Biorad, Strips Catalogue Number TLS-
0851, Caps Catalogue Number TCS-0803). Tube strips were spun briefly. Reactions
were performed on a DNA Engine Opticon System (MJ Research) with initial data
analysis performed using Opticon Monitor v1.08. The following program was used
for all qRT-PCR experiments:
1. 95◦C for 5 minutes
2. Cycle 50 times:
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(a) 94◦C for 15 seconds
(b) 55◦C for 30 seconds
(c) 72◦C for 30 seconds
3. Run melting curve: from 60−95◦C, read plate, hold for 1 second and increment
temperature by 1◦C.
r2 values and melting curve peaks were provided by the Opticon Monitor software.
The cycle threshold for each RNA was chosen at the point in the region of exponential
amplification where r2 was highest. Following standard practice, percentage efficien-
cies was calculated as E = (10−1/Slope− 1) ∗ 100, where Slope is the slope of the
standard curve regression line, provided by the Opticon Monitor software.
2.5.4 Primers
Primers were designed using PerlPrimer (Marshall, 2004) using the Ensembl se-
quences listed in Table 4.5 as input. The primers were checked for other matching
sequences against the mouse genome using BLAST (Altschul et al., 1990). PerlPrimer
produces a list of likely primer-dimers and primers with low probability of forming
primer-dimers were selected based on this list. The primers were all designed to be
intron spanning except for 18S, which only has one exon. Primers were supplied by
MWG Biotech.
2.6 Equipment and software
In this section, the tools used to analyse data and prepare this thesis are listed.
2.6.1 Microscopy
2.6.1.1 Light microscopy
Slides were photographed using a Leica DMLB upright compound microscope
connected to a Leica DSC480 digital camera, using Leica IM50 image management
software.
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2.6.1.2 Confocal microscopy
Fluorescent staining was viewed using a Leica DMRE compound microscope, part of
a Leica TCS NT confocal system using ‘Leica Lite’ software.
2.6.2 Software
Figures and tables were prepared using Numbers, the spreadsheet program in Apple’s
iWork’08 office suite (www.apple.com/iwork/). Numerical and statistical analysis
was performed using iWork and NeoOffice (www.neooffice.org). Figures 4.1,
4.2 and 4.9 were produced using the Opticon Monitor software which controlled
the qRT-PCR machine. Figure 4.11 was produced using R (R Development Core
Team, 2008), using the errbar function in the package Hmisc (Harrell, 2005).
The image editor Pixelmator (www.pixelmator.com) was used to carry out minor
edits on the figures in Chapter 1, draw the diagram in Figure 3.2 and to remove
air bubbles and other debris from the images in Chapter 6. The thesis, includ-
ing all mathematical formulae, was typeset in LaTeX using the editor TeXShop
(www.uoregon.edu/˜koch/texshop/) and a template by Mary Ellen Foster (avail-
able from www.inf.ed.ac.uk/systems/tex/local-packages.html).
Chapter 3
Harvesting Axonal RNA for
Amplification by qRT-PCR
3.1 Introduction
The identification of multiple RNAs in an axonal system poses a number of technical
challenges. Firstly, the detection of the very small amounts of RNA present in axons
requires an extremely sensitive identification method. Secondly, the method should be
high throughput, so that many RNAs can be tested with a relatively small amount
of time and effort. To meet these challenges, a method using quantitative reverse
transcription polymerase chain reaction (qRT-PCR) technology has been developed.
This chapter explains and justifies the novel development of a method for harvesting
axonal RNA in such a way that the amounts of RNA in axons can be quantified by
qRT-PCR. Chapter 4 describes the quantification of thalamic RNA harvested using
this method.
3.2 Materials and methods
3.2.1 Harvesting of RNA
A method for isolating axonal RNA from embryonic thalamic axons is now described,
which should be applicable to any axonal system which will grow in culture. A flow
diagram of the entire method can be seen in Figure 3.1. For detailed protocols and
recipes, see Section 2.2. The qRT-PCR design will be more fully explained in Chapter
4.
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Figure 3.1: Flow diagram of a method for harvesting and quantifying thalamic axonal RNA. 1. Both
thalami from up to 12 coronal sections of E14.5 mouse brains were dissected along the lines shown
in red, producing up to 24 thalami. 2. Explants were cultured in serum-fed medium on collagen-
coated Teflon inserts for 4-6 days to produce axonal carpets. 3. Inserts were dissected into four sets
of pieces: axonal carpets, labelled Axons, explants, labelled Cells, blank pieces of insert next to the
explants, perpendicular to the direction of fibre growth, labelled Blank Near, and blank pieces of insert
from the edges of the insert, labelled Blank Far. Pieces of insert were stored in the RNA stablisation
buffer RNAlater at 4◦C for 0-2 days. 4. RNA was extracted at most two days after dissection. 5.
cDNA was synthesised from extracted RNA using reverse transcription. One cDNA synthesis reaction
was performed for each sample of RNA (C, A, BN, BF) and the No RNA control. In addition, a tube
containing no reverse transcriptase was processed using the cDNA synthesis protocol for each of the
four RNA samples (C, A, BN, BF) to control for the presence of contaminating DNA. 1µL of Cells
RNA was used for each of the C and CnoRT reactions, whereas 4µL of Axons, Blank Near or Blank
Far RNA was used for each of the A, AnoRT, BN, BNnoRT, BF and BFnoRT reactions respectively to
improve the amplification of small signals. A tube containing no RNA, labelled No RNA, was processed
using the cDNA synthesis protocol to control for the presence of contaminating RNA during processing.
6. qRT-PCR was performed on three samples at a time (for full details, see Chapter 4). Abbreviations:
C, Cells; A, Axons; BN, Blank Near; BF, Blank Far; noRT, No Reverse Transcriptase.
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3.2.1.1 Culture
Embryonic mouse brains (CBA strain, E14.5) were dissected in ice-cold oxygenated
EBSS. Each brain was sliced coronally into 200µm sections using a MacIlwain Tissue
Chopper (Mickle, UK). Thalamic sections were dissected from these brain sections
using sterile technique. The epithalamus and prethalamus were removed, leaving the
thalamus (see Figure 3.2). These thalamus explants were placed on Costar collagen-
coated Teflon inserts, 24mm membrane diameter, 3µm pore size (Fisher Scientific, UK)
in 6-well dishes containing 75% basal culture medium (see Section 2.2 for recipe),
25% fetal calf serum, pre-incubated at 37◦C in 95% oxygen, 5% carbon dioxide.
Twenty-four explants were prepared for each culture, with three explants in each of
eight inserts.
3.2.1.2 Dissection
The explants were cultured for 4-6 days, during which time the explants adhered to
the insert and axons grew along the fibres of the membrane. The inserts were then
dissected and the pieces placed into sterile 1.5ml Eppendorf tubes each containing
350µl of RNAlater (Qiagen), an RNA stabilisation agent which neutralises RNAses. A
schematic of the dissection for one well is shown in Figure 3.3.
Four sets of pieces of insert were dissected: Cells, Axons, Blank Near and Blank
Far. Cells was the explants, Axons was the axonal carpet and Blank Near and Blank
Far were pieces of insert which appeared to be free of tissue and uncontaminated.
Blank Near pieces were taken from blank regions roughly as far from each explant
as the pieces of insert containing the axonal carpets, in the direction perpendicular
to the direction of fibre growth. Blank Far pieces were taken from the edges of the
insert away from all explants. The Blank Near pieces were dissected first, followed by
Axons, Cells and Blank Far (the reason for dissecting pieces in this order is explained
in Section 3.4.1).
For each well containing three explants, all three Blank Near pieces of insert were
dissected, followed by all three Axon pieces and so on, in order to minimise cross-
contamination. A different sterile scalpel blade and different sterile pair of forceps
were used to dissect and transfer each type of insert piece. Before dissection, inserts
were inspected for contamination under the microscope by eye and only included if
no cells or other contaminating matter could be seen (see Section 3.3.2 for further
discussion).





Figure 3.2: A diagram of a coronal section of an E14.5 mouse brain. Cuts were made along the red lines
to isolate the thalamus. Key: t, thalamus, pt, prethalamus, e, epithalamus, ge, ganglionic eminences.





Direction of fibre growth
Figure 3.3: A schematic representation of the dissection of a single insert into four sets of pieces:
Cells (shown in red), Axons (green), Blank Near (orange) and Blank Far (blue). Blank Near
sections taken perpendicular to the direction of growth (see arrow). Images of explants taken from
immunohistochemical stains for neurofilament.
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3.2.1.3 RNA extraction and cDNA synthesis
The pieces of insert containing cellular and axonal tissue, as well as blank pieces
of insert, were kept at 4◦C in RNAlater and homogenised using a rotor-stator
homogeniser. The RNA was extracted from the homogenised tissue 0-2 days after
dissection using a QIAGEN RNeasy Micro Kit, following manufacturer’s instructions
and including DNAse treatment. 20µL cDNA was synthesised from this RNA for use
in qRT-PCRs (see Section 2.5 for detailed methods). 1µL of RNA was used for each
Cell condition, as this was sufficient to detect a signal from the Cells, whereas 4µL of
RNA was used for each of the Axon, Blank Near and Blank Far conditions. Several
control conditions were generated in addition to the four Cells, Axons, Blank Near and
Blank Far conditions. Samples of each of the four cultured conditions containing no
reverse transcriptase were run through the cDNA synthesis procedure, to control for the
detection of any remaining DNA in these samples apart from any newly synthesised
cDNA. These No Reverse Transcriptase (noRT) tubes were labelled CnoRT, AnoRT,
BNnoRT and BFnoRT, for Cells (C), Axons (A), Blank Near (BN) and Blank Far
(BF) respectively. In addition, a tube containing water alone, labelled No RNA, was
processed using the cDNA synthesis kit, to detect any contaminating RNA.
3.2.2 Other methods
Explants for all figures in Section 3.3 were cultured and dissected according to the
method in Sections 3.2.1.1 and 3.2.1.2, except for those in Figure 3.4, where fetal calf
serum was added to or omitted from the culture medium as noted, and those in Figure
3.7 (see Section 3.2.2.2 below). Methods for standard RT-PCR and gel electrophoresis
for Figures 3.8, immunohistochemistry for Figures 3.3, 3.4 and 3.6 and microscopy
and image analysis for all figures are described in Chapter 2.
3.2.2.1 Use of GFP embryos
Figure 3.5 shows an explant cultured from embryos collected from a transgenic mouse
which ubiquitously expresses green fluorescent protein (GFP) (strain T P6.3[tauGFP+],
Pratt et al. (2000)). Embryos from this mouse were cultured in the same way as wild-
type embryos. The embryos were confirmed to be expressing GFP before dissection
by inspecting them under fluorescent light.
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3.2.2.2 Optimisation of RNA extraction method
Explants for the RNA extraction tests shown in Figure 3.7 were dissected according
to the method in Section 3.2.1.1 but were not cultured. Explant pieces were taken
from a single explant which was cut in half and then in half again. Two quarters of
equivalent size (established by eye under the microscope) were selected and used for
RNA extraction. RNAlater samples were homogenised just before RNA extraction.
QIAGEN Micro and Mini Kits were used according to manufacturer’s instructions.
qRT-PCRs were run according to the method in Section 2.5.3 using primers for β-actin
(see Figure 4.5). A standard curve dilution series for units 1000, 500, 250 and 125 was
used for quantification, prepared from cDNA synthesised from RNA from thalamic
explants prepared as above.
3.3 Results
In the course of designing the method described in the previous section, several
experiments were carried out to optimise the isolation of axonal RNA. The results
of these experiments are presented here and will be discussed in the following section.
3.3.1 Effect of serum
To maximise the amount of axonal growth, 25% fetal calf serum was added to basal
culture medium at the beginning of the axonal culture. Figure 3.4 shows that, whereas
explants in serum-free medium produced short axons which require high magnification
to be seen clearly (see Figure 3.4e), explants in medium with serum added grew many
long axons which in some cases were as long as the explant itself (see Figure 3.4a).
The figure shows three serum-fed explants and three serum-free explants which were
selected from four serum-free explants and six serum-fed explants; the same difference
in growth was seen across all serum-free and serum-fed explants. As a result of these
tests, serum was used in all subsequent cultures.
In the pictures in Figure 3.4, cells can be seen to be spread out around the explant
and on the axons. This is due to cells being dislodged during the immunohistochem-
istry procedure and not because the cells were present at time of dissection. For
evidence of this, see Section 3.3.3.
































































































































































Chapter 3. Harvesting Axonal RNA for Amplification by qRT-PCR 101
3.3.2 Test using GFP mouse embryos
Not all explants would grow axons and some axonal carpets would become contami-
nated with cells. Usable pieces of insert were identified by eye under the microscope
using white light. As it was thought possible that cells would not be visible under this
light, embryos from a transgenic GFP mouse, which express green fluorescent protein
(GFP) throughout, were cultured and examined under fluorescent light. Figure 3.5
shows one of these GFP explants under white light and fluorescent light. As cells are
clearly visible in a number of different places on this explant, it would not have been
included for use in an RNA sample. It can be seen that there is no substantial difference
in clarity between the two pictures; in fact, it is perhaps easier to see cells under white
light than under GFP. Therefore all samples were collected from wild-type embryos
dissected under white light.
3.3.3 Test for cellular contamination
To increase confidence that the RNA extracted from axonal samples was indeed
axonal rather than cellular, some dissected axonal inserts which were believed to be
free of cells during dissection were stained for the axonal marker neurofilament by
immunohistochemistry and by the fluorescent dye and cell marker propidium iodide.
Figure 3.6 shows that, if whole explants with intact axons are stained, cells are found
to be present around the explant and on the axons. However, if the axons are dissected
away from the explants before staining commences, no cells can be detected on the
axonal carpets. Therefore, although the axons which were actually used for the qRT-
PCR experiments in Chapter 4 could not be tested in this way because the tissue was
homogenised in order to extract the RNA, it is believed that no cells are present in
these samples based on these tests.
3.3.4 Storage of RNA
Once the explants have been dissected, there are a number of different ways to store
and extract RNA from each set of explants. Figure 3.7 shows that storing explants in
RNAlater and using a QIAGEN RNAeasy Micro Kit to extract the RNA produced the
highest RNA yield.
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a
b
Figure 3.5: Cultured explant from a GFP mouse photographed using (a) fluorescence and (b) white
light. Arrows point to cells on the axonal carpet, showing that cells are easier to identify under white
light than under fluorescence. Scale bar, 20µm.
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Figure 3.7: Comparison of RNAlater and lysis buffer storage and QIAGEN RNeasy Micro and Mini
kits. The kit, storage buffer and temperature for each test are listed. Yield of RNA shown in units based
on qRT-PCR using arbitrary 1000-unit scale. Tests not performed are labelled N/A.
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3.3.5 Number of explants
The limit of detection of RNA was investigated by reducing the number of explants
in each sample. Figure 3.8 shows the result of attempts to detect axonal RNA with
small numbers of explants. 18S ribosomal RNA and β-actin and β-catenin mRNA
were tested as representative RNAs of interest; 18S because ribosomes are known to
be present in axons and rRNA is expected to be more abundant than mRNAs, and the
mRNAs because β-actin mRNA has been found in several other axonal systems and β-
catenin was identified in Thomas Pratt’s library of thalamic mRNAs (see Sections 1.5.5
and 1.6.2 for discussion). While it was possible to detect 18S ribosomal RNA in axonal
samples from 1, 7 or 12 explants, it was not possible to detect β-actin or β-catenin from
12 explants, indicating that more than 12 explants are required to ensure the possibility
of detecting small quantities of mRNAs in axons, including at least two of the mRNAs
of interest identified in Thomas Pratt’s library of thalamic axonal mRNAs (see Section
1.6.1). However, it was possible to detect 18S, β-actin and β-catenin in a 16 explant
sample. Therefore 16 explants or more should be sufficient to detect at least these three
RNAs in axons.
Because of this result, each RNA sample contained at least 15 explants (see Section
4.4.2 for details of the collected usable samples).
3.4 Discussion
In this section, the decisions made during the design of the above method are discussed
and justified. The criteria for considering an RNA to be present in axons and the
choices made in the design of the culture system and RNA extraction process are
explained.
3.4.1 Is the RNA axonal?
If an RNA is found to be present in a sample of axonal tissue, does this mean the RNA
was present in the axons? In fact, there are a number of sources of contamination
which must be controlled for before it is valid to claim that the RNA is indeed axonal.
Contamination may come from one of three sources. Firstly, as the axons are grown
from thalamic explants, cells from the explants may be found to have floated onto or
migrated with the axons (as axon growth and neuronal migration are closely linked;
see, for example, Guan et al. (2007)), or dying cells may have burst and released
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mRNA into the culture medium. Secondly, despite being prepared in sterile conditions,
contaminants may be introduced into the culture system during the culturing or
incubation of the explants. Thirdly, contaminants might be introduced during the
extraction and quantification of RNA.
Contamination from floating cells or other sources in the culture system is
controlled for with the two blank conditions, Blank Near and Blank Far. The Blank
Near pieces, from next to the explant, are dissected first, followed by the axonal tissue,
as the dissection of the axonal tissue, which involves severing the axonal tissue from
the explant, might cause many cells to float onto what was a blank piece of insert.
However, performing the dissection in this order might cause cells to float onto the
axonal tissue. To control for this possibility, the Blank Far pieces are dissected at
a distance from the explant after the explants are removed. This piece of insert is
considered to control for floating cells and any other contaminants which may have
entered the culture system.
The explants, labelled Cells, are quantified for two reasons. Firstly, this sample can
be used to demonstrate that the primers used for qRT-PCR are valid. This is important
in the case where an RNA is below the level of detection in axons. If a negative result
is found in the axonal and blank conditions, it may be that the RNA is not present in
axons or that the qRT-PCR has failed. By also testing a sample of cells and finding a
positive signal in this sample, the latter possibility can be ruled out and the RNA can be
considered to be absent from the axons. Secondly, the cells can be used as a standard
of comparison for the axonal RNA and allow different RNAs to be compared to each
other. This will be discussed further in Section 4.5.3.
To check for the absence of migrating and floating cells on axonal carpets,
transmitted light and fluorescence microscopy was used to look for cells after treatment
with the cell nucleus stain propidium iodide. Figures 3.5 and 3.6 show that firstly, it
was possible to see cellular matter on the axonal carpet and omit cultures containing
contaminated axons and secondly, no cells could be detected on dissected axonal
carpets.
Finally, contamination during the RNA extraction and cDNA synthesis procedures
is controlled for with the No RNA and No RT controls. RNA contaminating the
water or plasticware or introduced during the cDNA synthesis procedure is detected
with the No RNA control, as any contaminating RNA should be reverse transcribed
and detected by subsequent qRT-PCR. DNA contaminating the samples or introduced
during the RNA extraction and cDNA synthesis procedures is controlled for by the
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No RT controls, which contain RNA from the collected samples but no reverse
transcriptase. Any signal from these controls detected by qRT-PCR must therefore
represent a signal from contaminating DNA.
Therefore, comparison between the Cells and Axons samples, Blank Near and
Blank Far samples, and No RNA and No RT controls, allow conclusions to be drawn
as to whether an RNA can be considered axonal.
3.4.2 Culture and extraction of RNA samples
The culture system for these experiments was optimised to harvest the maximum
amount of uncontaminated axonal tissue. An in vivo system is not suitable for this
purpose because although axons are plentiful, it is not possible to isolate them from
other brain tissue. Similarly, in a system where explants are dissociated or dissected
and cultured on glass (similar to those described in Chapter 5), many axons may grow
but it will not be possible to separate them from cellular matter which will adhere to
all parts of the coverslip.
The basic explant culture system described here was used by Thomas Pratt to
generate axonal matter for the library of mRNAs described in Section 1.6.1 and is
similar to the method used by Olink-Coux and Hollenbeck (1996).
Olink-Coux and Hollenbeck (1996) used 20-50 chick sympathetic ganglion ex-
plants in their experiments. However, for this particular application of the present
system using thalamic explants, it proved difficult to produce more than twenty-four
good quality explants for one culture. Four to six explants could be acquired from one
E14.5 brain in roughly forty-five minutes. This means that twenty-four explants could
be acquired from four to six brains in three to four and a half hours. It was found that
brains dissected after this time tended to become more brittle and more likely to shed
cells than at earlier times, which increased the chance of cellular contamination when
the explants were placed on the insert.
Cross-contamination of cells, axons and blanks was minimised by dissecting all
of the pieces of insert for each condition in each well at the same time, rather than
dissecting each explant sequentially. Cross-contamination was also minimised by the
use of four separate sterile scalpel blades to dissect the insert and four different sterile
pairs of forceps to pick up the inserts once they have been dissected, for each of the
four conditions.
The QIAGEN RNeasy Micro Kit, which is optimised for small quantities of RNA,
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was used to extract the RNA from these tissue samples (see Figure 3.7). The use of
the Micro Kit means that only 14µL of RNA in solution can be obtained. Diluting this
solution further made the axonal signal impossible to detect. This meant that only one
cDNA synthesis was possible from each RNA extraction, producing a maximum of
20µL of cDNA. In practise, it proved that roughly 15 qRT-PCRs could be performed
on one set of cDNA samples.
Figure 3.4 shows the substantial increase in axonal growth when fetal calf serum
was added to basal culture medium. Because of this increase in growth, which enables
a much larger amount of axonal tissue to be dissected, serum has been used in all
cultures. However, this may have an effect on the expression of RNAs in axons as it is
not known which molecules are present in the serum and the content of the serum in
different batches may vary (Even et al., 2006; Lutz and Rössner, 2007). This was not
considered to be a serious problem given the advantage of using serum but it may be
something that should be investigated in the future.
In conclusion, the method described in this chapter is proposed as a general system
for harvesting axonal RNA. The next chapter describes an implementation of this
method for quantifying RNA in thalamic axons.
Chapter 4
Characterising RNA in Developing
Thalamic Axons Using qRT-PCR
4.1 Introduction
This chapter provides evidence for the presence of many RNAs and the absence
of several others in thalamic axons. The evidence is based on quantitative reverse
transcription polymerase chain reactions (qRT-PCRs) for the RNAs of interest on
axonal samples collected according to the method described in Chapter 3. qRT-PCRs
will be introduced and the relevant technical terms defined. The methods used to select
RNAs for investigation, to run and analyse the qRT-PCRs, and to generate a dilution
series used to create a standard curve are explained. The results for two sets of qRT-
PCRs testing for the presence of RNAs in thalamic axons are given. The quality of
these results and the value of the method are then discussed, explaining the type and
validity of the conclusions that can be drawn from this application of the method.
4.2 qRT-PCR methodology
In this section the basic qRT-PCR methodology will be explained, and technical terms
which will be used in the rest of the chapter are defined.
4.2.1 Polymerase chain reaction
Polymerase chain reaction (PCR) (Saiki et al., 1988) is a method for amplifying DNA
by exploiting the fact that DNA is composed of two complementary strands. A double
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stranded DNA molecule can be separated into two strands. Enzymes called DNA
polymerases (Hübscher et al., 2002) can then synthesise the complements of each of
these single strands, producing two identical copies of the original DNA molecule.
If the reaction is repeated, these two copies will both be duplicated, producing four
copies of the original molecule. This exponential growth in DNA copy number means
that millions of copies of a very small number of DNA molecules can be produced
with just tens of these reactions (or cycles).
DNA polymerases can not bind to a single strand of DNA and begin to synthesise
its complement, but must extend a region of the DNA which is already double stranded.
Therefore, for PCR to work, small single strands of DNA, roughly 20-24 base pairs in
length, must be bound to a single DNA strand of interest, to form a double stranded
region to which DNA polymerase can bind and extend. These starter strands are called
primers, and two different primers are required for any PCR, a forward and a reverse
primer. These primers complement the start and end of the DNA sequence of interest,
with the forward primer binding to the start of the DNA sequence, and the reverse
primer binding to the end of the complement of the DNA sequence. This means when
double stranded DNA is separated into two strands, the forward primer will bind to
and enable the extension of one strand of the DNA, and the reverse primer will bind to
and enable the extension of the other strand.
PCR therefore requires many copies of both forward and reverse primers and a
supply of nucleotides which can be incorporated into new DNA strands. A PCR
of many cycles can be split into four phases, initial, exponential, linear and plateau
(see Figure 4.1). In the initial phase, there are very few DNA molecules and so the
amplification is stochastic. In the exponential phase, there are less DNA molecules
than primer pairs, and so the number of DNA molecules can be doubled with every
cycle, causing an exponential growth in total DNA copy number. In the linear phase,
the number of DNA molecules grows to exceed the number of primer pairs, which
means that the maximum number of new DNA molecules that can be synthesised in one
cycle is limited by the number of primer pairs, and so there can only be linear growth
in DNA copy number. Finally, when all of the nucleotides have been incorporated into
DNA copies, no further DNA synthesis can take place, causing the reaction to plateau.
The requirement for primers for the initiation of DNA synthesis means that it is
possible to amplify a particular sequence of interest by synthesising primers which
match that sequence. The sequence which is amplified by a PCR using a particular
pair of primers is known as an amplicon.
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To amplify RNA using PCR, complementary DNA (cDNA) must be synthesised
from the RNA, using enzymes called reverse transcriptase to reverse transcribe the
RNA. This cDNA can then be amplified using DNA polymerases in a PCR. The
combination of cDNA synthesis and PCR is known as reverse transcription PCR or RT-
PCR. Reverse transcriptase reactions must also be primed; it is common to use either
random hexamers, which as a set bind to many different parts of the RNA molecules,
or oligo dT primers, which bind only to the 3’UTR of mRNAs which contain a poly-A
tail.
The final quantity of DNA amplified by PCR will not accurately reflect the initial
quantity of DNA prior to PCR amplification, because the reaction is limited by the
amount of nucleotides and primers. This means the number of cycles in each of
the initial, exponential, linear and plateau phases is not known and the amount of
amplification during each phase cannot be estimated. Therefore, quantification of
initial DNA cannot be done by analysing the end products of a PCR. However, it is
possible to quantify initial DNA by examining the reaction as it progresses, which is
the approach of quantitative RT-PCR, or qRT-PCR, which will now be explained.
4.2.2 Quantitative Reverse Transcription PCR
qRT-PCR (Bustin, 2006) is a method for quantifying the amount of RNA in a sample
prior to PCR by reverse transcribing the RNA into DNA and quantifying the amount
of amplified DNA present after each cycle of PCR. Molecules which fluoresce when
bound to double stranded DNA (SYBR Green for the qRT-PCR experiments presented
in this thesis (Zipper et al., 2004)) are introduced into the PCR solution. After each
cycle of the PCR, the amount of fluorescence is quantified. This means the reaction
curve of the PCR through the initial, exponential, linear and plateau phases can be
plotted from the readings of fluorescent emissions for all cycles (see Figure 4.1).
Using a plot like that shown in Figure 4.1, the exponential phase of each reaction
can be identified. The cycles at which this phase occurs during the reaction are
determined by the amount of initial DNA present. For example, consider a sample
A which contains sixteen times as much initial DNA as another sample B. Sample
A will reach the exponential phase of the reaction earlier than Sample B because
initially the primers and DNA polymerase will be sixteen times more likely to amplify
DNA in Sample A than in Sample B. In turn, this means that Sample A will contain a
particular number of DNA molecules, and produce the level of fluorescence generated






















Figure 4.1: An example of the reaction curve for one qRT-PCR from the experiments presented in this
chapter, for α-tubulin. The x-axis shows the cycle number of the qRT-PCR (from a 50 cycle qRT-PCR).
The y-axis shows fluorescence detected, measured in logarithmic units. The graph shows, in the bottom
left, background fluorescence noise levels before DNA is amplified, followed by the exponential phase
which, because the graph is on a log scale, appears linear. The linear phase is shown where the lines
begin to curve and the plateau phase begins when the lines are horizontal. The phase labels on the right
show some overlap because there are multiple samples in the figure which progress to different phases
at different points. The dashed line shows the threshold, T, chosen for this reaction, which is at a point in
the early exponential phase. During the exponential phase, it can be seen that all samples in this sample
were amplified with roughly the same efficiency, as the lines remain parallel until the linear phase begins
(see Section 4.2.3.2 for discussion.)
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by that number of DNA molecules bound to SYBR Green, earlier than will Sample B.
Therefore, by comparing the cycle at which Sample A reaches a chosen threshold level
of fluorescence with the cycle at which Sample B reaches that same level, it is possible
to measure the relative quantities of DNA in these samples. In this case, provided the
amount of DNA is reliably doubling in the exponential phase, it would be expected that
Sample B would cross the threshold 4 cycles later than Sample A, because a sixteen-
fold increase is equivalent to 4 doublings.
The threshold level of fluorescence chosen for comparison, hereafter T, can be
anywhere in the exponential phase of the reaction, although it is preferable to choose
a point early in this phase because there will be small variations in the amount of
DNA amplified at each cycle and this variation will also be exponentially amplified,
causing error to be introduced into the quantifications, with more error introduced
the more cycles are carried out. In theory, these errors could be accounted for by
measuring the slope of the line between each pair of cycle points and taking variations
of amplification into account when estimating unit values, but in practise it is simpler
and more accurate to choose a threshold early in the exponential phase and avoid
having to correct for this variation. Once a threshold is chosen, the cycle at which
a sample reaches this threshold can be determined and labelled C(T) for “Cycle at
threshold T”. These C(T) values are calculated for all samples in the reaction and are
used to quantify the amounts of DNA in each sample relative to the other samples.
Quantification of a DNA sample using qRT-PCR is always relative to some other
DNA sample which was amplified in the same reaction. Two types of quantification
are commonly used; comparative quantification and standard curve quantification. In
comparative quantification, C(T) values for two samples are converted into a fold
difference of expression; so, for example, for Samples A and B above, a difference of 4
between the C(T) values for these cycles could be reported as a sixteen-fold difference
in starting amount. In standard curve quantification, a dilution series of DNA samples
is prepared where the fold differences between the samples in the series is known,
and arbitrary units can be assigned to the samples in the series. For example, a large
quantity of starting DNA could be labelled 1000 units and diluted two-fold three times,
producing 500 unit, 250 unit and 125 unit samples.
When the samples in the dilution series are amplified, it should be possible to draw
an exponential curve through the C(T) values for these samples, because the C(T)
values should reflect the two-fold dilutions of the samples. This curve is known as
the standard curve, and can be used to infer quantifications in arbitrary units for other
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samples amplified in the same reaction by inferring the unit value for the point in the
curve representing the C(T) value of the sample of interest. Standard curves are usually
represented on logarithmic graphs as straight regression lines (see Figure 4.2).
A different standard curve must be generated for each RNA of interest, although
the same pool of source cDNAs can be used to generate the standard curve. Different
standard curves are necessary because amplifications of different amplicons will be
affected by the length and structure of the amplicons and so the amplifications will
usually not be equally efficient; in fact, even if the amplifications were equally efficient,
it could not be guaranteed that original copy number was related to C(T) value in the
same way for both amplicons. For example, variations in length may mean different
copy numbers produce the same amount of fluorescence, and variations in structure
may affect the ability of the fluorescent molecule to bind to the cDNAs. While in theory
the C(T) values could be adjusted to take account of amplicon length and structure, as
it is possible to adjust the C(T) values to account for efficiency, in practise the effects
of these factors are not well understood and so have not been modelled accurately.
Therefore direct comparison of C(T) values has not been attempted here.
This in turn means that, although standard curve unit values for different samples of
one RNA can be compared, unit values for different RNAs are not compared directly
because the units for one RNA do not relate to the units for another RNA. 100,000
units of β-actin are not the same as 100,000 units of 18S, even if the C(T) values are
exactly the same for both samples and the amplicons are amplified with exactly the
same efficiencies (or, indeed, if the unit values were adjusted to account for variation
in efficiency; see Section 4.2.3.2). The two identical unit values may refer to different
copy numbers of the two cDNAs because the two cDNA molecules may each produce
a different amount of fluorescence. Therefore, if comparison of RNAs is required, it is
necessary to cancel out the standard curve units by comparing ratios of expression of
each RNA in different tissues.
If different qRT-PCRs are to be compared, whether they are for the same RNAs or
for different RNAs, it is imperative that cDNA samples from the same tissue source
are used to generate standard curves for all qRT-PCRs, because samples from different
sources will have different complements of cDNA and so will produce different scales
of measurement.
A comparison of expression in different tissue samples is only meaningful if the
amount of biological material is controlled for. For example, measurements of the
differential expression of genes in brain and heart tissue are only meaningful if the
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Figure 4.2: A standard curve generated from dilution series samples amplified in the qRT-PCR shown in
Figure 4.1 at the threshold shown in that figure. Black dots represent dilution series samples. C(T) Cycle
values for each black dot are measured during the reaction. Each sample in the dilution series is labelled
with a quantity of arbitrary units. Base 10 logarithms are used, so a Log Quantity of 5 represents a unit
value of 100,000. Two samples are amplified for each quantity to ensure the amplification is reliable.
A regression line called the standard curve is calculated for all dilution series samples, the equation for
which is shown at the top of the graph. The grey dots represent the other samples of interest in this
reaction, whose C(T) values have been calculated and are then used to infer unit values based on the
standard curve. The coefficient of determination r2 is also provided for the regression line.
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same amount of brain and heart tissue is being compared, or if different amounts of
tissue are being controlled for. To do this, a different gene to those being investigated
is selected as an internal standard and all expression levels of genes of interest
are normalised to the expression of this standard gene. For this comparison to be
meaningful, expression of this internal standard gene per unit of material should not
change from one sample to the next (Bas et al., 2004; Bustin et al., 2005).
Because the amplification of DNA by qRT-PCR varies from reaction to reaction, it
is desirable in any experiment to include not only biological replicates, where multiple
biological samples are tested to measure the variation in the biological data, but also
technical replicates, where a number of DNA samples from each biological replicate
are amplified in several different qRT-PCRs, to provide a measure of the variation
introduced by qRT-PCR amplification.
4.2.3 Quality indicators of a qRT-PCR
The reliability of any quantifications inferred using qRT-PCR should be assessed
by measuring a number of quality indicators. These include the coefficient of
determination, r2, which is a measure of the fit of the standard curve to the C(T) values
of the standard dilution series, the efficiency of the qRT-PCR, and the melting curve,
which is a measure which can be used to determine the number of different products
which have been amplified in the reaction. These indicators will now be introduced.
4.2.3.1 Coefficient of determination
As discussed in Section 4.2.2 and shown in Figure 4.2, the unit values which are
recorded for samples of interest are inferred from the standard curve, a regression
line which is fit to a standard dilution series. The accuracy of the quantification is
dependent on the correlation of the regression line and the actual C(T) values for the
standard curve dilution series. If the dilution series C(T) values do not fit the regression
line well, then the quantifications inferred from this regression line will not be accurate.
This correlation can be measured using the coefficient of determination, or r2, which
is a measure of the proportion of the variation in C(T) value which is accounted for by
the regression line.
r2 should be as close to 1 as possible, as this indicates that C(T) varies with input as
predicted by theoretically ideal PCR kinetics. r2 values below 1 indicate that the C(T)
values of the standard curve dilution series do not perfectly match the recorded raw
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fluorescent intensities for these samples, which indicates that there is some variability
in the amplification of samples of different sizes which will reduce the accuracy of
the inferred unit values of the experimental samples. Typically, a threshold is set
for r2 and the quantifications from a qRT-PCR with an r2 value below this threshold
are considered to be unreliable. In this chapter, r2 values of 0.95 and above will be
accepted, following Pfaffl (2001).
4.2.3.2 Efficiency of qRT-PCR
During an ideal cycle of a qRT-PCR, the amount of product is expected to double,
as every strand of cDNA should be duplicated. A qRT-PCR where this doubling
occurred at every cycle is considered to be 100% efficient. However, there are a
number of confounding factors which may cause varying efficiencies, such as quality
and purity of RNA (Fleige et al. (2006); this is of most concern when amplifying
directly from total RNA rather than cDNA, but can also be a problem with cDNA
amplification where many partial copies of the amplicon may have been synthesised
from degraded RNA and these partial copies may compete with full length ones
during amplification) and factors involving primers such as amplicon length, secondary
structure of cDNA and the formation of primer-dimers (Peters et al. (2004); primer-
dimers may fluoresce during amplification and so increase the signal for the cycle,
appearing to cause amplification with greater than 100% efficiency, or may prevent
primers from amplifying amplicons and so prevent 100% amplification, particularly in
later cycles where the number of amplicons is large).
Variation in efficiency is undesirable because of the exponential nature of PCR
amplification; small changes in efficiency can lead to large changes in the amount of
final product, because differences in amplification at early cycles are exponentially
magnified (Wong and Medrano, 2005). This is why the threshold T is chosen to be
as early in the exponential phase as possible, to minimise the magnification of such
variation and avoid having to correct for it (see Section 4.2.2).
The efficiency of a qRT-PCR is usually estimated from the slope of the regression
line of the reaction at the chosen threshold T (see Section 2.5.3). The efficiency value
is sometimes important for accurate quantification. There are two ways in which
variation in efficiency can affect quantification. Different amplicons may be amplified
with different efficiencies, or different amplifications of the same amplicon may have
varying efficiency.
A number of early and regularly used methods for quantification of RT-PCR
Chapter 4. Characterising RNA in Developing Thalamic Axons Using qRT-PCR 119
assume that reactions occur with 100% efficiency or that the efficiency of different
reactions is identical, such as the comparative Ct method (Schmittgen and Livak,
2008; Yuan et al., 2008). However, there are other methods available which correct
for or cancel out varying efficiencies from amplifications of the same amplicon (see,
for example, Pfaffl (2001)). These methods do not require efficiencies to be equal
across reactions.
For standard curve comparisons, it is possible to compare RNAs which have been
amplified with different efficiencies by transforming the curve units into ratios (see
Section 4.3.4). It would also be possible to adjust standard curve C(T) values for a
particular amplicon to be consistent with one another if they had different efficiencies
by adjusting the C(T) values using the slopes for each sample. However, it is
desirable that the standard curve samples are amplified with the same efficiencies as
this increases confidence that the amplification is repeatable and reliable and avoids
the need for adjustment of the C(T) values. The fact that different amplifications of
the same amplicon have the same efficiency can be seen by observing high r2 values
(because if different samples from the standard curve dilution series were amplified
at different efficiencies, it would not be possible to closely fit a regression line to the
C(T) values for the dilution series) and by observing that the exponential phases for all
samples follow the same trajectory (as can be seen in the example qRT-PCR curve in
Figure 4.1).
4.2.3.3 Melting curves
A qRT-PCR reading (using the SYBR Green method presented here) is a measure
of the total amount of double-stranded DNA in a sample, regardless of how many
different PCR products are present. As the intention is to measure only a single
amplicon which the primers used have been designed to amplify, it is essential that
no other types of DNA are present in the sample. This includes primer-dimers, which
can be created when left and right primers are bound together, although primers are
usually designed to minimise this effect (see Section 2.5.4).
It is possible to see how many products are present in one sample by generating a
melting curve after the qRT-PCR is completed. The samples in the reaction are heated
from 60◦C to 95◦C, with the fluorescent signal from the samples being read every
1◦C. As described earlier, the qRT-PCR products are double-stranded DNA bound
to SYBR Green, which only fluoresces when it is bound to double-stranded DNA but
cannot bind to single-stranded DNA. As the tubes are heated, the DNA separates into
Chapter 4. Characterising RNA in Developing Thalamic Axons Using qRT-PCR 120
single strands, releasing the SYBR Green and causing a decrease of fluorescent signal.
The changes in signal are measured and plotted on a graph.
If only one product has been amplified in a tube, it is expected that one large change
of signal will be detected, shown as a peak on the melting curve. If more than one
product is present, it is likely that there will be more than one peak on the melting
curve, as the many products will separate into single strands at different temperatures
according to their lengths and conformations. Therefore the melting curve can be used
to ensure that the qRT-PCR signal represents the amplification of one product only
and that tubes which contain primer-dimers or other contaminants can be discarded. A
melting curve has been generated for every qRT-PCR presented in this chapter.
With the qRT-PCR method outlined and technical terms defined, it is now possible
to turn to the application of this method for quantifying thalamic axonal RNAs.
4.3 Methods
4.3.1 Selection of RNAs
mRNAs from Thomas Pratt’s library (see Section 1.6.1) were selected by prioritising
the sequences which were cloned from the 3’UTR, 5’UTR and coding regions as
opposed to the introns. Intronic clones were not prioritised because they were not
likely to be part of the canonical mRNA for the identified gene; however, they may
have been part of a splice variant of the mRNA or a separate mRNA and so should be
investigated in future. One exception was made in the case of reticulon-1, which was
cloned from an intron, and was selected because it has been linked to axonal behaviour
(see Section 1.6.1). Several mRNAs from the library were not investigated because it
was not possible to generate suitable primers for them. Several further mRNAs which
had been identified as present or absent in other axonal systems were selected from the
literature to investigate whether they were present or absent in thalamic axons.
4.3.2 Standard curve
In order to provide scales of units to measure quantities of RNA, a set of cDNA samples
was used to create a dilution series. This set of cDNA samples was generated from
samples of thalamic cellular RNA collected using the method described in Chapter 3,
some of which were also used for qRT-PCRs. Aliquots from four of the samples listed
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1. Aliquot from cellular RNA sample i ii iii x
2. Synthesise cDNA
3. Pool cDNA
4. Produce dilution series
5. Aliquot dilution series
100,000 10,000 1,000 100 10 1
Used for PCR Set 1
Used for PCR Set 2






1 2 3 4 5 6 7 8 9 10
1 µl each
20 µl each
200 µl cDNA Pool
100,000 10,000 1,000 100 10 1
100,000 10,000 1,000 100 10 1
100,000 10,000 1,000 100 10 1
100,000 10,000 1,000 100 10 1
Figure 4.3: A flowchart showing the generation of cDNA samples used to produce a standard curve
for use in all qRT-PCRs. Thalamic cellular RNA was taken from the extractions from cultures i, ii,
iii and x, shown in Figure 4.6 below. 10 cDNA synthesis reactions were run, each containing 1µL of
cellular RNA and producing a 20µL solution containing newly synthesised cDNA. These ten samples
were pooled together and 150µL was removed and labelled as 100,000 units. 15µL of this solution
was aliquotted into a new tube with 135µL of sterile RNase-free water, a dilution of 1:10, and labelled
10,000 units. This was repeated for four further tubes to produce 1,000, 100, 10 and 1 unit tubes. These
units are arbitrary and simply reflect the dilution steps. These 135µL solutions were then aliquotted
into four sets of 30µL tubes which were stored at −20 ◦C, the first set of which was used for the Set 1
qRT-PCRs and the second set of which was used for the Set 2 qRT-PCRs described below. The other
sets were unused.
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in Figure 4.6 were used to produce the standard curve cDNA. The process is shown in
Figure 4.3.
Ten separate cDNA synthesis reactions were run, labelled Samples i-x, each on
1µL of RNA, with 1µL taken from Sample i, 1µL from Sample ii, 4µL from Sample
iii and 4µL from Sample x (see Section 2.5.1 for cDNA synthesis method). Once
the cDNA synthesis reactions were complete the ten cDNA samples were pooled
together. Pooling this many separate cDNA samples should minimise the impact of
any variability in cDNA synthesis. 150µL of this pool of cDNA (approximately 200µL
in size) was aliquotted and labelled as 100,000 units. This pool was then serially
diluted to 1 part in 10 with sterile RNase-free water five times to produce separate
10,000, 1,000, 100, 10 and 1 unit samples. These units are arbitrary and simply reflect
the dilution steps. These six samples of 135µL each were then separated into four sets
of 30µL aliquots and a set of remainders. The first set of qRT-PCRs were run on one set
of aliquots 1-10 days after the aliquots were prepared and the second set on a separate
set of aliquots 209-221 days after the aliquots were prepared.
4.3.3 qRT-PCRs
Two sets of qRT-PCRs were run (see Section 2.5.3 for program). Each set of qRT-
PCRs tested a different group of three biological replicates (sets of RNA samples) for
the presence of selected RNAs. Each set of RNA samples contained Cells, Axons,
Blank Near, Blank Far, CnoRT, AnoRT, BNnoRT, BFnoRT and noRNA samples. Each
RNA was tested in a separate qRT-PCR. The Cells, Axons, Blank Near and Blank Far
Figure 4.4 (following page): Design of qRT-PCRs for Set 1 and Set 2 experiments. One RNA was
tested in each qRT-PCR experiment. All three samples in a set were tested in each qRT-PCR. For each
Set, all tubes including all controls were tested for 18S rRNA, but the noRT and noRNA controls were
not tested for other RNAs in Set 1 such as β-actin and β-catenin (see more concise design for these
RNAs, which was also used for all other RNAs tested). In Set 2, as a further precaution, the CnoRT
conditions were tested for all RNAs. The full design will now be explained by describing the plate for
Set 1, 18S at the top of the figure. 39 tubes are shown (tube numbers in superscript). One set of cDNA
synthesis reactions (see Figure 3.1) are labelled a sample; for example, tubes 01-09 are from Sample 1a
(see Figure 4.6). Two further samples were processed simultaneously (tubes 10-18, Sample 1b; tubes
19-27, Sample 1c). Two dilution series, used to produce a standard curve, a unit scale against which
samples can be quantified, are processed in every experiment (tubes 28-33, Standard curve 1; tubes 34-
39, Standard curve 2). A control containing only water was processed by qRT-PCR to control for DNA
and RNA contamination (tube 40, Water).
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01 C 02 CnoRT 03 A 04 AnoRT 05 BN 06 BNnoRT 07 BF 08 BFnoRT 09 No RNA
10 C 11 CnoRT 12 A 13 AnoRT 14 BN 15 BNnoRT 16 BF 17 BFnoRT 18 No RNA
19 C 20 CnoRT 21 A 22 AnoRT  23 BN 24 BNnoRT 25 BF 26 BFnoRT 27 No RNA
28 100,000  29 10,000  30 1,000  31 100  32 10  33 1








01 C 02 A 03 BN 04 BF
05 C 06 A 07 BN 08 BF




13 100,000  14 10,000  15 1,000  16 100  17 10  18 1
19 100,000  20 10,000  21 1,000  22 100  23 10  24 1
25  Water
01 C 02 A 03 BN 04 BF
05 C 06 A 07 BN 08 BF




13 100,000  14 10,000  15 1,000  16 100  17 10  18 1
19 100,000  20 10,000  21 1,000  22 100  23 10  24 1
25  Water
Set 1, !-actin Set 1, !-catenin
01 C 02 CnoRT 03 A 04 AnoRT 05 BN 06 BNnoRT 07 BF 08 BFnoRT 09 No RNA
10 C 11 CnoRT 12 A 13 AnoRT 14 BN 15 BNnoRT 16 BF 17 BFnoRT 18 No RNA
19 C 20 CnoRT 21 A 22 AnoRT  23 BN 24 BNnoRT 25 BF 26 BFnoRT 27 No RNA
28 100,000  29 10,000  30 1,000  31 100  32 10  33 1








01 C 02 CnoRT 03 A 04 BN 05 BF
06 C 07 CnoRT 08 A 09 BN 10 BF




16 100,000  17 10,000  18 1,000  19 100  20 10  21 1
22 100,000  23 10,000  24 1,000  25 100  26 10  27 1
28  Water
Set 2, !-actin Set 2, !-catenin
Repeat with same design for RPS3, EphB2, MAP2...
Repeat with same design for RhoA, Rock1, Ubiquilin-1...
01 C 02 CnoRT 03 A 04 BN 05 BF
06 C 07 CnoRT 08 A 09 BN 10 BF




16 100,000  17 10,000  18 1,000  19 100  20 10  21 1
22 100,000  23 10,000  24 1,000  25 100  26 10  27 1
28  Water
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conditions for each of the three samples in one group were run in one reaction, together
with two sets of standard curve samples and a control containing only sterile, RNase-
free water, labelled Water. After each qRT-PCR was completed, a melting curve was
performed on the set of tubes, as described in Section 4.2.3.3.
The noRT and noRNA controls were only run for 18S for the first set of qRT-PCRs.
Given that 18S is expected to be the most abundant RNA in the samples, it was thought
that if these controls were blank for 18S, there was no need to run them for all RNAs,
given the expense of qRT-PCR. However, as a precaution, for the second set of qRT-
PCRs the CnoRT condition was tested for all RNAs. 18S was repeated at least once
for both groups of three samples.
4.3.4 Ratio comparison
In order to compare the expression of different RNAs, mean ratios of expression
between axon and cell samples and their standard deviations were calculated as follows
from the Set 1 qRT-PCR results, using 18S as an internal standard.
As discussed in Section 4.5.1.3, two types of replicates were used in these qRT-
PR experiments: biological replicates, where many samples of RNA are tested, and
technical replicates, where each sample of RNA is tested several times. Each RNA
was tested with three biological replicates, but technical replicates were only carried
out for the internal standard, 18S rRNA.
4.3.4.1 Calculation of ratios
Uncontrolled ratios of axonal units to cellular units for each RNA for each biological





For 18S, the axonal and cellular units for the technical replicates (t) were averaged












where nt is the number of technical replicates. The same could be done for the
other RNAs if technical replicates for those RNAs were performed.
The standard deviations (s) and coefficients of variation (CV ) for 18S cellular and
axonal units for each biological replicate were calculated as follows:
















CV (A)18Sb = s(A)18Sb/Ā18Sb (4.6)







s(Ratio)18Sb = Ratio18Sb ∗CV (Ratio)18Sb (4.8)
Loading-controlled axon-to-cell ratios (LCR) were then calculated for each RNA,











The standard deviations for each of these ratios were calculated by combining the
deviations within the set of biological replicates for each RNA with the deviations




















The LCRRNA and s(LCR)RNA values are plotted in Figure 4.11.
Chapter 4. Characterising RNA in Developing Thalamic Axons Using qRT-PCR 126
4.3.4.2 Statistical comparison of ratios
To compare the set of ratios of axonal to cellular RNA expression, a Friedman analysis
of variance by ranks test was used, which is the appropriate non-parametric analysis of
variance test for related data (Coolican, 2004). As the standard deviations of the ratios
varied considerably (from 0.07 for β-catenin to 3.22 for RPS3) it could not be assumed
that the variances of the ratios was homogenous, and so it was not appropriate to use
the standard F test for parametric analysis of variance.
The Friedman test involves ranking the ratios of expression for each RNA for each
sample and then summing the ranks for each RNA over all samples. These summed




nb ∗ k(k +1)
6
(4.14)
where Ru and Rv are the summed ranks of ratios for two RNAs which are being
compared, k is the total number of RNAs to be compared, α is a chosen significance
level and zα/k(k−1) is the abscissa value from the unit normal distribution above which
lies α/k(k− 1)% of the distribution (Siegel and John, 1988). This equation can be
used to compare the difference in summed ranks for each pair of RNA ratios against
the critical value on the right side of the equation above. If the difference between the
summed ranks for a particular pair of RNAs is greater than the critical value, the RNAs
can be considered to be significantly different at p < α.
4.3.5 Other methods
The gel electrophoresis data presented in Figures 4.7b and 4.12b was generated using
the method in Section 2.3. The programs used for standard and quantitative RT-
PCR and the methods for primer generation and efficiency calculation are presented
in Section 2.5.
4.4 Results
4.4.1 Selection of RNAs
Figure 4.5 lists the RNAs that have been examined in these experiments, along with
their Ensembl (Flicek et al., 2008) and Mouse Genome Database (Bult et al., 2008)
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reference numbers, the reasons why these RNAs were tested, the sequences of the
primers used to amplify the RNAs and the expected length of the resulting qRT-PCR
products. As explained in Section 4.3.1, RNAs were selected for use because they were
found in Thomas Pratt’s library (see Section 1.6.1), or had previously been shown to
be present or absent in other axonal systems, based on reports from the literature as
indicated in the figure.
4.4.2 Collection of samples
Thalamic sections were cultured according to the method outlined in Section 3.2.
Fifteen cultures were carried out, four of which did not yield sufficient quantities of
axons or became contaminated. Eleven cultures were dissected and the RNA from
these cultures was extracted. Figure 4.6 shows the unit values for Axons, Blank Far
and Blank Near for a qRT-PCR for 18S, run as a test on each of the samples. It shows
that six of the eleven samples were deemed usable and five were discarded, according
to the fold differences between the axonal and blank conditions. The samples with
the highest fold differences between axonal and blank signals were chosen for use,
whereas samples with lower fold differences between axonal and blank signals or
samples where either of the blank signals were higher than the axonal signal were
discarded.
The six usable samples were tested in two different sets of qRT-PCRs, with
Samples 1a, 1b and 1c forming Set 1 and Samples 2a, 2b and 2c forming Set 2. These
sets of qRT-PCRs will now be considered separately.
4.4.3 Results for Set 1 samples
In this section, a series of results demonstrating the quality of the samples in Set 1 will
be presented, followed by the results for the qRT-PCRs on this set of samples.
4.4.3.1 Quality of Set 1 samples
For the three samples in Set 1, Figure 4.7a shows the number of days since culturing
for each of the steps of the process and the number of explants in each sample. The
table in the figure shows that RNA extraction and cDNA synthesis were carried out in a
timely fashion but that there was a significant amount of time between cDNA syntheses
and qRT-PCRs, due to unforeseen and uncontrollable circumstances.
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Figure 4.7: Quality of Set 1 samples, containing samples 1a, 1b and 1c. a) The days from culture to
processing steps and number of explants dissected for the Set 1 samples used for qRT-PCR. qRT-PCRs
were carried out over 11 days for Set 1 samples (1a, 1b and 1c). b) Quality of Set 1 RNA samples
shown by gel electrophoresis. All three samples show two bands, representing 18S and 28S rRNA, and
no band representing genomic DNA (gDNA), as shown in the left-most picture, which shows a sample
of cellular RNA where no DNase step was performed during RNA extraction. The small quantities of
RNA from axons and blanks are below the limits of detection for gel electrophoresis, but these bands
are shown to demonstrate the lack of contaminating gDNA in these conditions. BN, Blank Near; BF,
Blank Far.
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Figure 4.7b shows pictures of gels for the Set 1 samples used for qRT-PCR,
showing that the cellular conditions contained two bands representing 18S and 28S
rRNA (there is insufficient RNA in axonal and blank conditions to be detected by gel
electrophoresis). No contaminating gDNA was found in any condition for any sample
used for qRT-PCRs.
Figure 4.8a shows an example of a qRT-PCR result for one RNA, in this case
one of the qRT-PCRs for 18S for the Set 1 samples. The figure shows the C(T) and
unit values for each condition for each sample. As expected, the unit values for the
axonal conditions are very small compared to the unit values for the cellular conditions.
However, a clear difference can be seen between the axonal conditions and all of the
Blank, noRT, noRNA and Water conditions. The Axon unit values are significantly
higher than the Blank Near unit values (p=0.01) and Blank Far unit values (p=0.01)
but the Blank Near and Blank Far unit values are not significantly different (p=0.25),
according to one-tail paired t-tests.
Figure 4.9 shows an example of a melting curve, for 18S2 in Set 1 (see Section
4.2.3.3 for a description of melting curves). The graph shows that only one product
was present in all of the samples run in this qRT-PCR, with the exception of the
Water control where no product was present. Similar graphs were produced for every
qRT-PCR and used to calculate the melting temperatures for each product presented
in Figure 4.8b. Each pair of primers used produced only a single product in most
samples, including all samples where a significant signal could be detected. All
primers produced a single product in at least the Cells condition, demonstrating that
the primers functioned as expected and that any lack of signal in a particular tube was
not due to the problems with primers. Primer dimers did form in a minority of samples
where no original material was present (such as in some Blanks or noRT samples).
The melting curves were used to identify such samples and omit the readings for these
samples in further analyses.
Figure 4.8b show the r2 values, efficiencies, melting curve peaks and missing
standard curve values for all the qRT-PCRs carried out for Set 1. The missing standard
curve values are tubes in the standard curve dilution series (which contains two tubes
each for 100,000 units, 10,000 units, 1,000 units, 100 units, 10 units and 1 unit) where
no signal was detected. The figure shows that melting curve peaks were consistent
for RNAs which were repeated within and across sets. For example, 18S products
repeatedly separated at 89◦C (see also Figure 4.13b).
The figure shows that the r2 values for the Set 1 qRT-PCRs are all above 0.95,
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C(T) Units C(T) Units C(T) Units
5.05 63229.40 4.49 86944.65 4.58 82624.90
19.04 21.19 19.38 17.40 19.74 14.20
25.78 0.45 26.32 0.33 24.19 1.11
26.06 0.38 25.74 0.46 27.02 0.22
32.77 0.00 34.98 0.00 33.59 0.01
None 0.00 39.50 0.00 None 0.00
None 0.00 None 0.00 None 0.00
39.34 0.00 None 0.00 None 0.00




Paired one-tail t-tests, comparing unit values:
Axons & Blank Near, p=0.01
Axons & Blank Far, p=0.01
Blank Near & Blank Far, p=0.25
Set 1 r2 Efficiency Melting curve 
peak (°C)


















0.994 90% 87 2x1
1.000 90% 81 1x1
0.997 86% 82 1x1
0.984 74% 84
0.989 86% 81 1x1
0.998 86% 85 2x1
Figure 4.8: Quality of Set 1 qRT-PCRs. a) An example of a complete qRT-PCR for 18S for Set 1
samples. Cells, Axons, Blank Near and Blank Far results are shown, with corresponding No Reverse
Transcriptase (noRT) controls. Water and noRNA controls are also shown. For each condition, C(T) and
Unit values are given. The text shows that Set 1 Axonal Units were significantly above both Blank Near
and Blank Far units according to paired one-tail t-tests. b) Quality of qRT-PCRs for Set 1, indicated by r2
values, efficiencies, melting curve peaks and missing standard curve values. The r2 values are coloured
green where r2 > 0.95 and red where r2 < 0.95 (all Set 1 samples have r2 > 0.95). Single melting curve
peaks were found in all tubes where significant signal was detected, indicating that only one product
was present in each tube. The same peak was found in all tubes for each RNA and repeated RNAs (such
as 18S) produced the same melting curve peak when repeated within and across sets (see also Figure
4.13b). Missing standard curve values are readings from the two standard curve dilution series, which
were run with every qRT-PCR, where no signal was detected. So, for example, for Synaptotagmin-13,
no signal was detected from either of the 1 unit tubes.
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which indicates that the standard curve C(T) values are well correlated with their
expected unit values and the quantifications from this set of PCRs are reliable. The
efficiencies for Set 1, while somewhat below 100%, do not indicate any serious
problem with these reactions. The high r2 values indicate that each amplicon could be
amplified with the same efficiency reliably. Also, it is encouraging that the efficiencies
for both 18S qRT-PCRs were identical, indicating that the amplification of at least this
RNA was reliable and consistent across different qRT-PCRs.
4.4.3.2 qRT-PCR results for Set 1 samples
To claim that an RNA is present in thalamic axons, it is necessary to show that a signal
can be found for that RNA in the axonal conditions which is above any signal in either
of the blank conditions. Figure 4.10 shows the Axon and Blank unit values for the
qRT-PCRs carried out on the Set 1 samples. The unit values for each RNA are inferred
from standard curves specific to each RNA and so cannot be compared directly. The
figure shows that, according to one-tailed, paired t-tests, significant differences could
be found between Axons and Blank Near signals, and between Axons and Blank Far
signals, for 18S, β-actin, β-catenin, Reticulon-1, RPS3 and Synaptotagmin-13, and
also for RNAs which have not been found in other axonal systems, α-tubulin and
MAP2.
For two RNAs, RalA and EphB2, the differences between Axons and at least one
of the blank conditions were not significant. However, this may be due to the variation
between samples, which cannot be controlled for in this analysis (see Section 4.5.1.1
for discussion). The data for each individual sample are provided for these RNAs in the
figure, and it can be seen that, for RalA, the axonal signal is above both blank signals
in all three samples, and that for most blank signals a 0 unit value was recorded. For
EphB2, a signal could be detected in axons in two samples and no signal was present
in the blanks in any sample. This indicates that both RalA and EphB2 can be found in
axons above levels of contamination and should be considered to be present in thalamic
axons.
4.4.3.3 Comparison of RNAs tested on Set 1 samples
Figure 4.11 shows ratios of axonal to cellular expression for RNAs from Set 1,
controlled for tissue quantity against the internal standard, 18S (see Section 4.5.1.2).
These ratios were calculated using the method described in Section 4.3.4.
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Mean Units Mean Units Significant 
difference from 
axons
Mean Units Significant 
difference from 
axons
 17.59 (SD   3.50) 0.63 (SD 0.42) p<0.01 0.35 (SD 0.12) p<0.01
 16.28 (SD   3.55) 0.61 (SD 0.60) p<0.05 0.41 (SD 0.39) p<0.01
 23.44 (SD   8.25) 0.25 (SD 0.17) p<0.05 0.30 (SD 0.12) p<0.05
 25.38 (SD   6.83) 1.19 (SD 1.03) p<0.05 0.90 (SD 0.80) p<0.05
 10.35 (SD   2.76) 0.47 (SD 0.47) p<0.05 0.49 (SD 0.55) p<0.05
  3.25 (SD   0.42) 0    (SD 0   ) p<0.05 0    (SD 0   ) p<0.05
 15.27 (SD   5.50) 0.14 (SD 0.24) p<0.05 0.13 (SD 0.22) p<0.05
267.99 (SD 124.08) 2.20 (SD 2.03) p<0.05 1.43 (SD 1.40) p<0.05
 15.22 (SD   5.15) 0    (SD 0   ) p<0.05 0    (SD 0   ) p<0.05
  4.67 (SD   4.04) 0    (SD 0   ) p>0.05 0    (SD 0   ) p>0.05
  6.11 (SD   3.83) 0.65 (SD 1.13) p<0.05 0    (SD 0   ) p>0.05
a
b















Figure 4.10: qRT-PCR results for Set 1. a) Comparison of axon and blank unit values for RNAs tested on
Set 1 samples. Colouring of RNA names reflects the quality of the qRT-PCR for that RNA indicated by
the r2 value for the qRT-PCR (see Figure 4.8b). The unit values for each RNA are inferred from standard
curves specific to each RNA and so cannot be compared directly. Means and standard deviations for
Axons, Blank Near and Blank Far Units are shown, and significant differences between Axons and Blank
Near, and Axons and Blank Far, are reported according to one-tailed paired t-tests. For the RNAs where
differences were insignificant (where p > 0.05), full data for all samples has been provided to show
where Axon signals were above Blank signals. b) RalA, c) EphB2. Axon unit values for a particular
sample which were above both Blank Near and Blank Far unit values for that sample are marked in
bold. 0 values where no signal was detected are coloured grey.
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A ratio of axonal RNA to cellular RNA equal to 1 would indicate that the RNA
is expressed at the same level in axons and cells relative to 18S. Except for RPS3,
with a mean ratio of 9.43, indicating an almost 10-fold increase in expression in axons
compared to cells, all of the ratios are below 1. A ratio of 1 is within 1 standard
deviation of the mean ratios for α-tubulin, β-actin and synaptotgamin-13. The ratios
for β-catenin, EphB2, MAP2, RalA and Reticulon-1 indicate that these RNAs are
expressed at a considerably lower level in axons compared to cells, with the MAP2
having a mean ratio of 0.11, or a 9-fold difference in expression between axons and
cells.
There are significant differences within the set of mean ratios (Friedman’s analysis
of variance by ranks test, χ2 (7) = 18.48, p < 0.01) but the only significant difference
that could be found between RNAs with posthoc multiple comparisons was between
RPS3 and MAP2 (p < 0.05, see Section 4.3.4.2 for calculation). If RPS3 is omitted
from the analysis, significant differences can still be found using a Friedman test (χ2
(6) = 16.81, p < 0.01) but the particular differences cannot be identified by posthoc
tests (comparisons of all pairs of RNA are all p > 0.05).
Therefore, these ratios cannot be used to infer differences in axonal to cellular
expression for particular pairs of RNAs other than RPS3 and MAP2. However, the
ratios do indicate that, with the exception of RPS3, RNAs are mostly depleted in axons
compared to cells. Also, the fact that there are differences in the ratios in the set both
when RPS3 is included and when it is excluded increase confidence that the RNAs in
the axonal samples did indeed come from axons rather than cellular contamination.
This is because it might be expected that if the RNA came from cells alone, the ratios
of expression would all be 1, or at least show the same enrichment or depletion of
RNA, because the comparison would be between two samples of thalamic cells, which
might be expected to express the same levels of RNA. However, this assumption needs
to be confirmed experimentally.
In summary, a set of high quality qRT-PCRs have been presented in this section
demonstrating the presence of 18S, α-tubulin, β-actin, β-catenin, EphB2, MAP2,
RalA, Reticulon-1, RPS3 and Synaptotagmin-13 in thalamic axons, and indicating
variability in the expression profile of these RNAs in axons compared to their
expression in cells.
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4.4.4 qRT-PCRs on Set 2 samples
In this section, a series of results testing the quality of the samples in Set 2 will be
presented, followed by the results for the qRT-PCRs on this set of samples.
4.4.4.1 Quality of Set 2 samples
For the three samples in Set 2, Figure 4.12a shows the number of days since culturing
for each of the steps of the process and the number of explants in each sample. The
table in the figure shows that there was a significant amount of time between cDNA
syntheses and qRT-PCRs for Set 2. Also, the steps up to cDNA synthesis were all later
for Set 2 than for Set 1. It may be that delays in RNA extraction and cDNA synthesis
affected the Set 2 samples although no systematic tests of the effects of storage have
been performed. However, when the qRT-PCRs were begun for the second set, it
became clear that some evaporation had occurred in the samples. As this should
only have affected the water in each tube but not the DNA, the samples were ethanol
precipitated again to ensure an even amount of water in each tube, which was essential
to ensure that equivalent quantities of DNA were present in each tube when running
each qRT-PCR, but undesirable because each ethanol precipitation causes some RNA
to be lost. This subsequently lead to a loss of signal and cDNA quality, which will be
discussed in Section 4.5.1.4.
Figure 4.12b shows pictures of gels for the Set 2 samples used for qRT-PCR,
showing that the cellular conditions contained two bands representing 18S and 28S
rRNA (there is insufficient RNA in axonal and blank conditions to be detected by gel
electrophoresis). No contaminating gDNA was found in any condition for any sample
which was tested and used for qRT-PCRs.
Figure 4.13a shows one of the 18S results for the three samples in Set 2. It
shows the axon unit values are all above the unit values for the Blanks and the noRT,
noRNA and Water controls for all three samples. This shows that no significant
contaminating DNA was introduced into the reactions during culture, RNA extraction,
cDNA synthesis or qRT-PCR. However, although the axon unit values are all higher
than the blank unit values, the difference is not statistically significant (Axons and
Blank Near, p=0.1, Axons and Blank Far, p=0.1) due to the large variation in axon unit
values (mean = 20.29, standard deviation = 18.21). Despite this, as these were the best
samples that it was possible to obtain in the time available (see Section 4.4.2), these
three samples were used for qRT-PCR. This is discussed further in Section 4.5.1.1.
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Figure 4.12: Quality of Set 2 samples, containing samples 2a, 2b and 2c. a) The days from culture to
processing steps and number of explants dissected for the Set 2 samples used for qRT-PCR. qRT-PCRs
were carried out over 13 days for Set 2 samples (2a, 2b and 2c). b) Quality of Set 2 RNA samples shown
by gel electrophoresis (Sample 2c not tested). Each sample shows two bands, representing 18S and
28S rRNA, and no band representing genomic DNA (gDNA), as shown in the left-most picture, which
shows a sample of cellular RNA where no DNase step was performed during RNA extraction. The small
quantities of RNA from axons and blanks are below the limits of detection for gel electrophoresis, but
these bands are shown to demonstrate the lack of contaminating gDNA in these conditions. BN, Blank
Near; BF, Blank Far.
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Set 2 r2 Efficiency Melting curve 
peak (°C)


















0.982 55% 89 1x100
0.975 51% 89
0.974 51% 89
0.860 55% 84 1x1000, 2x100, 2x10, 2x1
0.915 48% 84 2x1
0.961 70% 82 1x10, 2x1
0.964 58% 88 2x10, 2x1
0.960 86% 83 2x10, 2x1
0.932 66% 84 1x10, 2x1
0.950 73% 82 2x10, 2x1
0.960 78% 84 2x10, 2x1
0.967 91% 82 1x10
0.932 55% 80 2x10, 2x1
0.992 66% 84 1x1000, 2x100, 2x10, 2x1
0.962 74% 81 2x10, 2x1
0.933 66% 80 2x10, 2x1
a
b











C(T) Units C(T) Units C(T) Units
6.69 53462.80 6.23 62644.59 4.54 41747.43
30.31 14.13 27.27 40.78 23.26 5.95
36.03 1.92 34.45 3.33 28.52 0.49
39.71 0.53 36.12 1.86 26.27 1.43
32.77 0.00 34.98 0.00 31.54 0.12
47.67 0.00 47.40 0.01 36.53 0.00
None 0.00 None 0.00 48.54 0.00
None 0.00 None 0.00 37.41 0.00
None 0.00 None 0.00 33.47 0.01
None 0.00
Paired one-tail t-tests, comparing unit values:
Axons & Blank Near, p=0.1
Axons & Blank Far, p=0.1
Blank Near & Blank Far, p=0.23
Figure 4.13: Quality of Set 2 qRT-PCRs. a) An example of a complete qRT-PCR for 18S for Set 2
samples. Cells, Axons, Blank Near and Blank Far results are shown, with corresponding No Reverse
Transcriptase (noRT) controls. Water and noRNA controls are also shown. For each condition, C(T)
and Unit values are given. For the three samples in Set 2, Axonal Units were all above Blank Near
and Blank Far units, but due to the wide variation in Axonal Units the differences between the axonal
and blank conditions were not significant. b) Quality of qRT-PCRs for Set 2, indicated by r2 values,
efficiencies, melting curve peaks and missing standard curve values. The r2 values are coloured green
where r2 > 0.95 and red where r2 < 0.95. Single melting curve peaks were found in all tubes where
significant signal was detected, indicating that only one product was present in each tube. The same
peak was found in all tubes for each RNA and repeated RNAs (such as 18S) produced the same melting
curve peak when repeated within and across sets (see also Figure 4.8b). Missing standard curve values
are readings from the two standard curve dilution series, which were run with every qRT-PCR, where
no signal was detected. So, for example, for BPGM in Set 2, no signal was detected from 1 of the 10
unit tubes and both of the 1 unit tubes.
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Figure 4.13b show the r2 values, efficiencies, melting curve peaks and missing
standard curve values for all the qRT-PCRs carried out for Set 2. The figure shows that
melting curve peaks were consistent for RNAs which were repeated within and across
sets. For example, 18S products always separated at 89◦C, twice for Set 1 (see Figure
4.8b and three times for Set 2 (see Figure 4.9 for an example of a melting curve).
The figure shows that most r2 values for the Set 2 qRT-PCRs fall above 0.98 but that
five of the sixteen values fall below 0.95. The r2 values for β-actin, BPGM, Ubiquilin-
1, Rock1 and α-tubulin(OH) are all below 0.95, which means the quantifications for
these five qRT-PCRs cannot be considered to be reliable.
In addition, the efficiencies for Set 2 are considerably lower than those for Set 1,
and, significantly, unlike the melting curve peaks, the efficiencies for RNAs which
were repeated such as 18S and β-actin are not the same in both sets. This suggests that
something in the samples interfered with the efficiency of the reactions, which means
that these low efficiencies cast further doubt on the validity of quantifications from this
set.
In addition, many standard curve values could not be detected for this set, which
may indicate that the standard curve cDNA had degraded (which would explain why
standard curve values were missing for β-actin and β-catenin in Set 2 but not in Set 1),
or that the RNAs were of such low abundance that they could not be detected in some
of the higher dilution standard curve samples (see, for example, RPA1). The failure to
detect the whole standard curve for some RNAs means that the unit values at the lower
end of the scale for these RNAs may not be accurate. For example, Figure 4.14 shows
that Bat2d1 has a mean axonal unit value of 2.58. However, as neither of the 10 unit
or 1 unit standard curve samples were detected, the mean value has been inferred from
the samples for the range 100 - 100,000, and cannot be considered to be accurate.
The low r2 values, low efficiencies and several missing standard curve values for
Set 2 shown in Figure 4.13b indicate that the quantifications resulting from this set are
not reliable. As a result, in what follows, while these quantifications will be considered,
these qRT-PCRs will be interpreted as standard RT-PCRs, examining only presence or
absence of signal in Axons, Blank Near and Blank Far conditions, and no comparison
of RNA quantity will be presented.
4.4.4.2 qRT-PCR results for Set 2 samples
Figure 4.14 shows the Axon and Blank unit values for the qRT-PCRs carried out on the
Set 2 samples. As with the Set 1 results, the unit values for each RNA are inferred from
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Mean Units Mean Units Significant 
difference from 
axons
Mean Units Significant 
difference from 
axons
19.31 (SD 21.42) 1.50 (SD 1.14) p>0.05 2.90 (SD 2.28) p>0.05
17.54 (SD 13.52) 2.07 (SD 1.40) p>0.05 1.26 (SD 1.57) p>0.05
14.97 (SD 12.35) 4.51 (SD 3.83) p>0.05 0.16 (SD 0.15) p>0.05
 2.58 (SD  4.47) 0    (SD 0   ) p>0.05 0    (SD 0   ) p>0.05
13.18 (SD 14.11) 8.31 (SD 7.22) p>0.05 2.55 (SD 4.42) p>0.05
 5.14 (SD  4.45) 1.27 (SD 2.19) p>0.05 0    (SD 0   ) p>0.05
 1.19 (SD  2.05) 0    (SD 0   ) p>0.05 0    (SD 0   ) p>0.05
 0.32 (SD  0.56) 0    (SD 0   ) p>0.05 0    (SD 0   ) p>0.05
 4.74 (SD  5.07) 0    (SD 0   ) p>0.05 0    (SD 0   ) p>0.05
49.06 (SD 42.65) 0    (SD 0   ) p>0.05 0    (SD 0   ) p>0.05
 0    (SD  0   ) 0    (SD 0   ) p>0.05 0    (SD 0   ) p>0.05
 0    (SD  0   ) 0    (SD 0   ) p>0.05 0    (SD 0   ) p>0.05
 0    (SD  0   ) 0    (SD 0   ) p>0.05 0    (SD 0   ) p>0.05
 0    (SD  0   ) 0    (SD 0   ) p>0.05 0    (SD 0   ) p>0.05
 0    (SD  0   ) 0    (SD 0   ) p>0.05 0    (SD 0   ) p>0.05
 0    (SD  0   ) 0    (SD 0   ) p>0.05 0    (SD 0   ) p>0.05
a
















































































Figure 4.14: Comparison of axon and blank unit values for RNAs tested on Set 2 samples. Colouring of
RNA names reflects the quality of the qRT-PCR for that RNA indicated by the r2 value for the qRT-PCR
(see Figure 4.13b). The unit values for each RNA are inferred from standard curves specific to each
RNA and so cannot be compared directly. Means and standard deviations for Axons, Blank Near and
Blank Far Units are shown, and significant differences between Axons and Blank Near, and Axons and
Blank Far, are reported according to one-tailed paired t-tests. For the RNAs where differences were
insignificant (where p > 0.05) and signal was detected in at least one condition, full data for all samples
has been provided to show where Axon signals were above Blank signals. b) 18S 1, c) 18S 2, d) 18S
3, e) Bat2d1, f) β-actin, g) β-catenin, h) Reep5, i) RhoA, j) RPS3, k) Ubiquilin-1. Axon unit values for
a particular sample which were above both Blank Near and Blank Far unit values for that sample are
marked in bold. Axon unit values for a particular sample which are below either Blank Near or Blank
Far unit values for that sample are italicised. 0 values where no signal was detected are coloured grey.
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standard curves specific to each RNA and so cannot be compared directly. Also, as
established in Section 4.4.4.1, the quantifications from these qRT-PCRs are not reliable
and should be interpreted cautiously.
The figure shows that, according to one-tailed, paired t-tests, no significant
differences could be found between Axons and Blank Near signals, or between Axons
and Blank Far signals, for any RNA. This is perhaps unsurprising, as it was known that
no significant difference could be found between these signals when the set of samples
was first collected due to the wide variation in axonal signals (see Section 4.4.4.1) and
these samples subsequently degraded after this first analysis. The figure shows the
complete data sets for the RNAs where a signal was detected in any one condition (the
RNAs where no signal was detected in Axons, Blank Near and Blank Far, which are
Ascc3l1, BPGM, Rac1, Rock1, RPA1 and α-tubulin-OH, are considered to be absent
from thalamic axons).
These full data sets show that where signals were found in the Blank Near or Blank
Far conditions, the Axonal signal was above the blank signals, for all samples for 18S
1, 18S 2, 18S 3 and β-catenin. This is not true for β-actin, where the signal for Sample
2b was below the Blank Near signal for that sample, although the quantification for
β-actin is not reliable because the r2 value for this qRT-PCR was below the acceptable
threshold. Indeed, because of the general doubts over the quality of these samples
(discussed in Section 4.4.4.1), any unit value above 0 for a particular condition can
only be used to indicate the presence of a signal in that condition. This means that it
cannot be concluded that 18S, β-actin and β-catenin were present above contamination
in these samples, although it is encouraging that axonal signals were detected in at least
two samples for each of these RNAs.
For the remaining RNAs, Bat2d1, Reep5, RhoA, RPS3 and Ubiquilin-1, no signal
was detected in either the Blank Near or Blank Far conditions for any sample, which
indicates that signal detected in the axons is not from contamination. Signal was
detected in two out of three samples for RPS3 and Ubiquilin-1 but only one sample
for Bat2d1, Reep5 and RhoA. While the absence of these RNAs from at least one
sample is concerning, it can be tentatively concluded that these RNAs are present in
thalamic axons, although further confirmation with RNA samples of higher quality is
desirable.
β-actin, β-catenin and RPS3 were repeated in Set 2 to confirm that they were
present in both sets of samples. As discussed above, these RNAs were detected in
both sets, although the signals found in Set 2 were considerably smaller than those
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found in Set 1 and could not be statistically differentiated from the blank signals, but
it is believed this is due to the poor quality of the Set 2 samples.
In conclusion, these two sets of qRT-PCRs provide good evidence for the presence
of 18S, α-tubulin, β-actin, β-catenin, MAP2, Reticulon-1, RPS3 and Synaptotagmin
13 RNAs, and the absence of Ascc3l1, BPGM, Rac1, Rock1 and RPA1 RNAs in
thalamic axons, and also suggest the presence of Bat2d1, EphB2, RalA, Reep5, RhoA
and Ubiquilin-1 RNAs in these axons.
4.5 Discussion
There are several aspects of the method described in this chapter, and the results
acquired using the method, which require further discussion. The qRT-PCR method
has been modified in a number of ways which require justification, and the quality and
validity of the results needs to addressed. Once these subjects have been considered,
the presence or absence in thalamic axons of the RNAs investigated here can be put
into context.
4.5.1 Application of qRT-PCR method
A number of decisions were made in the application of qRT-PCR to the detection of
RNAs in axons which need to be justified. These decisions will now be explained.
4.5.1.1 Comparing axons and blanks
The primary purpose of using qRT-PCR rather than standard RT-PCR for these
experiments is to discriminate between very small signals, such as those acquired from
the Axons, Blank Near and Blank Far conditions, which it would not be possible to do
with standard RT-PCR. Therefore, unit values for Axons, Blank Near and Blank Far
have been compared for each RNA tested over each set of samples using one-tailed
t-tests. These unit values are inferred from a standard curve for the RNA. The primary
criterion for the presence of an RNA in axons is to find a significant difference between
the signal from the axons and both of the two blank conditions.
As discussed in Section 4.2.2, variation in quantity of tissue is often controlled for
using an internal standard. This does not make sense for the comparison of axons to
blanks because it is not known what contaminating tissue may be present in the blanks
and so it is expected that the internal standard will reflect the amount of contamination
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reliably. This means that variation in number and size of explants between samples
is not directly controlled for, although variation within samples is accounted for by
taking the same number of pieces of insert for each of the Cells, Axons, Blank Near
and Blank Far conditions. This lack of control for variation between samples does not
matter where axonal conditions are of good quality, because the difference between
these conditions and the blank conditions should be much larger than any variance
caused by varying numbers of explants, as is the case for the Set 1 samples (see Figures
4.8 and 4.10). However, it may affect samples of poorer quality, such as those of Set
2, where it may be that the wide variation in axonal signal and the small signal from
Sample 2c seen in Figure 4.13a meant that differences between axons and blanks could
not be statistically distinguished.
It is not clear how this problem could be addressed, although it is probably best
to simply ensure that axonal samples are of higher quality than those used for Set
2. The unit values could not be weighted by number of explants, for example, as
the number of explants is not a reliable indicator of amount of axonal tissue in each
sample, because the amount of axonal tissue dissected from each explant will depend
on how much axonal tissue grew from the explant and how much could be dissected
without contaminating the sample. However, it is not thought that this problem poses
a significant difficulty for future applications of the method, providing samples of high
quality are collected and processed promptly.
4.5.1.2 Internal standard for quantity of tissue
Although the primary purpose of the use of qRT-PCR is to detect differences between
axons and blanks, it is also possible to compare cellular and axonal signals, and also
to compare different RNAs, through the use of an internal standard, as presented in
Section 4.4.3.3. Because each RNA is measured on a standard curve scale specific
to the RNA, the units for one RNA can not be translated into units for another RNA.
These units must be cancelled out by calculating ratios of axonal to cellular expression.
These ratios can then be controlled for tissue quantity using the internal standard and
compared.
As explained in Section 4.2.2, an internal standard gene is chosen to represent
the amount of biological material in the test sample, so that any variation in amount
of tissue across different samples can be controlled for. To study axonal RNA using
qRT-PCR, an internal standard is required which is expressed in cells and axons at
the same or similar levels. For these experiments, the ribosomal RNA 18S has been
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used as a internal standard. It is known that ribosomes are present in axons (Bassell
et al., 1998; Alvarez et al., 2000) and so the presence of 18S is expected. 18S has
been shown to be the most stable indicator of amount of material compared to other
standard controls such as β-actin and GAPDH in a number of studies on human cell
populations (Bas et al., 2004; Goidin et al., 2001). There are also particular reasons
for considering β-actin and GAPDH to be unsuitable as axonal internal standards.
β-actin is known to be present in axons, as is 18S, but its expression is known to
vary at the growth cone and so it is not suitable as an internal standard (see Section
1.5.5). It is not known whether GAPDH is present in axons or not, and therefore it
cannot be relied on as an internal standard; given its roles in cellular processes such as
glycolysis, transcription activation and apoptosis (Chuang et al., 2005) it would seem
unlikely that it would be be present in axons as well, although the finding that GAPDH
is involved in Src-dependent retrograde transport (Tisdale and Artalejo, 2007) might
suggest otherwise, as the same mechanism is known to function in axons (Hüttelmaier
et al., 2005). Nevertheless, given the lack of knowledge about GAPDH in axons at
present, 18S remains the best choice for an axonal internal standard.
One of the implications of choosing 18S as an internal standard is the requirement
to use random hexamers to prime the cDNA synthesis reaction, rather than oligo dT
primers, because ribosomal RNA does not have a poly-A tail. In fact, random hexamers
are known to be more efficient than oligo dTs and so are the best choice for cDNA
synthesis regardless of choice of internal standard (Peters et al., 2004). A number
of sources suggest that gene specific primers are ideal for cDNA synthesis (Peters
et al., 2004; Wacker and Godard, 2005) but this is not feasible for this study because
sufficient mRNA would be required to perform separate cDNA synthesis reactions for
each RNA of interest and this quantity of mRNA cannot be easily acquired from axons.
4.5.1.3 Cycle number and replicates
Finally, the issues of cycle number and replicates must be addressed. Each qRT-PCR
was run for 50 cycles to ensure that all reactions involving very small amounts of cDNA
reached plateau. Rameckers et al. (1997) show that 30-35 cycles are not sufficient
to successfully amplify small amounts of cDNA, particularly at less than perfect
efficiency, and claim that using as high as 60 or 70 cycles should pose no problem
as long as appropriate negative controls are performed to control for contaminants, as
they have been here. In fact, for the qRT-PCRs presented in this chapter, 40 cycles
would have been sufficient and should be considered sufficient for future applications
Chapter 4. Characterising RNA in Developing Thalamic Axons Using qRT-PCR 147
of the method. Also, the risk of amplifying contaminants is not as serious a problem
for qRT-PCR as for standard RT-PCR, because it does not rely on end-point detection
(measuring only the end products of a PCR) and so contaminants can be separated
from amplicons by examining quantities and melting temperatures of products in
experimental and control samples.
As described in Section 4.2.2, two types of replicates are desirable in a qRT-
PCR experiment; biological replicates, where several samples of tissue are tested, and
technical replicates, where the same sample is tested multiple times. Three biological
replicates have been used for each set of RNAs tested for these experiments. However,
because so few qRT-PCRs could be performed on each sample, and because so many
RNAs were candidates for presence in axons, technical replicates were only performed
for one RNA, 18S. It would be desirable to perform more technical replicates for each
RNA, but given the difficulty of acquiring the samples, and the fact that the most
important result of the method is to determine the presence or absence of the RNA in
axons rather than the precise quantity of RNA in the axons, it is thought that a single
qRT-PCR is sufficient for each RNA in this study.
4.5.1.4 Quality of Set 2 samples
As presented in Section 4.4.4.1, Figure 4.13b shows that while several indicators
demonstrate that the samples used for the qRT-PCRs in Set 1 were of high quality
(see Figure 4.8b), the Set 2 qRT-PCRs had a number of problems. The coefficients of
determination (r2 values) were questionable or unacceptable for most qRT-PCRs and
the efficiencies of the reactions were almost all much lower than those for the Set 1
qRT-PCRs. Also, it was not possible to amplify many samples in the standard curve
dilution series. This indicates that the standard curve dilution series used for these
experiments had degraded and was not suitable for use. In addition, the Set 2 samples
themselves were known not to be as high quality as those of Set 1 after cDNA synthesis
and had degraded between cDNA synthesis and qRT-PCRs (see Section 4.4.4.1).
These problems mean that the quantifications for Set 2 cannot be considered
reliable. However, this does not mean that the results are unusable. If a signal is
found for a particular RNA in axons but no signal is found in either blank condition,
this result can be treated as a standard RT-PCR and considered to indicate the presence
of that RNA in axons. Using this criterion, the Set 2 data indicates that Bat2d1, Reep5,
RhoA, Ubiquilin-1 and RPS3 are present in thalamic axons, and Ascc3l1, BPGM,
Rac1, Rock1 and RPA1 are not. However, while signal was detected in axons for 18S,
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β-actin and β-catenin in this set, nothing further can be concluded about these RNAs
because signal was also detected in at least one of the blank conditions. The evidence
for the presence of these RNAs in axons is solely to be found in the Set 1 data, but it is
encouraging that the Set 2 data at least does not contradict this Set 1 data, as all of the
repeated RNAs (18S, β-actin, β-catenin and RPS3) were detected in axons.
4.5.2 Presence of RNAs
What do the two sets of qRT-PCR results indicate about the presence or absence of
RNAs in thalamic axons? Figure 4.10 shows that, for Set 1, there are significant
differences between the axonal samples and blank samples for all the tested RNAs
except EphB2 and RalA, which indicates that all of these RNAs were present in these
samples of thalamic axons. For EphB2 and RalA, where no significant difference
between axons and blanks could be found, it was the case that no signal was present in
the blank conditions at all, and therefore it is reasonable to conclude that these RNAs
are also present in thalamic axons.
For Set 2, while the quantifications are not reliable and no significant differences
can be found between axons and blanks, there are several RNAs where a signal was
detected in axons and no signal was detected in either of the blanks (Bat2d1, Reep5,
RhoA, RPS3, Ubiquilin-1) and several more where no signal was detected in any of
the samples (Ascc3l1, BPGM, Rac1, Rock1, RPA1, α-tubulin-OH). This indicates that
the first group of RNAs is present in axons but the second group is not.
Therefore, to summarise, it can be concluded that the qRT-PCRs presented here
provide evidence for the presence of 18S, α-tubulin, β-actin, β-catenin, Bat2d1,
EphB2, MAP2, RalA, Reep5, RhoA, RPS3, Reticulon-1, Synaptotagmin-13 and
Ubiquilin-1 RNAs in thalamic axons, and indicate the absence of Ascc3l1, BPGM,
Rac1, Rock1 and RPA1 from these same axons.
Of these mRNAs, α-tubulin, β-actin, RhoA and EphB2 proteins have well
characterised roles in axon growth and guidance and the identification of their mRNAs
in thalamic axons supports the case for the involvement of the proteins in thalamic
axon development. α-tubulin and β-actin are core components of the cytoskeleton,
with α-tubulin forming microtubules and β-actin forming actin filaments. RhoA is an
intermediary between Sema3A and actin filaments, with a crucial role in axon collapse
in some systems (see Section 1.5.4). The identification of RalA here indicates that a
wider survey of the small GTPases would be of interest in these axons and in other
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axonal systems, especially since RalA has been shown to regulate neurite branching in
rat sympathetic neurons (Lalli and Hall, 2005).
EphB2 is the only guidance cue-related molecule which has been investigated here,
but the identification of the mRNA for this receptor suggests that the mRNAs for
other receptors known to be present in thalamic axons should be investigated, such
as EphA2, DCC, Robo1 and Robo2. In addition, while the regulation of mRNAs for
cytoskeletal proteins such as β-actin has been investigated in some detail, very little
is known about how new receptors are translated in response to guidance cues (as
shown by Brittis et al. (2002)). Thalamic axons may prove to be a good model of this
behaviour given the variety of responses to guidance cues by different populations of
thalamic axons (see Section 1.4.2.4).
The identification of RPS3 mRNA and 18S rRNA in thalamic axons in these
experiments strongly suggests the presence of ribosomes in these axons, and indicates
that further experiments should be carried out to detect the location of these ribosomes
in these axons and to demonstrate that protein synthesis occurs at these locations.
Many mRNAs for ribosomal proteins were identified by Willis et al. (2007) in their
survey of regenerating rat dorsal root ganglion axons, which suggests that other
ribosomal protein mRNAs will be found in developing thalamic axons. Similarly, the
identification of reticulon-1 mRNA in these experiments suggests that the reticulon
proteins should be investigated further in thalamic axons, as reticulon-1 has been
shown to colocalise and interact with spastin, which is involved in microtubule
dynamics and vesicle transport in axons (Mannan et al., 2006; Steiner et al., 2004),
and reticulon-4 is known to trigger growth cone collapse (although this is via
oligodendrocytes; Yang and Strittmatter (2007)).
The functions of ubiquilin-1 and synaptotagmin-13 in axons is less clear, although
synaptotagmin-13 has been shown to bind to neurexin 1α (Fukuda and Mikoshiba,
2001), and neurexins are required in axons for presynaptic terminals to form (Dean
et al., 2003). Similarly, the β-amyloid precursor protein (APP), the precursor of β-
amyloid, which is the peptide that clusters together in plaques and causes Alzheimer’s
disease, is expressed in neuronal processes and is required for neurite outgrowth
(Young-Pearse et al., 2008), and ubiquilin-1 is required to transport APP from
intracellular compartments to the cell surface (Hiltunen et al., 2006), and so it is
possible that it performs a similar function in axons. The remaining RNAs, Bat2d1
and Reep5, have been identified in large surveys of gene expression and have not yet
been investigated in their own right, and so it is not possible to speculate on what might
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be their roles in axonal function.
These results mostly agree with the literature on RNAs in other axonal systems,
in that 18S (Alvarez et al., 2000), β-actin (Bassell et al., 1998), EphB2 (Brittis et al.,
2002) and RhoA (Wu et al., 2005) were all found to be present in thalamic axons,
whereas Rock1 and Rac1 were not (Wu et al., 2005). In addition, seven of these RNAs
(Bat2d1, RalA, Reep5, RPS3, Reticulon-1, Synaptotagmin-13 and Ubiquilin-1) have
never been identified in any axonal system prior to this study, and none of the RNAs
identified here (or any other RNAs) have previously been identified in thalamic axons.
There are also two mRNAs which have been found in thalamic axons which have not
been found in other axonal systems, namely α-tubulin and MAP2. It is possible that
these mRNAs are present in thalamic axons but not other systems; however, it is also
possible that they are absent from thalamic axons and the detection of these mRNAs is
due to the presence of contaminating cellular or dendritic mRNA in the axonal samples.
These alternatives will now be considered.
4.5.2.1 α-tubulin
α- and β-tubulin are crucial proteins in developing neurites, as they form the backbone
of microtubules which are central parts of the neurite cytoskeleton and which are
heavily involved in growth cone turning (see Section 1.5.1). Therefore, given the
presence of the mRNA for the similarly crucial β-actin (see Section 1.5.5), it is perhaps
not surprising that α-tubulin mRNA might be found in axons. Indeed, β-tubulin has
already been shown to be synthesised in distal rat sympathetic ganglion axons (Eng
et al., 1999).
Despite this, α-tubulin was found to be absent from sympathetic ganglion axons in
chick using qRT-PCR by Olink-Coux and Hollenbeck (1996) and in rat using in situ
hybridisation by Bruckenstein et al. (1990). This result does not necessarily negate
the result presented here, because it may be that thalamic axons, or axons in the brain
in general as opposed to the spinal cord, behave differently to sympathetic ganglion
axons. Indeed, α-tubulin mRNA has been found in Aplysia central nervous system
neurites (Moccia et al., 2003).
In fact, the discrepancy between the results presented here and those in the
literature can be accounted for by examining the primers used. The primers used here
for α-tubulin for the Set 1 qRT-PCR results were designed de novo from the α-tubulin
mRNA sequence and did not match the primers used by Olink-Coux and Hollenbeck
(1996). The primers used were designed to bind to mouse α-tubulin 1a, whereas the
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primers used by Olink-Coux and Hollenbeck (1996) were designed to bind to chick
α-tubulin 5 (tba5 chick), which is the homologue of mouse α-tubulin 1c. However,
the discrepancy between the results presented by Olink-Coux and Hollenbeck (1996)
and those presented here cannot be accounted for by the fact that they were designed
to bind to two different variants of α-tubulin, because both α-tubulin 1a and α-tubulin
1c contain binding sites for both the primers used in this thesis and the primers used
by Olink-Coux and Hollenbeck (1996) and are homologous throughout the regions
amplified by both pairs of primers.
A further qRT-PCR using primers which were homologous in mice to the primers
used by Olink-Coux and Hollenbeck (1996) in chicks (labelled α-tubulin (OH) in
Figures 4.5, 4.13 and 4.14) showed that it was not possible to detect α-tubulin in
thalamic axons using these primers, although a signal could be detected in thalamic
cells (in agreement with Olink-Coux and Hollenbeck (1996), who found a signal in
chick sympathetic ganglion cells with these primers). This indicates that differences
in the primers led to a difference in detection. Either something prevents the primers
used by Olink-Coux and Hollenbeck (1996) from binding to either α-tubulin variant
efficiently (perhaps this region is folded in such a way to interfere with binding with
another RNA, or a protein is already bound to this region), or the primers used in
this thesis may be binding to something other than α-tubulin. While this cannot be
ruled out, a BLAST search for these primers against the mouse genome reveals no
other known gene sequence which matches the sequences of both primers. Therefore
it seems likely that the primers used by Olink-Coux and Hollenbeck (1996) were less
efficient than the primers used in this thesis and, while these primers could amplify
mRNA in cells, they were not able to amplify the very small quantities of α-tubulin
mRNA present in axons.
In addition, in a separate experiment to their α-tubulin in situ hybridisation,
Bruckenstein et al. (1990) were unable to detect any poly(A) RNA in axons, although
they were able to detect some in dendrites, which indicates that their in situs were not
sufficiently sensitive to detect axonal RNA in general, and so their failure to detect
α-tubulin may simply reflect a lack of sensitivity of their in situ technique.
Finally, in their recent cDNA microarray survey of rat dorsal root ganglion axonal
RNAs, Willis et al. (2007) et al repeatedly identified α-tubulin as one of the RNAs
present in these axons. Therefore it seems reasonable to conclude that α-tubulin
mRNA can be found in thalamic axons.
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4.5.2.2 MAP2
A very small quantity of MAP2 was detected in the qRT-PCRs presented here (see
Figure 4.10). MAP2 had the lowest ratio of axon-to-cell expression of all the RNAs
tested, with 9-fold lower expression in axons than cells (see Figure 4.11).
MAP2 is often used as a marker to differentiate axons and dendrites (Dehmelt and
Halpain, 2004). This is supported by a series of papers showing that MAP2 protein and
mRNA is present in dendrites but absent from axons of cultured sympathetic neurons
(Higgins et al., 1988; Bruckenstein et al., 1990), hippocampal neurons (Caceres et al.,
1984a; Bruckenstein et al., 1990) and P19 neuronal cells (Aronov et al., 2001).
These in vitro results are supported by a number of in situ studies in cerebral cortex,
hippocampus and cerebellum (Caceres et al., 1984b; Camilli et al., 1984; Huber and
Matus, 1984). Aronov et al. (2001) also shows that when the 3’UTR of the axonal
marker tau is replaced with the 3’UTR of MAP2, the tau construct is found in dendrites
but not axons (see discussion in Section 1.5.3).
These results suggest that the MAP2 found in the axonal samples presented here
came from some other source, either dendrites or cells, and therefore the other detected
RNAs cannot reliably be considered axonal RNAs. However, there are a number of
reasons why the qRT-PCR results presented here may be accurate and that very small
amounts of MAP2 mRNA are present in axons.
Firstly, MAP2 is found in a number of different isoforms of high molecular weight
(MAP2a and MAP2b) and low molecular weight (MAP2c) (Langkopf et al., 1994).
The high molecular weight isoforms are the forms which are found in dendrites but
not axons. However, the low molecular weight isoform MAP2c has been found in
developing axons (Meichsner et al., 1993; Tucker et al., 1988) and so it is not surprising
to find it expressed in developing thalamic axons. The MAP2 primers used for these
qRT-PCRs identified a sequence present in both MAP2b and MAP2c. In light of this,
it is likely that the signal detected here is for the short MAP2c isoform rather than
the long MAP2b isoform, and that therefore this signal should not be considered to
invalidate the other results.
In addition, it is possible that the signal detected here is from the long MAP2b
isoform. Firstly, some of the early results cited above do show very small amounts of
staining for high molecular weight MAP2 in axons, although it is much lower than the
staining in dendrites (see for example Caceres et al. (1984b)), and it may be that there
was a very small amount of MAP2b present which was below the limits of detection
Chapter 4. Characterising RNA in Developing Thalamic Axons Using qRT-PCR 153
of the methods used in previous studies. Secondly, E14.5 thalamic axons have not
previously been tested for MAP2b and it may be that this system behaves differently
to previously tested systems, which were all tested at later points in development.
One reason for considering this possibility is that all of the results listed above are
from cultures containing axons and dendrites. Higgins et al. (1988), in addition to
showing the absence of MAP2 in such a culture, show that in cultures where dendrite
growth is suppressed, MAP2 protein is found in axons. This peculiar effect appears
not to have been investigated further, but it may be that in the cultures presented here
a similar effect took place.
To summarise, it is not clear whether the MAP2 signal detected here has come
from MAP2b sourced from cells or dendrites, MAP2c sourced from axons, or a novel
MAP2b signal from axons, but it is most likely that the signal is from MAP2c as this
is known to be expressed in developing axons. The matter could be settled by running
more qRT-PCRs on similar axonal samples using primers designed specifically for
MAP2b. But it seems reasonable to conclude that, given the small amount of signal,
this result should not be considered to compromise the other qRT-PCR results.
4.5.3 Comparison of RNAs
The main reason for using quantitative RT-PCR rather than standard RT-PCR for these
experiments was to detect very small differences in RNA quantity. For example, in a
standard RT-PCR it would not be possible to distinguish between axons and blanks
where a small blank signal is detectable, because both reactions would plateau at
similar levels which do not represent the actual quantities of RNA in the original
samples. The quantitative data from qRT-PCR allows the axon and blank signals to
be distinguished.
In addition to this primary use, the quantitative data can be used to compare
the expression of different RNAs in axons and cells. Using the method described
in Section 4.3.4, ratios of axonal to cellular expression can be produced, which are
controlled for tissue quantity by standardising each ratio against the ribosomal RNA
18S (see Section 4.5.1.2 for justification of the use of 18S as internal standard). The
ratios for the qRT-PCRs in Set 1 are shown in Figure 4.11. No comparison of ratios
has been made for Set 2 because the quality of the quantitative data from this set of
qRT-PCRs is questionable (see Section 4.5.1.4).
These ratios must be interpreted with care. For example, MAP2 shows 9-fold
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less expression in axons than in cells, compared to a 2.5-fold decrease of β-catenin
expression. But this does not mean that there is 3.6 times less MAP2 than β-catenin
in axons, because the cellular expression of these two RNAs may not be equivalent.
However, the ratio does indicate that there is 3.6 times less enrichment of MAP2 in
axons than of β-catenin when compared to cellular expression, which may reflect a
real difference in cellular and axonal metabolism.
Indeed, the fact that the expression ratios for different RNAs vary supports the case
that axonal RNA has been detected rather than potential contaminating cellular RNA.
Assuming that different samples of cellular RNA will exhibit the same profiles of gene
expression, it would be expected that a comparison of cellular RNA to cellular RNA
would not show any variation in expression ratios. As the ratios of expression in the
Set 1 RNAs do vary, with one showing enrichment and the others showing different
levels of depletion, this suggests that the RNAs shown here have come from a different
type of tissue, thalamic axonal tissue, in which genes are expressed at different levels
to their expression in thalamic cells.
The ratios shown here indicate that overall there is less of an enrichment for the
RNAs tested in axons than there is in cells (with the exception of the enriched RPS3).
This perhaps explains why RNAs were not detected in axons for many years (Alvarez
et al., 2000). It appears that a very small quantity of RNA is required in axons for
sufficient protein to be locally translated. It is also worth speculating that this might
reflect requirement for the RNAs in the growth cone but not in the main body of the
axon. Ribosomes are found all the way along axons and in growth cones, and some
RNAs such as GAP-43 mRNA have also been found in axons and growth cones (Smith
et al., 2004). However, if an RNA was only found in growth cones, it would appear to
be depleted when measured against the expression of 18S, because 18S, as part of the
ribosome, should be found all the way along the axon. Therefore the depletions seen
in the axon:cell expression ratios may reflect the fact that the RNAs are only expressed
in part of the axon.
4.6 Conclusion
In this chapter, the results from a study of RNAs in developing thalamic axons using the
method described in Chapter 3 and the current chapter have been presented. Evidence
has been provided for the presence of several novel RNAs in these axons, many of
which already have intriguing connections with axonal function which are worthy of
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further investigation. This evidence indicates that the roles demonstrated for β-actin
mRNA (Leung et al., 2006; Yao et al., 2006) and hypothesised for RalA, Reticulon-1,
RPS3, Synaptotagmin-13 in other axonal systems (see Section 1.6.1) are also worth
investigating in thalamic axons. They also suggest that the speculations about β-
catenin function in axons in Section 1.6.2 could be tested in thalamic axons. Despite
some problems with sample quality, it has been shown here that it is possible to
generate high quality quantifications of RNA from axonal samples and to use these
quantifications to infer the presence or absence of these RNAs in axons. This method
should be applicable to any system where axons can be isolated from other tissue.
Chapter 5
In situ hybridisations for β-catenin and
other RNAs in thalamic axons
5.1 Introduction
Several RNAs have previously been identified in axons using in situ hybridisation,
where a detectable probe is bound to an RNA of interest in a tissue sample (Bassell
et al., 1998; Wu et al., 2005; Aronov et al., 2001). This chapter describes a number of
attempts to use in situ hybridisation to identify β-catenin mRNA in thalamic axons. β-
catenin mRNA was chosen for investigation from the mRNAs identified in Thomas
Pratt’s mRNA library (see Section 1.6.1) due to the known presence of β-catenin
protein in growth cones, and its known roles in cell adhesion and Wnt-signalling-
related pathways, which are required for Slit and neurotrophin growth cone signalling
(see Section 1.6.2 for details). In addition, β-catenin mRNA has been shown to be
present in thalamocortical axons in Chapter 4. Many probes, cultures and in situ
protocols have been attempted in order to demonstrate the presence of β-catenin
mRNA in thalamic growth cones, each of which will be considered in what follows.
In the process, it will also be shown that β-actin mRNA and 18S rRNA are present in
thalamic axons and growth cones.
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5.2 Materials and methods
5.2.1 Probes
In situ hybridisation requires a labelled probe which will bind to an mRNA of interest
by complementary base-pairing. These probes can be DNA or RNA molecules, can be
of varying lengths and can be synthesised with different labels.
Long β-actin (βActL) Antisense probes were synthesised using a control template
from Ambion (Catalogue number 7423) which complements and is intended to bind to
a 249bp fragment of mouse β-actin mRNA.
Long β-catenin (βCatL1 and βCatL2) Antisense and Sense probes were synthe-
sised using two separate templates constructed for this project according to the methods
in Section 2.3.2. The probes were constructed from the i3156732 clone of β-catenin
from the I.M.A.G.E. Consortium (Lennon et al., 1996). βCatL1 was constructed from
the full i3156732 clone; βCatL2 was constructed from a subclone of the i3156732
clone containing only the β-catenin 3’UTR.
Clones were inserted into a vector and amplified. βCatL1 was inserted into pCMV-
SPORT6 (Invitrogen) whereas βCatL2 was inserted into pBSIIKS(+) (Stratagene).
The clones were then linearised to produce Antisense and Sense cDNA templates for
each probe; these cDNA templates were then transcribed into digoxigenin-labelled
RNA probes. The βCatL1 Antisense template was cut using SalI (Roche, Catalogue
Number 10348783001) and transcribed from a T7 promoter. The βCatL1 Sense
template was cut using NotI (Roche, Catalogue Number 11014706001) and transcribed
from an SP6 promoter. The βCatL2 Antisense template was cut using PstI (Roche,
Catalogue Number 10621625001) and transcribed from a T7 promoter. The βCatL2
Sense template was cut using NotI and transcribed from a T3 promoter. T7 (Roche,
Catalogue Number 10881767001), T3 (Roche, Catalogue Number 11031163001) and
SP6 (Roche, Catalogue Number 10810274001) RNA Polymerases were used for
transcription. See Figure 5.2 for probe maps.
All oligoprobes were designed with OligoArray software (Rouillard et al., 2003)
and synthesised by MWG. OligoArray tests for specificity of designed oligos by
attempting to align input sequences (eg β-catenin 3’UTR) against a reference genome
with the sequence alignment software BLAST (Altschul et al., 1990), only keeping
those parts of the input sequence which do not match any other sequence in the
genome. Only the forward strand of input DNA is searched as this is the strand which
will produce labelled probes during reverse transcription. The smallest BLAST word
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size possible (7) is used to detect the maximum number of sequence similarities.
Labelling of all probes was carried out by in vitro transcription, as described in
Chapter 2.
5.2.2 Cultures
Two different culture methods were used to generate thalamic axons for testing using
in situ hybridisation, one based on dissociated thalamic cells and one based on thalamic
explants. These methods are now described.
5.2.2.1 Dissection of thalami
Thalamic explants for both culture systems were dissected as follows. Embryonic
mouse brains (CBA or CD1 strains, E14.5) were dissected in ice-cold EBSS. The
midbrain and hindbrain were cut away from the forebrain and cut in half along the
sagittal plane. Each half was laid flat, allowing the thalamus to be seen and dissected.
These whole thalami were then cultured as described below.
5.2.2.2 Coverslips
Coverslips for both culture systems were prepared as follows. Coverslips were
sterilised by heating, placed in Nunclon 4-well dishes (well area 1.9cm2, VWR, UK),
coated for at least two hours with 0.1mg/mL poly-L-lysine (from 10mg/mL solution,
Sigma, UK), washed three times with distilled water, coated for at least one hour with 1
µg/mL fibronectin (from 1mg/mL solution, Sigma, UK) and briefly washed once with
basal culture medium (see Section 2.2.2 for recipe).
5.2.2.3 Dissociated culture
Thalami were dissociated using a Worthington Papain Dissociation Kit (Lorne Lab-
oratories, USA) according to the manufacturer’s instructions, and plated on glass
coverslips (see Section 5.2.2.2). The density of dissociated cells was calculated using
a haemocytometer. Cells were plated at a density of 1,500 cells/mL, diluted in basal
culture medium, and incubated at 37◦C in 95% oxygen, 5% carbon dioxide for two
days.
Chapter 5. In situ hybridisations for β-catenin and other RNAs in thalamic axons 159
5.2.2.4 Explant culture
Thalami from E14.5 mouse brains were sliced into roughly 50-70 pieces each using
a sterile blade (Altomed, UK, Catalogue Number A10136). Thalamic pieces were
plated on coverslips prepared as described in Section 5.2.2.2, with all the pieces from
one thalami being plated on one coverslip. As far as possible, pieces were evenly
distributed across the coverslip. Explants were incubated at 37◦C in 95% oxygen, 5%
carbon dioxide for 4-6 days.
5.2.3 In Situ Protocols
Several different protocols which were used to detect RNA in thalamic axons are now
described. The recipes for the solutions for these protocols can be found in Section
2.4.2. All treatments were performed at room temperature unless otherwise stated.
5.2.3.1 Colorimetric wax section in situ protocol
E14.5 mouse heads were fixed in 4% paraformaldehyde, washed three times in 1xPBS,
embedded in wax and sectioned. Slides containing wax sections were treated twice
with histoclear for ten minutes, twice with 100% ethanol for five minutes, twice with
70% ethanol for five minutes and once with 2xSSC for five minutes. Slides were
permeabilised in 5µg/mL Proteinase K for 7.5 minutes and washed with 2xSSC for
thirty minutes. Slides were fixed with 4% paraformaldehyde for fifteen minutes and
treated with 0.2M HCl for fifteen minutes. Slides were acetylated in 1xTEA for thirty
seconds followed by 3µL/mL acetic anhydride in 1xTEA for ten minutes. Slides were
pre-hybridised in hybridisation mixture in a humid chamber for thirty minutes and
hybridised with probe (120ng per slide) at 50◦C overnight.
After hybridisation, slides were washed with 2xSSC at 50◦C for ten minutes,
2xSSC/50% formamide at 60◦C for forty-five minutes and 4xSSC at 50◦C for five
minutes. Slides were treated with RNAse A (2µg/mL) in 4xSSC at 37◦C and washed
with 2xSSC at 50◦C for thirty minutes, 1xPBS/0.1% Triton-X at room temperature for
ten minutes, 1xPBS/0.1% Triton-X/1% BSA at room temperature for thirty minutes.
Anti-DIG AP antibody (1:2000) in 1xPBS/0.1% Triton-X/1% BSA was applied at 4◦C
overnight. Slides were washed in 1xPBS/0.1% Triton-X three times for twenty minutes
and Buffer 3 for five minutes. NBT/BCIP (1:1000) in Buffer 3 was applied overnight
to stain antibody. Slides were rinsed in distilled water and mounted with Aquamount
under glass coverslips.
Chapter 5. In situ hybridisations for β-catenin and other RNAs in thalamic axons 160
5.2.3.2 Fluorescent axon in situ protocol
This protocol was kindly provided by Samie Jaffrey (Weill Cornell Medical College;
protocol used for axonal in situs in Wu et al. (2005)). Cultured axons were fixed in 4%
paraformaldehyde/1xTBS overnight and washed twice for five minutes in 1xTBS. The
axons were permeablised for ten minutes in 0.5% Triton X-100 in 1xTBS, fixed for
another five minutes in 4% paraformaldehyde/1xTBS and washed three times for five
minutes in 0.1% Triton X-100/1xTBS. Axons were acetylated for ten minutes in fresh
acetylation solution, washed three times for five minutes in 0.1% Triton X-100/1xTBS
and pre-hybridised for 20 minutes in 4xSSC/50% formamide. Probes were hybridised
overnight at 60◦C in hybridisation buffer.
After hybridisation, axons were washed in 40% formamide/1xSSC for twenty
minutes at 37◦C, then three times for five minutes in 1xSSC, three times for five
minutes in 0.1xSSC and thirty minutes with Antibody Blocking Solution. Primary anti-
digoxigenin antibody (Clone DI-22, Sigma, UK), diluted 1:500 in Antibody Blocking
Solution, was applied to the axons overnight at 4◦C and washed with three five minute
washes in 0.1% Triton X-100/1xTBS. Secondary antibody (Molecular Probes, Alexa),
diluted 1:1000 in Antibody Blocking Solution, was applied for 1 hour at 4◦C in the
dark and washed with three five minute washes in 0.1% Triton X-100/1xTBS in the
dark. Coverslips were then dipped in distilled water, air dried and mounted in Mowiol
on glass slides.
5.2.3.3 Colorimetric axon in situ protocol
Cultured explants were fixed in 4% paraformaldehyde/1xPBT, pH 9.5, for 1 hour
and washed twice for five minutes in 1xPBS. The explants were permeabilised in
20µg/mL proteinase K in PBS at 37◦C, washed in 0.2% glycine in PBS and washed
twice for five minutes in 1xPBS. Explants were fixed for another 20 minutes in 4%
paraformaldehyde/1xPBS and washed twice for five minutes in 1xPBS. Explants were
pre-hybridised in hybridisation mixture at 70◦C in a humid chamber (humidified with
50% formamide/2xSSC). For each probe, 20µL of probe in hybridisation mixture
(1ng/µL) was placed on a hydrophobic slide. Coverslips containing explants were
placed on top of probe mixtures and placed in a humid chamber overnight for
hybridisation.
After hybridisation, explants were washed for five minutes in 2xSSC (pH 4.5) and
twice for fifteen minutes in 50% formamide/2xSSC at 65◦C. The explants were then
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washed three times for 10 minutes in PBS/0.1% Tween and pre-blocked for 1 hour
in 1% Boehringer block (Roche, UK). Anti-digoxigenin alkaline phosphatase (Roche,
UK) in Boehringer block (1:500) was applied to explants at 4◦C overnight and washed
with three five minute washes in PBS/0.1% Tween and one ten minute wash in Buffer
3. Explants were stained with NBT/BCIP (Roche, UK) in Buffer 3 (1:50). When
staining was considered complete, the coverslips were dipped in water and mounted in
10µL Mowiol mounting solution.
5.2.3.4 Image processing
Images of colorimetric staining of axons (Figures 5.8, 5.12 and 5.15), where back-
ground intensities varied across different images, were normalised to the same
background intensity using ImageJ, so that staining across images could be compared
(Abramoff et al., 2004). For Figures 5.12 and 5.15, the mean pixel intensity of an
area of background was calculated for each image. The image with highest mean pixel
intensity was chosen as a standard. Each other image was then lightened to match the
mean pixel intensity of the background of the chosen standard. For each image, each
pixel in the image was multiplied by a scale factor to lighten the image. The scale
factor was the ratio of the mean pixel intensity of background of the standard image
compared to the mean pixel intensity of background of the image to be modified.
Different background levels were used for long probes and oligoprobes. For Figure
5.8, the images were darkened rather than lightened by matching to the image with
the lowest mean pixel intensity and also processed using ImageJ’s Sharpen facility to
make the axons visible.
For quantification and statistical analysis of staining, axons from multiple images
of a single in situ hybridisation were traced using ImageJ (see Figure 5.17 for example
trace) and the intensities of pixels along each axon were recorded. As many axons
as possible were selected, provided the following criteria were satisfied: axons were
selected where no crossover with other axons or cells could be seen, and where the
axon could be seen along its entire length above background levels, so that the length
of the axon could be traced with accuracy. These pixel intensity traces were then
analysed using the R program listed in Appendix A. As with image normalisation,
long probes and oligoprobes were treated as separate sets of images.
So that different axons could be compared, the intensity and position of each pixel
along each axon were converted to percentages. Positions of pixels were converted to
percentages of axon length, and intensity was converted to percentages of the highest
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pixel intensity for all axons in the set (either long probes or oligoprobes). Each trace
was then split into bins of 5% axon length; for example, all of the pixels in the first 5%
of the length of the axon for an image were placed in the first bin. The means of the
pixel intensities for all pixels in each bin for each image were calculated, and an overall
mean pixel intensity and standard error of the mean calculated for each bin over all
images. The sets of mean pixel intensities for each bin and image for different probes
could then be compared using a one-tailed Wilcoxon rank sum test for independent,
non-parametric distributions and the results plotted using the errbar function in the
R Hmisc package (Harrell, 2005). The Wilcoxon rank sum test was conservatively
used instead of Student’s t test as some (but by no means all) of the distributions of
binned intensities were skewed away from normality. The set of p-values for each pair
of probes (20 p-values for each set) were adjusted using Bonferroni’s correction to
reduce the chance of making Type I errors with multiple tests.
5.3 Results
In this section, a series of in situ hybridisation experiments are presented, designed
to test for the presence or absence of β-catenin mRNA in thalamic axons. Several
different probes, culture systems and protocols have been used for these experiments.
The design of all the probes used is given, followed by the results acquired with two
different long probes and a set of oligoprobes. Finally, a statistical analysis of the
images acquired with these probes is presented, which demonstrates the presence of
β-catenin, β-actin and 18S RNAs in thalamic axons.
5.3.1 Probe design
A series of in situ hybridisations were performed using long riboprobes designed
to bind to β-catenin mRNA. Two separate long DNA templates were designed both
of which were based on a clone from the I.M.A.G.E. Consortium (Lennon et al.,
1996) which matched part of the β-catenin mRNA sequence. Each template was
used to produce two separate RNA probes by in vitro transcription, one for each of
the two strands of the DNA template (see Figure 5.1 for diagram and Figure 5.2a/b
for probe maps). One of these probes should therefore be the same as part of the β-
catenin mRNA sequence and is labelled the sense probe. The other probe should be
complementary to the β-catenin mRNA sequence and is labelled the antisense probe.
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The antisense probe is used to detect β-catenin mRNA in situ, whereas the sense probe
is used as a negative control. The use of antisense and sense probes is discussed further
in Section 5.4.1.3.
Figure 5.1 shows the design of the two long riboprobes used to detect β-catenin
using in situ hybridisation. The figure shows that both probes bind to the 3’UTR of β-
catenin, which is found in the last exon of the gene, Exon 15. This exon also contains
a protein-coding region upstream of the 3’UTR.
The two probe templates are denoted as βCatL1 and βCatL2, where L stands for
Long probe. The first probe template, βCatL1, matches the entire 3’UTR but also
matches the protein coding region of Exon 15 and part of the intron between exons
14 and 15. Because of problems using this probe template (which will be shown in
the following sections), the second probe template, βCatL2, was designed to match the
3’UTR only, although it does not match the entire 3’UTR as βCatL1 does. Both probes
match only the NCBI reference and Celera alternative β-catenin genomic sequence
when BLASTed against the NCBI mouse build 37 genome database using the default
parameters (E=0.01). The probe maps for both probes can be seen in Figure 5.2a/b.
In addition to these two probes, a β-actin cDNA template was purchased from
Ambion, which was used to make a β-actin antisense probe for use as a positive control.
This probe is denoted βActL Antisense from this point forward. As this template only
had RNA polymerase promoters at one end, it was not possible to make a sense probe
for β-actin using this template.
Figure 5.2 shows the sequences of thirteen oligoprobes used to detect 18S rRNA
and β-catenin, β-actin and RPS3 mRNAs. For each RNA, three separate oligoprobes
intended to bind to different parts of the RNA molecules were used, to maximise any
signal present. All oligoprobes were tested for specificity by the oligo design software
OligoArray by running BLAST against the mouse genome on each sequence that the
oligoprobes were intended to bind to against, with only unique parts of these sequences
used to find suitable oligos (see Section 5.2.1 for details). A single control probe was
designed, called Scrambled, which was a randomised sequence of nucleotides which
did not match any part of the mouse genome (BLAST returned no hits against Ensembl
release 47 of the mouse genome, E=1e-10). RPS3 oligoprobes were not used for axonal
in situ hybridisations but were used for the in situ hybriidsations on coronal sections
presented in Chapter 6.



























T7 Promoter SP6 Promoter
AS S NotI PstI
T7 Promoter T3 Promoter
AS S
Figure 5.2: a,b) Probe maps for β-catenin long probes. Maps not to scale. AS, Antisense; S, Sense.
a) βCatL1 probe in pCMV-SPORT6 vector. Antisense strand cut with SalI and transcribed from
T7 promoter. Sense strand cut with NotI and transcribed from SP6 promoter. b) βCatL2 probe in
pBSIIKS(+) vector. Antisense strand cut with PstI and transcribed from T7 promoter. Sense strand cut
with NotI and transcribed from T3 promoter. c) Sequences of oligoprobes used for in situ hybridisations.
Probes for 18S, β-actin, β-catenin and the scrambled control probe used in the present chapter are shown.
Also shown are probes for RPS3, as used for in situ hybridisations on coronal sections in Chapter 6.
Probe sequences are shown in bold, with the T7 promoter sequence in normal type.
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a b
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!-actin (!ActL) Antisense No Probe
!-catenin (!CatL1) Sense!-catenin (!CatL1) Antisense
e
!-catenin E15.5 WT
Figure 5.3: On coronal sections of E14.5 mouse heads, in situ hybridisations for (a) βCatL1 Antisense
probe, (b) βCatL1 Sense probe, (d) βActL Antisense probe and (e) no probe show that both the βCatL1
Antisense and βActL Antisense probes stain areas of the cortex whereas the βCatL1 Sense probe does
not substantially stain any region of the section, indicating that the three probes function as expected.
(c) shows expected pattern of expression for β-catenin in E15.5 wild-type mouse, taken from Chenn and
Walsh (2002), in close agreement with the expression in (a). Scale bars, 500µm; bar in (a) for (a) and
(b); bar in (d) for (c), (d) and (e).
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5.3.2 βCatL1
In this section, results for the first long probe for β-catenin (βCatL1) are presented,
showing its use with several different culture systems and in situ hybridisation
protocols.
5.3.2.1 βCatL1 on coronal sections
To confirm that the βCatL1 Antisense and Sense probes functioned as expected, they
were tested on wax coronal sections of E14.5 mouse heads. Figure 5.3 shows four
coronal sections, stained with the βCatL1 Antisense probe, the βCatL1 Sense probe,
the βActL Antisense probe and with no probe. The figure shows that both the βCatL1
Antisense- and βActL Antisense-treated sections are strongly stained across the cortex,
whereas the same strength of staining cannot be seen on either the βCatL1 Sense-
treated section or the unstained section.
The βCatL1 Antisense- and βActL Antisense-treated sections show a similar level
of staining, indicating that the βCatL1 template could be used to produce antisense
probe of a similar quality to a commercial template. These pictures also indicate that
the two probes bind specifically to particular mRNAs, because similar levels of staining
were not seen with the βCatL1 Sense probe. The βCatL1 Antisense expression pattern
is in close agreement with that seen in the literature (see, for example, Chenn and
Walsh (2002), shown in Figure 5.3c).
Given that these results show that these probes appear to function correctly, they
were used for further in situs on thalamic axons.
5.3.2.2 βCatL1 Probe on dissociated axons
Figure 5.4 shows the results of an in situ hybridisation staining for βCatL1 Antisense,
βCatL1 Sense and βActL Antisense probes using the fluorescent protocol described in
Section 5.2.3.2 on dissociated thalamic cells (see Section 5.2.2.3). The figure shows
Figure 5.4 (following page): βCatL1 Antisense probe stains axons of dissociated E14.5 mouse thalamic
cells above staining with βCatL1 Sense probe. However, βActL probe only shows background staining.
Probes diluted 1:10 in hybridisation buffer. (a,c,e,g) Probes shown in green, GAP-43 in red and TOPRO
in blue. (b,d,f,h) Probe stain only. (a,b) βCatL1 Antisense probe. (c,d) βCatL1 Sense probe. (e,f) βActL
probe. (g, h) No probe. (i-l) Magnified single cells and axons (shown in white boxes in (a-d)), stained
with (i,j) βCatL1 Antisense probe and (k,l) βCatL1 Sense probe. (i,l) Probe in green, GAP-43 in red
and TOPRO in blue. (j,k) Probe stain only. Scale bar, 20µm.
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that signal can be detected for the βCatL1 Antisense probe above the level of both the
βCatL1 Sense probe and no probe control staining, indicating that β-catenin is present
in the cells of these cultures. The magnifications show that there is also some evidence
of β-catenin in the neurites of these cells. However, the βActL Antisense probe did not
stain the cells or axons above background levels.
To try to improve this result and detect βActL Antisense probe, another in situ
hybridisation was performed using 40% more probe than in the previous figure, the
results of which are shown in Figure 5.5. The figure shows that βActL Antisense
could now be detected in axons above the background staining shown where no probe
was applied. However, the same improvement in staining could not be seen for the
βCatL Antisense probe above the βCatL Sense probe. The staining of cells is slightly
higher for the βCatL Antisense probe than for the βCatL Sense probe and the no probe
condition, but no axonal staining can be detected (see magnified images of single cells
and axons for examples).
Further attempts to replicate the result shown in Figure 5.4 failed to improve
the staining of βCatL Antisense and βActL Antisense probes above the level of
background or the βCatL Sense probe (see Figure 5.6 for an example, where no
difference in staining between any of the four conditions can be seen).
These three figures illustrate that the neurites of dissociated cultured thalamic cells
are very short, which means it is not possible to determine axons from dendrites. The
neurites are also difficult to distinguish from each other and to trace to their parent cells
because the cells are plated at high densities. The cells in the cultures presented in the
above figures were plated at 1500 cells per mm2 and cultured for 2 days. When cultured
at 1000 cells per mm2, cells did not survive even for two days and did not produce
neurites. Cells also died when cultured for longer than 2 days (see also Asavaritikrai
et al. (2003)). Therefore this culture system was not of sufficient quality to detect
axonal staining.
Figure 5.5 (following page): Increasing probe dilution from 1:10 to 1.4:10 (an increase of 40%)
improves βActL Antisense staining but not βCatL Antisense staining above βCatL Sense staining.
(a,c,e,g) Probes shown in green, GAP-43 in red and TOPRO in blue. (b,d,f,h) Probe stain only. (a,b)
βCatL1 Antisense probe. (c,d) βCatL1 Sense probe. (e,f) βActL probe. (g, h) No probe. (i-l) Magnified
single cells and axons (shown in white boxes in (a-d)), stained with (i,j) βCatL1 Antisense probe and
(k,l) βCatL1 Sense probe. (i,l) Probe in green, GAP-43 in red and TOPRO in blue. (j,k) Probe stain
only. Scale bar, 20µm.
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!-actin (!ActL) Antisense No Probe
!-catenin (!CatL1) Sense!-catenin (!CatL1) Antisense
a b
c d
Figure 5.6: βCatL1 Antisense and βActL Antisense staining could not be replicated reliably. Further
attempts using the same probes, culture and protocol as Figures 5.4 and 5.5 did not produce strong
staining for βCatL1 Antisense and βActL Antisense probes compared to βCatL Sense or no probe, as
shown in this example, where no substantial difference in staining can be seen between any pair of the
four conditions. (a) βCatL Antisense, (b) βCatL Sense, (c) βActL Antisense, (d) No Probe. Pictures
taken with 9 second exposure. Scale bar, 20µm.
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5.3.2.3 βCatL1 Probe on explant cultures
Because it was not possible to obtain reliable differences in staining with any probes
using the fluorescent protocol described in Section 5.2.3.2, it was decided that further
in situs should be performed using a colorimetric protocol which was known to work
in the lab (see Section 5.2.3.3 for method). Also, because the dissociated cell culture
method had failed to yield sufficient neurite growth, an explant culture system was
used to produce neurites (see Section 5.2.2.4 for method).
In this system, where whole thalami were sliced into between 50-70 pieces
and plated on glass coverslips, the explants survived for many days and produced
substantial neurite growth after three days. An advantage of this system is that some
cells were dissociated from the explants during the vigorous dissection procedure and
were also plated with the explants. These dissociated cells were found to grow neurites
which were as long or longer than those found in the earlier dissociated cell cultures.
Figure 5.7 shows an example of an explant and a dissociated cell from this culture
system stained with the axonal marker neurofilament (for other examples, see the
remaining figures in this chapter). The figures shows that considerable axonal growth
could be found from both explants and dissociated cells. Therefore this culture system
was used for all further in situ hybridisation experiments.
Figure 5.8 shows the results of a colorimetric in situ with the βCatL1 Antisense
and βActL Antisense probes on dissociated cells and their axons in an explant culture.
The figure shows that the βActL Antisense probe stained cells and axons above
the background level shown for no probe staining, confirming that this probe was
functional. The figure also shows light staining above background for both the βCatL1
Antisense and βCatL1 Sense probes, but no substantial difference between these two
probes. This figure therefore mirrors the result acquired using the fluorescent in situ
protocol shown in Figure 5.5.
Because it had not been possible to acquire a successful repeatable result using
the βCatL1 probes with two different protocols, and because βCatL1 was a very long
probe containing sections of RNA which may interfere with its binding to endogenous
β-catenin mRNA, it was decided that new probes for β-catenin should be designed.
5.3.3 βCatL2
In this section, results for the second long probe for β-catenin (βCatL2) are presented.
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a
b
Figure 5.7: Explant culture produces substantial axonal growth from both explants and dissociated cells.
(a) Confocal image of E14.5 mouse thalamic explant stained with axonal marker neurofilament. Both
explant and axons are clearly stained and substantial axonal growth from the explant can be clearly
seen. (b) Fluorescent image of single dissociated cell from the same culture system, stained with
neurofilament, shows considerable axonal growth. Scale bars both 20µm.
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No Probe!-actin (!ActL) Antisense









Figure 5.8: Dissociated E14.5 mouse thalamic cells from explant cultures, stained for 3 hours with (a,b)
βCatL1 Antisense probe, (c,d) βCatL1 Sense probe, (e,f) βActL Antisense probe and (g,h) No probe.
Both βCatL1 probes and βActL Antisense probe stained axons above background. βActL Antisense
probe stains cells and axons. However, no clear difference in staining can be seen between βCatL1
Antisense and βCatL1 Sense probes. Scale bar, 20µm.
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5.3.3.1 βCatL2 Probe on explant cultures
The template used to make βCatL2 Antisense and βCatL2 Sense probes was designed
to match only the 3’UTR of β-catenin, and does not include the coding and intronic
regions that are part of the βCatL1 template (see Section 5.3.1), based on the
hypothesis that the intronic region may have been interfering with the ability of the
probe to bind to β-catenin mRNA in axons in situ.
Using these probes, it was possible to successfully and repeatedly detect a signal
for the βCatL2 Antisense probe in explants and single cells above the control levels
detected for the βCatL2 Sense probe and with no probe, as shown in Figures 5.9,
5.10 and 5.11. However, some refinement was required to detect a signal in processes
above control levels. Once bound to mRNA in situ, the digoxigenin-labelled probe
is bound to anti-digoxigenin alkaline phosphatase. Alkaline phosphatase catalyses
the conversion of the colorimetric stain NBT/BCIP into a purple precipitate, so when
tissue samples are treated with NBT/BCIP the presence of alkaline phosphatase, and
therefore digoxigenin-labelled probe bound to mRNA, can be visualised by observing
this precipitate.
Figure 5.9 shows that staining for 3 hours, while sufficient to detect signal above
control levels in explants and single cells, was not sufficient to detect signal in
processes above control levels, with no processes in any conditions being clearly
stained. However, staining for 24 hours, as shown in Figure 5.10, caused the processes
to be saturated, with all processes clearly visible and stained above background in all
four conditions, and no substantial difference in staining detectable between the two
Antisense probes and the control probes.
Therefore, cultures were stained for 10 hours, which enabled the processes to be
stained above background but below saturation levels for both the βCatL2 Antisense
and βActL Antisense probes, as shown in Figure 5.11. While the processes in both the
βCatL2 Sense and No Probe conditions are visible, several processes, including axons,
can be seen to be stained above these control levels for both βCatL2 Antisense and
βActL Antisense conditions. In particular, several axons in these two conditions show
punctate staining both along the axon and at the growth cone (marked with arrowheads
in the figure; absence of punctate staining in βCatL2 and No Probe conditions is also
shown with arrowheads).
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5.3.3.2 βCatL2 Probe on axons
The difference in staining in processes between the two Antisense probes and the
control conditions shown in Figure 5.11 is clearly small when compared to the
difference in explant or cell staining. Does this truly reflect the presence of β-catenin
and β-actin in these processes? Can this staining be reliably seen across many different
axons? Figure 5.12 shows a number of different cells with axons, taken from the same
in situ hybridisation shown in Figure 5.11. There is clear punctate staining for both
the βActL and βCatL2 Antisense probes. In particular, the βCatL2 Antisense probe
appears to stain the growth cone repeatedly. This staining is also above the levels seen
in the growth cones and axons stained with βCatL2 Sense probe and no probe, but the
difference is small in all cases, and some light staining can be seen in the processes
stained with both βCatL2 Sense probe and with no probe.
Several attempts were made to improve the staining shown here, by increasing
the pH of the fixative (as recommended by Basyuk et al. (2000)) or modifying the
hybridisation temperature, but these modifications either did not improve the signal or
were too stringent for the neurites projecting from the explants or from dissociated cells
to survive the protocol. Attempts were also made to detect a signal using fluorescent
antibodies rather than a colorimetric stain, by hybridising the probes using the method
shown in Section 5.2.3.3 (as this hybridisation was known to work) but then detecting
these probes using the method shown in Section 5.2.3.2. As shown in Figure 5.13,
these attempts also failed, with no detectable difference visible between any of the
probes, even in explants.
Therefore Figures 5.11 and 5.12 show the best result for β-catenin and β-actin
staining in thalamic axons that it was possible to acquire in the time available.
Conclusions about these results will be drawn after further analysis of the images has
been presented in Section 5.3.5.
5.3.4 Oligoprobes
Figure 5.15 shows the results of a colorimetric in situ hybridisation using the
oligoprobes presented in Section 5.3.1. The figure shows that 18S, β-catenin and β-
actin oligoprobes could be detected above the signal detected for the Scrambled control
probe in explant and single cells, demonstrating that the oligoprobes were functional.
The figure also shows that the 18S and β-catenin probes can be detected above the level
of the Scrambled probe in axons. However, only very slight staining above background























Figure 5.12: Single cells with axons from the same in situ hybridisation shown in Figure 5.11. (a-d)
βActL Antisense, (e-h) βCatL2 Antisense, (i-k) No Probe, (l-o) βCatL Sense. Punctate staining can be
seen for βActL and βCatL2 Antisense probes along axons, above control levels. Scale bar, 20µm.
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Figure 5.13: Probes hybridised according to the method in Section 5.2.3.3 but bound to fluorescent
antibodies as described in Section 5.2.3.2 could not be detected on thalamic explant cultures above
background levels. (a) βCatL2 Antisense probe, (b) βCatL2 Sense probe, (c) βActL Antisene probe,
(d) No probe, (e) 18S Oligoprobes, (f) β-actin Oligoprobes, (g) β-catenin Oligoprobes, (h) Scrambled
oligoprobe. Pictures taken at 9 second exposure. No difference can be seen in explants, cells or axons
between any pair of probes. Scale bar, 20µm.
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can be seen in axons for the β-actin oligoprobes.
Figure 5.15 shows a set of cells with axons from the same in situ hybridisation
shown in Figure 5.14. The figure shows that the 18S oligoprobes can be reliably and
strongly detected throughout cells and axons. It also shows that the β-actin and β-
catenin oligoprobes can be detected in cells, but there is only slight staining in axons
above the level of the Scrambled control probe. However, it was possible to detect
staining of the growth cone for β-catenin in some axons (see pictures i and j in the
figure) similar to that seen in Figure 5.11. These results are further analysed in Section
5.3.5 below.
5.3.5 Image Analysis
The pictures shown in the previous sections appear to demonstrate differences in
staining between experimental and control probes. In this section, these differences
will be quantified and shown to be statistically significant, following the method
described in Section 5.2.3.4.
All of the axons analysed here were taken from the same in situ hybridisation
shown in Figures 5.11, 5.12, 5.14 and 5.15. As many axons as possible were selected
from this in situ, following the criteria listed in Section 5.2.3.4. Axons were traced
as shown in Figure 5.17a and the intensities of the pixels in the trace were recorded.
The number of axons traced for each probe are shown in Figure 5.16. The means and
standard error of the mean of pixel intensities for all images in each 5% bin are given
as percentages of the maximum intensity found for each set of probes. These means
and standard errors of the mean are plotted for eight different pairs of probes in Figures
5.17, 5.18, 5.19 and 5.20.
Figure 5.17 shows that there is significant staining for the βCatL2 Antisense probe
above both the βCatL2 Sense and No Probe controls at the cell (in the leftmost bins)
and the growth cone (in the rightmost bins), but not along the bulk of the axon.
Conversely, Figure 5.18 shows that there is significant staining for the βCatL probe
in the cell and along the axon, but not in the growth cone, compared to the βCatL2
Sense and No Probe controls. These plots demonstrate that at least a small quantity of
β-catenin mRNA is present in thalamic growth cones and that β-actin mRNA is present
in thalamic axons.
Figure 5.19 shows that the same significant different in staining cannot be seen
for either the β-catenin or β-actin oligoprobes above the staining for the Scrambled















































































































































































































Figure 5.15: Oligoprobes detected on E14.5 mouse thalamic explants using colorimetric in situ
hybridisation. Staining in explants, cells and axons is apparent for (a) 18S, (b) β-catenin and (c) β-
actin when compared to (d) Scrambled oligoprobe, although axonal staining is slight for β-actin and
β-catenin. Scale bar, 20µm.
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control oligoprobe, indicating that these mRNAs cannot be detected reliably with
these oligoprobes. However, Figure 5.20a shows that the 18S oligoprobes do stain
significantly above the levels of the Scrambled control probe in the cell and along the
entire length of the axon. An increase in staining can be seen at the growth cone (see
90-95% bin).
Finally, the staining for the two long probe controls (βCatL2 and No Probe) is not
significantly different, as seen in Figure 5.20b, further indicating that the significant
staining seen in the other figures shows genuine staining and is not an artifact of image
collection and processing. Therefore it can be concluded that this analysis of the in
situ hybridisations shown in this chapter demonstrate the presence of β-catenin mRNA
in thalamic growth cones, β-actin mRNA in thalamic axons and 18S rRNA in thalamic
axon and growth cones.
5.4 Discussion
In this chapter, a series of attempts to identify mRNAs in thalamic axons using in situ
hybridisation has been presented. In this discussion, the probes, cultures and protocols
used will be considered and several conclusions will then be drawn about the presence
of RNAs in thalamic axons based on the results presented above.
5.4.1 Technical considerations
In this section, the choice of RNAs used for the in situ hybridisations is defended, and
the choices of probe type, culture and protocol are explained.
5.4.1.1 Selection of RNAs
The RNAs investigated here are β-catenin, β-actin and 18S. All three of these RNAs
have been shown to be present in samples of thalamic axonal RNA in Chapter 4. As
discussed in Section 1.5.5, β-actin has previously been shown to be in axons of other
systems (Bassell et al., 1998) and ribosomes, which contain 18S rRNA, have been
shown to be present in axons (Wu et al., 2005; Alvarez et al., 2000). However, β-
actin and 18S have not been previously shown to be present in thalamic axons and
therefore the demonstration of their presence in thalamic axons here is a novel result. In
particular, demonstrating the presence of 18S mRNA in thalamic axons would support
its use as an internal standard in the PCR experiments presented in Chapter 4.
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Figure 5.17: Comparison of staining along multiple axons for β-catenin long probe. a) Example of
axon trace. Axons were traced by hand from a region of high staining in the cell (to measure the
level of cellular staining) to the edge of the growth cone. b-c) Comparisons of βCatL2 Antisense
staining to controls. The x-axes show distance along axons in bins of 5%; therefore the left side of
each plot represents the cell and the right side of each plot represents the growth cone. The y-axes show
intensity of axon staining as a percentage of the highest intensity seen over all axons for all long probes.
Each asterisk indicates there is a significant difference between the intensities for the two probes in the
corresponding 5% bin, at the p<0.05 significance level. The absence of an asterisk indicates p>=0.05. p
values calculated using a one-tailed Wilcoxon rank sum test with Bonferroni correction. The plots show
that βCatL2 Antisense staining is significantly above staining for b) βCatL2 Sense and c) No Probe in
the cell and the growth cone, but not along the trunk of the axon. Number of axons in each sample:
βCatL2 Antisense, 12; βCatL2 Sense, 15; No Probe, 6.
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Figure 5.18: Comparison of staining along multiple axons for β-actin long probe. See Figure 5.17
for description of plots. βActL significantly stains axons, but not growth cones, above the level of b)
βCatL2 Sense and c) No Probe controls. Number of axons in each sample: βActL, 11; βCatL2 Sense,
15; No Probe, 6.
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Figure 5.19: Comparison of staining along multiple axons for β-catenin and β-actin oligoprobes. See
Figure 5.17 for description of plots. Neither a) β-catenin oligoprobes or b) β-actin oligoprobes stain
axons significantly above the level of the Scrambled control oligoprobe, except in the cell body. Number
of axons in each sample: β-Catenin Oligo, 7; β-Actin Oligo, 6; Scrambled, 7.
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Figure 5.20: Comparison of staining along multiple axons for 18S oligoprobes and long probe controls.
See Figure 5.17 for description of plots. a) 18S significantly stains cells, axons and growth cones above
the level of the Scrambled control oligoprobe. An increase in staining can be seen at the growth cone
(90-95% bin). b) βCatL2 Sense and No Probe control stains are not significantly different according to
one-tailed Wilcoxon rank sum test with Bonferroni correction in either direction. Number of axons in
each sample: 18S, 6; Scrambled, 7; βCatL2 Sense, 15; No Probe, 6.
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In contrast, β-catenin mRNA has never been shown to be present in any axonal
system. However, as described in 1.6.2, several lines of evidence indicate that β-
catenin mRNA may be present in axons; β-catenin protein has been found in other
axonal systems, β-catenin is central to cell adhesion behaviour which may also play
a role in axon guidance, and β-catenin has been implicated in the regulation of both
the Slit/Robo and Eph/ephrin guidance cue systems. In this thesis, it has been shown
that β-catenin mRNA was cloned in a library of axonal mRNA and was successfully
amplified by qRT-PCR using the method described in Chapters 3 and 4. Therefore, a
series of in situ hybridisations for β-catenin were carried out, firstly to add weight to
the evidence presented in Chapter 4 for the presence of β-catenin mRNA in thalamic
axons, and secondly to see if β-catenin is localised to a particular region of the axon or
growth cone.
The β-catenin and β-actin probes were all designed to bind to the 3’UTR of the
RNAs, as this region has been shown to be required for several mRNAs, including
β-actin, EphB2, tau and RhoA, to be translated in axons (see Sections 1.5.3, 1.5.4 and
1.5.5).
5.4.1.2 Selection of Probe Type
The probes used for the experiments presented here were short and long RNA probes.
Single short RNA probes, or oligoprobes, 50 base pairs in length, have been used
successfully for axonal in situ hybridisation by the Jaffrey lab (Hengst et al., 2006;
Wu et al., 2005). Long RNA probes, or riboprobes, of 500-1000 base pairs in length,
have been used by the Ginzburg lab (Aronov et al., 2002; Litman et al., 1994). In
each case, cDNA templates must be produced which can be used to transcribe labelled
RNA strands. This is done by incorporating labelled uracil bases into the in vitro
transcription mix. The RNA probes used here were transcribed using digoxigenin-
labelled uracil bases. Digoxigenin is commonly used to label in situ probes and was
used by Jaffrey, Ginzburg and Bassell in their axonal in situ hybridisations.
RNA oligoprobes are ideal for the purpose of rapidly characterising many RNAs
using in situ hybridisation, because the cDNA templates used to make them can be
synthesised quickly and cheaply and labelled oligoprobes can be rapidly transcribed
from these templates. Long riboprobes are not suitable for this purpose; although the
transcription of labelled probes is performed in the same way as for the oligoprobes,
the construction of a cDNA template from a clone is time-consuming and expensive
and it would not be feasible to use these probes to validate large numbers of RNAs.
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However, here, where β-catenin was thought to be of particular interest, it was decided
to use long riboprobes to attempt to detect β-catenin, as a clone for β-catenin was
readily available and in situ hybridisation with long riboprobes was well-established in
the laboratory, whereas RNA oligoprobes were untested.
Another reason for preferring long probes to short probes is that long probes will
contain more labelled bases than short probes and so may be easier to detect. This
problem can be partly alleviated by including multiple short probes in the same mixture
which will bind to different parts of the mRNA. In these experiments, three different
oligoprobes have been used for each RNA (see Section 5.3.1).
Whereas the Jaffrey lab use 50 base pair oligoprobes (Wu et al., 2005), 40 base
pair oligoprobes were used for the in situ hybridisations presented here. This was
because each oligoprobe required a T7 promoter region to be synthesised to the
end of the probe, to enable the probe to be transcribed using T7 RNA polymerase,
making each oligoprobe 60 base pairs in length. The price of synthesis by MWG
increased considerably for oligoprobes over 60 base pairs in length, and so it was not
economically possible to make multiple longer oligoprobes.
The Bassell lab use multiple DNA oligoprobes for their axonal in situ hybridi-
sations (eg Antar et al. (2006); Zhang et al. (2001); Bassell et al. (1998)). The
probes are constructed with amino-modified thymidine bases which are able to bind to
digoxigenin, using a DNA synthesiser. While the results from these probes appear to
be specific and strong, no DNA synthesiser was available to be used to construct probes
in this way, and purchasing amino-modified or digoxigenin-labelled DNA oligoprobes
was prohibitively expensive. Therefore DNA probes have not been used for these
experiments.
5.4.1.3 Selection of controls
To conclude that an RNA of interest is present in axons, it is not sufficient to only stain
the axons using a labelled probe designed to bind to the RNA. It may be that the probe
has not bound specifically to the RNA of interest, or that the fluorescent antibodies or
colorimetric stain used has not bound specifically to the labelled probe. Extra probes
should be used to control for these possibilities.
For oligoprobes, a scrambled probe should be constructed which is confirmed
(using BLAST) not to bind to any known RNA molecule. If this probe is labelled
and detected as the other probes are and no signal is detected once the protocol is
complete, this indicates that the scrambled probe did not bind to any RNA and that
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any stain is indiscriminate. This means that any stain for other probes above the level
shown for the scrambled probe can be considered to reflect accurate staining for those
other probes.
For long probes, it is not possible to construct scrambled probes of the required
length efficiently. However, suitable controls can be constructed using the double-
stranded DNA vectors which are used to construct cDNA probe templates. If the
sequence of the RNA of interest is defined as the sense strand, the probe which will
be used to bind to this RNA should be the antisense strand. This antisense strand
is constructed using one strand of the DNA vector. However, the other strand of the
vector can be used to construct sense probes. These sense probes should not bind to any
RNA, unless the antisense strand is endogenously transcribed. While it is customary to
compare antisense probes to sense probes from the same transcript, it is also possible
to compare antisense probes with sense probes for other genes, as has been done with
βActL and βCatL2 Sense here.
The use of scrambled or sense probes is sufficient to establish that the other oligos
or antisense probes have bound to RNA. In addition, a condition where no probe is used
but the protocol is otherwise the same has been used to demonstrate a baseline level of
background staining, to determine if the scrambled or sense probes have produced any
staining at all.
5.4.1.4 Cultures and Protocols
Two culture systems were used for these experiments; dissociated thalamic cells
and thalamic explants. Dissociated thalamic cells plated on fibronectin-coated glass
coverslips were not able to survive for more than two days and so did not grow axons
of substantial length. However, thalamic explants plated on the same substrate were
able to survive for at least a week, producing substantial axonal growth. In addition,
single cells in these explant cultures were able to grow longer axons than those in
the dissociated cell cultures. This suggests that the explants contained factors which
enabled the survival of thalamic cells and the growth of thalamic axons. It may be that
thalamic cells require interactions with other thalamic cells to survive, but it seems
more likely that secreted factors are involved given that single cells were able to survive
and grow axons away from thalamic explants.
Although the explant cultures were more robust than dissociated cell cultures, it
still proved difficult to preserve a large number of explants and cells throughout the full
length of an in situ hybridisation protocol, and it was not possible in the time available
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to improve on the staining shown here without damaging the cultured explants and
cells. This is regrettable given the small levels of staining observed, and the failure
to achieve a high quality fluorescent staining of axons. It is clear that the sensitivity
required for axonal in situs is far above that of in situs on sections; the βCatL1 probes
worked well on coronal sections (see Figure 5.3) but could not be used reliably on
either axonal culture system with either fluorescent or colorimetric protocols.
It may be that the addition of serum, which was not attempted with in situ
hybridisations but which proved crucial for the qRT-PCR experiments, as shown in
Chapter 3, would improve the growth and stability of axons in explant cultures.
Alternatively, other protocols such as those of Bassell et al. (1998) or Aronov et al.
(2002) could be attempted in place of the Wu et al. (2005) protocol used here. It would
also be of interest to attempt an in situ with DNA probes synthesised to incorporate
DIG-labelled thymine bases, as is done by the Bassell lab.
5.4.2 Presence of mRNAs in thalamic axons
Figures 5.4, 5.11, 5.12, 5.14 and 5.15 provide evidence that 18S rRNA, β-actin mRNA
and β-catenin mRNA are present in thalamic axons, in agreement with the evidence
presented in Chapter 4. It also appears that β-catenin can be found in particular at
the growth cone (see Figure 5.12). Statistical analysis of these results demonstrates
significant signal for β-catenin mRNA in thalamic growth cones but not axons (see
Figure 5.17), for β-actin mRNA in thalamic axons but not growth cones (see Figure
5.18) and for 18S rRNA in thalamic axons and growth cones (see Figure 5.20). This
analysis also supports what is apparent from the pictures, that there is a small but
significant increase in β-catenin mRNA at the growth cone. An increase at the growth
cone can also be seen for 18S rRNA, but not for β-actin mRNA, with either long probes
or oligoprobes.
These results support the case for the presence of β-catenin in thalamic growth
cones in Section 1.6.2.1; given the presence of β-catenin mRNA in thalamic growth
cones, the known role of β-catenin in Slit functioning, and the requirement for Slit to
induce thalamic axons to turn away from the hypothalamus, it is highly likely that β-
catenin is essential for this turning event to occur. It also seems likely that β-catenin is
involved in the response of thalamic axons to ephrin-A5 in the ventral telencephalon.
The results also support the hypothesis that β-catenin is locally translated at the
growth cone, in common with other molecules such as β-actin and RhoA. This suggests
Chapter 5. In situ hybridisations for β-catenin and other RNAs in thalamic axons 195
that GSK-3β regulation of β-catenin should be investigated at the growth cone. β-
catenin accumulates in the cell when GSK-3β is inhibited, but it is unclear if this is
due to β-catenin protein transport or due to synthesis of new β-catenin protein. The
presence of β-catenin mRNA at the growth cone indicate that the latter may be the
case, but this requires detailed investigation of both β-catenin mRNA and GSK-3β at
the growth cone.
In addition, the results lend further support to the results presented in Chapter 4,
in that they provide another demonstration of the presence of β-catenin, β-actin and
18S RNAs in thalamic axons, but also that the level of staining matches the general
pattern seen when comparing ratios of axon-to-cell expression in the PCR experiments
(see Section 4.4.3.3), with 18S staining being more intense than β-actin staining and
β-catenin staining.
The differences in staining between the probes are intriguing. β-actin mRNA has
been shown to be expressed along the whole axon and growth cone in other systems
such as rat cortical neurons (Bassell et al., 1998); however, other RNAs such as EphA2
have been shown not to be expressed in the axon but are only found in the growth cone
(see Section 1.5.3). Here, β-catenin mRNA appears to follow the pattern of EphA2;
there is no significant staining in the axon, but there is a noticeable and significant rise
in staining at the growth cone (see Figure 5.17). In contrast, β-actin mRNA is found
along the axon but not in the growth cone.
It may be that this apparent difference is the result of variation in in situ protocols
and probes in the literature and in the experiments presented in this thesis, but it may
also reflect a genuine difference in biological function. It may be that some RNAs are
distributed across the axon whereas others are restricted at the growth cone; β-actin
and RhoA, while they have been identified in the growth cone, may have additional
cytoskeletal roles along the whole axon, whereas the majority of β-catenin and EphB2
mRNAs, which have mostly membrane-bound roles, may be restricted to the growth
cone. Further investigation of mRNAs in thalamic axons, in particular time-sensitive
investigations of mRNA transport and new synthesis such as those carried out by Leung
et al. (2006), are required before this issue can be resolved.
It should be noted that this data is congruent with that presented in Section 4.4.3.3,
where β-actin was shown to have a higher axon:cell expression ratio (relative to
18S) compared to β-catenin. This is what would be expected if β-actin is expressed
throughout the axons, whereas β-catenin is only expressed at growth cones, as the
growth cones form a smaller percentage of the total quantity of tissue compared to the
Chapter 5. In situ hybridisations for β-catenin and other RNAs in thalamic axons 196
axons. It may be that expression of β-catenin in growth cones is actually more dense
than β-actin in axons, but due the large volume of axonal tissue compared to growth
cone tissue there is a greater quantity of β-actin present overall.
Why is there apparent β-actin staining in the growth cones of the axons shown
in Figure 5.12(a-d), but this cannot be detected statistically with a larger population
of axons? This may be a problem with the method of image analysis; tracing a line
through the axon and growth cone covers most of the axon but only a small portion
of the growth cone, and it may be that there is staining in the growth cone which is
less dense than that in the axon and so is not detected using this analysis method.
Alternatively, the population of axons chosen for analysis may be heterogenous.
The pictures in the figure were chosen to show the best staining achieved over all
axons for β-actin and β-catenin. It is known that the population of thalamic cells is
heterogeneous, because they differentiate into many nuclei (see Section 1.3.3) and
because axons from different parts of the thalami behave differently in the same
environment (see Section 1.4.2). Therefore it may be that β-actin and β-catenin
mRNAs are differently expressed within the population of cells and explants examined
here, given that the cells come from very small pieces of thalamus. This point will
be returned to in Chapter 6. However, this should not affect the results presented
in Chapter 4, where whole thalami (and whole axonal carpets) were cultured and
dissected, and so the whole population of thalamic cells should be represented.
Nevertheless, it may be that the analysis shown here represents a real difference in
biological function. If so, it agrees with reports that β-actin mRNA is not localised to
the growth cone in minimal essential medium or even when stimulated with NGF, but it
is localised to the growth cone when stimulated by BDNF and neurotrophin-3 (Zhang
et al., 1999). It also appears that β-actin mRNA is upregulated in the growth cone when
stimulated with netrin-1, but that expression is low prior to stimulation (Leung et al.
(2006); see Figure 1.12). Therefore it may be that while a small quantity of β-actin
mRNA is present in growth cones, it is transported to the growth cone from the axon
upon stimulation. Unfortunately, while these studies did quantify differences in growth
cone expression under various conditions, they did not quantify differences in axonal
and growth cone expression. It would be of great interest to compare axonal and growth
cone expression levels of β-actin mRNA, as it would indicate whether stimulation
causes a general upregulation of β-actin in axons and growth cones, or whether there
may be transportation of mRNA from axon to growth cone upon stimulation. This
is particularly of interest given the apparent small increase in β-actin expression just
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prior to the growth cone in these in situs (see 75% to 80% bin in Figure 5.18), which
may represent an area in the axon or perhaps the C-domain of the growth cone, and
raises the possibility that β-actin mRNA is sequestered at the base of the growth cone
and transported into the growth cone upon stimulation.
The image analysis clearly shows that β-catenin mRNA is expressed in thalamic
growth cones without stimulation. These same growth cones should now be tested
for β-catenin mRNA expression under stimulation with guidance cues such as Slit1/2
and ephrin-A5, which are likely to be involved in regulating β-catenin in thalamic
growth cones (see Section 1.6.2.1 for discussion), and with the neurotrophins BDNF,
neurotrophin-3 and NGF. This will reveal if β-catenin mRNA responds to stimulation
as β-actin mRNA does, although it might be expected that the particular responses of
these mRNAs to the same stimuli will vary, given their opposite expression without
stimulation. For example, β-actin mRNA expression does not change in the presence
of NGF, but β-catenin protein is known to be downregulated by NGF in mouse DRG
growth cones (Zhou et al., 2004b). It may be that the regulation of these mRNAs
and proteins is intertwined, with adherens junctions containing β-catenin forming to
stabilise the actin cytoskeleton, and the same junctions being dismantled to allow the
cytoskeleton to respond to stimulation.
The localisation of β-catenin mRNA to thalamic growth cones also suggests that its
3’UTR should be investigated for targeting elements such as those found in the EphA2,
tau, MAP2 and β-actin mRNAs, and constructs containing any predicted elements
should be introduced into thalamic cells to test if they are transported to the growth
cone. It will be of interest to see if the β-catenin mRNA is transported in the same
protein complexes as β-actin, or if other proteins may be involved in the regulation of
other axonal mRNAs such as β-catenin.
Chapter 6
Visualising RNA in the Thalamus and
Internal Capsule with In Situ
Hybridisation
6.1 Introduction
In previous chapters, RNAs have been shown to be present in axons grown in vitro.
In this chapter, in situ hybridisations on vibratome sections are presented in order to
visualise RNA in vivo, focussing on the thalamus and on the internal capsule which
contains axons grown from the thalamus to the cortex and also from the cortex to the
thalamus. These regions have been studied at two different stages of development to
see if any difference in levels of RNA could be detected during the development of the
thalamocortical and corticothalamic projections. These in situ hybridisations are now
presented.
6.2 Materials and methods
The in situ hybridisations presented here were all performed on 100µm-thick coronal
sections, cut using a vibratome, from the heads of E14.5 mice (CD1 strain). Heads
were fixed in 4% paraformaldehyde in PBT, pH 9.5, at 4◦C overnight, washed three
times in 1xPBS for ten minutes and stored in 1xPBS + sodium azide at 4◦C until
they were sectioned. Before sectioning, heads were embedded in 3% agarose in
DEPC-treated water. Sections were cut onto SuperFrost Plus slides (VWR) and dried
overnight before in situ hybridisation commenced.
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The probes used for the in situ hybridisations were all used for the in vitro in
situs presented in Chapter 5. Details of their construction and design can be found in
Sections 5.2.1 and 5.3.1.
6.2.1 Vibratome in situ hybridisation protocol
This protocol was kindly provided by Lynda Erskine (University of Aberdeen, UK;
Thompson et al. (2006)). All treatments were performed at room temperature unless
otherwise stated.
Slides were washed with PBT for five minutes, dehydrated with 50% and 100%
methanol in PBT for five minutes each, rehydrated with 75%, 50% and 25% methanol
in PBT for five minutes each and washed with PBT twice for five minutes. Slides were
treated with 6% hydrogen peroxide in PBT for one hour and washed three times in
PBT for five minutes each. Slides were treated with 5 µg/mL Proteinase K in PBT for
ten minutes and washed with fresh 2mg/mL glycine in PBT for ten minutes followed
by two five minute PBT washes. Slides were post-fixed in 4% paraformaldehyde in
PBT for twenty minutes and washed twice for five minutes in PBT. Slides were pre-
hybridised in pre-heated hybridisation mixture at 65◦C for sixty minutes. Probes were
prepared in hybridisation mixture at dilutions of 15µl/mL and denatured at 85◦C for
five minutes. 100 µl of probe mixture was added to each slide, covered with a plastic
coverslip and left to hybridise in a humid chamber containing filter paper soaked in
50% formamide at 65◦C overnight.
After hybridisation, slides were washed three times with pre-heated Solution 1 for
twenty minutes at 65◦C, three times with pre-heated Solution 3 for twenty minutes
at 60◦C and three times with 1xTBST for five minutes at room temperature. Slides
were incubated in 10% sheep serum in TBST for sixty minutes and then incubated in
anti-digoxigenin alkaline phosphatase in 1% sheep serum in TBST (1:2000) at 4◦C
overnight.
Slides were washed five times in 1xTBST for ninety minutes at room temperature
and three times in 1xNTMT for ten minutes at room temperature. Slides were
incubated in NBT/BCIP in 1xNTMT (1:50) at 4◦C for 25 hours. Slides were washed
twice with 1xNTMT for ten minutes, then washed in 1xPBT, pH 5.5, for ten minutes,
washed twice in 1xPBT for ten minutes, postfixed with 4% paraformaldehyde in
1xPBS for thirty minutes and washed twice in 1xPBS for ten minutes. Slides were
mounted in 90% glycerol in PBS.
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6.3 Results
Colorimetric in situ hybridisations on coronal vibratome sections of mouse E14.5 and
E15.5 brain were carried out. Figures 6.1 and 6.2 show the results for E14.5 sections;
Figure 6.3 and 6.4 show the results for E15.5 sections. β-catenin (βCatL2) Antisense,
β-catenin (βCatL2) Sense and β-Actin (βActL) Antisense long probes, and 18S, RPS3
and Scrambled oligoprobes were tested at each age. The figures show images of whole
coronal sections where the thalamus was visible and also higher magnifications of the
internal capsules in these sections where it was possible to clearly see these regions
(some regions in Figure 6.2 are not visible). The slides were stained for 25 hours,
saturating most of the section, in order to attempt to stain any small amounts of RNA
which may be present in the internal capsule. Figure 6.5 shows magnifications of the
thalami shown in Figures 6.1 and 6.3.
Figure 6.1 shows that both the β-catenin and β-actin Antisense long probes heavily
stained E14.5 coronal sections of mouse brain far above the level seen for the β-
catenin Sense probe. The thalamus is heavily stained for both probes, with some
heterogeneity of staining apparent in both cases (see Figure 6.5 for magnifications).
There are vertical strips of heavy β-catenin staining in the medial ventricular zone
and heavy staining lateral to the ventricular zone but only light staining within the
majority of the ventricular zone itself. In contrast, β-actin is heavily stained in most
of the ventricular zone with light strips of staining medial and lateral to the ventricular
zone. β-actin stains particularly heavily ventromedially. The epithalamus is stained
similarly to the thalamus for β-actin but is more heavily stained than the thalamus for
β-catenin. However, the internal capsules, which are the white, cell free regions in
the sections, and which contain the thalamocortical and corticothalamic tracts, are not
stained, despite the long exposure times. While there is some dark punctate staining
in some areas of the internal capsule, the same punctate staining can be seen in the
images of the control internal capsule, and so should be considered an artefact of the
protocol rather than a reflection of the presence of RNA.
Figure 6.2 shows that the 18S oligoprobes and, to a lesser extent, the RPS3
oligoprobes stained E14.5 coronal sections of mouse brain above the level of the
Scrambled control probe. Staining of the sections is broadly uniform for both probes
and as with the long probes, the internal capsule is not stained above control levels.
Figure 6.3 shows that the β-catenin and β-actin Antisense long probes both stain
E15.5 coronal sections of mouse brain far above the level of the β-catenin Sense probe.























































































































































































































































































































































































































































































































































































































































































































Chapter 6. Visualising RNA in the Thalamus and Internal Capsule with In Situ Hybridisation204
As with the E14.5 sections, heavy ventromedial staining for β-actin can be seen in the
thalamus (see Figure 6.5 for magnification). β-catenin is considerably upregulated in
the thalamus compared to the rest of the section, and variation in thalamic staining is
visible, with light and dark patches intermingled across the thalami and dorsal regions
particularly heavily stained (see Figure 6.5 for magnification). Once again, however,
no clear staining can be seen in any of the internal capsules above control levels.
Figure 6.4 shows that both the 18S and RPS3 oligoprobes stain E15.5 coronal
sections of mouse brain above the levels seen for the Scrambled control oligoprobe.
Staining is uniform across the thalamus for both probes except for strong staining for
RPS3 in the epithalamus. However, as with all the other pictures, no clear staining can
be seen in the internal capsule above control levels apart from cellular staining.
6.4 Discussion
These experiments were undertaken to confirm the expected expression of β-catenin,
β-actin, 18S and RPS3 RNAs in the thalamus at embryonic days E14.5 and E15.5,
when thalamocortical axons begin to grow from the thalamus to the cortex, and also
to attempt to detect these RNAs in the internal capsule. β-catenin, β-actin and 18S
were chosen because these probes had been examined in detail in the work presented
in Chapters 4 and 5. RPS3 (see Section 1.6.1) was chosen in addition, from all of the
RNAs identified in the qRT-PCR experiments presented in Chapter 4, because of its
high axon:cell ratio of expression shown in Section 4.4.3.3, which may indicate that it
has a significant role to play in the development of thalamocortical axons.
The results shown here demonstrate that β-catenin, β-actin, 18S and RPS3 RNAs
are expressed in the thalamus while the thalamocortical tract is growing towards the
cortex. This is not surprising given the central roles of these molecules in cytoskeletal,
adhesive and translation behaviour. However, they also show that β-catenin mRNA
appears to be upregulated in the thalamus during this time, which may indicate a
particular requirement for β-catenin mRNA in the thalamus. It may be that this mRNA
is transported from thalamic cells to the growth cones of the axons of these cells, in
order for these growth cones to respond to guidance cues such as Slit and ephrin-A5,
as discussed in Sections 1.6.2 and 5.4.2.
No staining in the internal capsule can be seen in any of the images above the
levels seen in the control images. This is not surprising given that only very small
quantities of RNA have been detected in axons in culture compared to that which can
























































































































































































































































































































































































































































































































































































































































































Chapter 6. Visualising RNA in the Thalamus and Internal Capsule with In Situ Hybridisation207
be detected in cells. However, this does highlight a problem with the investigation of
axonal RNA; almost all results published so far are based on in vitro studies, rather
than in vivo studies. There remains no reliable method of identifying and manipulating
axonal RNA in vivo in such a way that the axonal RNA can be discriminated from
cellular RNA. This point will be returned to in Section 7.3.2.
Finally, there is some evidence for heterogeneity of β-actin mRNA and β-catenin
mRNA expression across the thalamus, with patches of light and dark staining being
visible at E14.5 and E15.5. Therefore it is possible that there is heterogeneous
expression of β-actin and β-catenin mRNA in thalamic axons and growth cones. This
may account for some of the difficulty of achieving significant in situ hybridisation
staining in axons, as discussed in Chapter 5, as it may be that only a subset of axons
within the population express the mRNAs in question. It also suggests that it would
be useful to further investigate the staining of the regions of the thalamus, and to find
some way of discriminating between prospective nuclei at early embryonic ages, in
order to investigate the populations of axons which they produce.
Most notably, it appears that expression of β-catenin mRNA and β-actin mRNA is
different in the ventricular zone compared to the rest of the thalamus, with β-catenin
mRNA having low expression in the ventricular zone but high expression on either side
of the zone, and β-actin mRNA having high expression in the ventricular zone but low
expression on either size of the zone (although there is high β-actin mRNA expression
on the lateral side of the thalamus). This is congruent with evidence that β-catenin
protein is expressed in precursor cells in the cortical ventricular zone and prevents
cells from differentiating, whereas it is downregulated in differentiated cells as they
travel through and exit the ventricular zone (Woodhead et al., 2006; Chenn and Walsh,
2002). This suggests that β-catenin has the same function in thalamic precursors as it
does in cortical precursors, as it appears to be highly expressed at the medial edge of
the ventricular zone where the precursors are located but is not highly expressed in the
majority of the ventricular zone itself. In contrast, β-actin mRNA appears to be highly
expressed as the cells progress through the ventricular zone, which is perhaps expected
as the cytoplasm of these cells is highly active at this point.
It is possible that β-catenin and β-actin are actually antagonistic at this point in
development, as is suggested by the staining patterns in Figure 6.5. In motile cells,
there is more requirement for actin filaments in order for the cells to move, whereas in
stable cells, there is more requirement for adherens junctions containing β-catenin to
stabilise the actin cytoskeleton. However, this requires further investigation, especially
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as the contrast between the staining patterns is not precise, with the strips of β-actin




In this final chapter, the implications of the results presented in earlier sections will be
discussed. The focus is on the conclusions which can be drawn from these results; for
discussion of the interpretation of the data and the usefulness of the qRT-PCR and in
situ hybridisation techniques, please see the discussions of the earlier chapters. The
presence of a number of RNAs in thalamic axons will be discussed, followed by a
consideration of further work which may arise from the results presented in this thesis.
7.2 Identification of RNAs in thalamic axons
The qRT-PCR experiments presented in Chapter 4 and the in situ hybridisation
experiments presented in Chapter 5 have demonstrated the presence of multiple RNAs
in thalamic axons, in particular the mRNA for β-catenin. This is the first time that
RNAs have been identified in thalamic axons.
The work presented here is consistent with the idea that thalamocortical axons
function via the same general mechanisms as axons of other systems and can be
investigated using the same methods as are used to investigate those other systems. In
particular, it strongly suggests that thalamocortical growth cones require local protein
synthesis to navigate to their targets. Many of the other RNAs which have been
identified in thalamic axons, namely β-actin, 18S, α-tubulin, EphB2, MAP2c and
RhoA, have been identified in other axonal systems, and local translation of β-actin
and RhoA in other systems has been shown to be crucial for axons in these systems
to respond to guidance cues. Therefore it is expected that thalamocortical axons will
209
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function in the same way, although this remains to be investigated.
The identification of β-catenin mRNA in thalamic growth cones is significant, for
the reasons outlined in Section 1.6.2. β-catenin protein has been identified in axons
of other systems and the actions of both Slit and ephrin-A5 have been implicated in
the binding of N-cadherin to β-catenin, which is required for adherens junctions to
form. β-catenin is also regulated by proteins which are linked to microtubule regulation
such as GSK-3β which are downstream of growth cone trophic factors such as the
neurotrophins and may therefore be involved in the regulation of the growth cone
cytoskeleton. Slits, ephrin-A5 and several neurotrophins are known to be crucial for
navigation of thalamocortical axons across the diencephalic-telencephalic boundary,
through the ventral telencephalon and into the cortex. Therefore the presence of
β-catenin mRNA in thalamic axons strongly suggests that this protein is important
for these navigation events to take place, and that these events require local protein
synthesis of β-catenin, although these hypotheses require validation. The in situ
hybridisation results in Chapter 5 also suggest that β-catenin mRNA is mostly found
in the growth cone and not in the length of the axon, as is the case for EphA2 in spinal
cord axons (Brittis et al., 2002) but in contrast to β-actin mRNA, which is found in
axons and growth cones in some axonal systems (Zhang et al., 1999; Leung et al.,
2006) but has only been found in thalamic axons and not growth cones in this study.
If this is correct, it further suggests that mRNAs are targeted to axonal regions, most
likely through their 3’UTR (as has been shown for EphA2, tau and β-actin).
Several novel mRNAs have been identified here which have not been identified in
any axonal system, namely Bat2d1, RalA, Reep5, RPS3, Reticulon-1, Synaptotagmin-
13 and Ubiquilin-1; in addition, several RNAs appear to be absent from thalamic axons,
namely Ascc3l1, BPGM, Rac1, Rock1 and RPA1. Of these mRNAs, little is known
about Bat2d1, Reep5, Ascc3l1 and BPGM which have mostly been reported in large
surveys of gene expression and have not yet been investigated in depth in their own
right, and so little further can be said of them here. However, it is encouraging that,
of the absent RNAs, Rock1 and Rac1 also appear to be absent from rat dorsal root
ganglion cells (Wu et al., 2005) and RPA1 is a DNA replication and repair protein
(Binz et al., 2004) and is therefore unlikely to be involved in axon development; of the
present RNAs, Reticulon-1, RalA, Synaptotagmin-13 and RPS3 have all been directly
or indirectly linked to axon growth. Reticulon-1 is associated with the microtubule-
and vesicle-regulating protein spastin, which is involved in axonal transport (Mannan
et al., 2006; Steiner et al., 2004), and reticulon-1 is also associated with endoplasmic
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reticulum which is known to be present in axons (Yamada et al., 1971); RalA regulates
neurite branching in rat sympathetic neurons (Lalli and Hall, 2005); Synaptotagmin-13
binds to neurexin-1α, which is required for presynaptic terminals to form (Dean et al.,
2003) and which was also identified in the library of thalamic mRNAs presented in
Section 1.6.1; and RPS3 is associated with ribosomes which are known to be present
in other axonal systems and, as 18S rRNA has also been identified here, are likely
to be present in thalamic axons (see Sections 1.6.1 and 4.5.2 for further discussion
of the identified mRNAs). It may therefore prove fruitful to investigate these RNAs
in other axonal systems as well as further investigate their roles in thalamocortical
axons. In particular, while it appears that only a subset of all expressed RNAs are
present in axons, it is as yet unclear whether different axonal systems contain different
complements of RNAs.
The experiments here have not exhaustively tested the mRNA library presented in
Section 1.6.1. The failure to identify the mRNA for the DNA replication and repair
protein RPA1 in thalamic axons suggests that some of the remaining untested mRNAs
may have come from contaminating cells (for example, DNA polymerase β, although
as the sequence identified for this mRNA was intronic it may be that this mRNA is for
some other product, not DNA polymerase β). However, there are reasons for believing
it would be valuable to test the remaining mRNAs using the qRT-PCR technique
presented here; for example, neurexin-1α, which is required for presynaptic terminals
to form in axons (Dean et al., 2003), interacts with synaptotagmin-13 (Fukuda and
Mikoshiba, 2001), which has been identified in thalamic axons in the results presented
here. In addition to the library, there are several axonal mRNAs from the literature
such as cofilin (Piper et al., 2006), tau (Aronov et al., 2001) and EphA2 (Brittis et al.,
2002) which remain to be tested in thalamic axons, not to mention the large surveys
of axonal RNAs reported by Willis et al. (2007) and Hengst and Jaffrey (2007). While
these large surveys are informative, the use of qRT-PCRs, following a method similar
to that presented in this thesis, will still be important in order to validate these surveys,
as there is still a requirement for specific identification of each mRNA to be sure that
the mRNA is indeed present in axons.
7.3 Further work
The demonstration of multiple RNAs in thalamic axons raises several issues about
the regulation of these RNAs and the behaviour of thalamic axons in general. In this
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section, this issue will be discussed and some methods for approaching them proposed.
7.3.1 Analysis of mRNA sequence and structure
It is clear that many mRNAs such as EphA2, tau and β-actin are targeted to the axon
or growth cone by regulation of their 3’UTR, most likely through their binding to
ribonucleoprotein complexes which transport the mRNAs (see Sections 1.2.1, 1.5.3
and 1.5.5). However, it is not clear how varied this regulation is and exactly what
form it takes. It is not known how particular mRNAs but not others become associated
with this complex, and exactly which proteins or, perhaps, RNAs are involved in the
turning on and off of translation. Also, the region of 3’UTR which targets β-actin to
the growth cone in some systems is not present in other axonal mRNAs, but the regions
which target those mRNAs have not been clearly identified at present. Therefore there
is a need for an analysis of the 3’UTRs of the axonal RNAs identified here and those
in the literature to attempt to determine the elements which may cause the mRNAs to
be targeted to the growth cone.
The advantage of the present study is that a number of mRNAs have been shown not
to be present in axons, at least as far as the methods used here can determine; therefore
it might be expected that these mRNAs will not contain elements which would enable
them to be targeted to the growth cone and they can be used as a control set to compare
with the axonal mRNAs. Both sequence and structure should be compared, as it may
be that the targeting element interacts with other transport proteins and so depends
on RNA structure, and an mRNA which has changed its sequence may retain its
structure. The evolutionary conservation of the mRNAs should also be examined, as
axonal RNAs have been shown to be present in several species including mouse, rat
and zebrafish and so it might be expected that any targeting elements will have been
conserved.
These analyses can be carried out computationally, using alignment algorithms
such as BLAST (Altschul et al., 1990) to detect similar elements in the sequences of
the 3’UTRs but also more complicated structural algorithms such as those provided
by mfold (Zuker, 2003) and RNAforester (Höchsmann et al., 2004), which aligns
multiple RNAs according to predicted structural elements. It is recommended that
the structural analysis is informed by the sequence analysis; as the number of possible
structures increases rapidly as sequence length increases, it is necessary to minimise
the length of sequence as much as possible to restrict the number of probable structures
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to a manageable size. Therefore the structural analysis should begin with any small
regions of sequence which can either be found in multiple mRNAs or which are highly
conserved.
Any predictions from these analyses can then be tested by creating 3’UTRs
attached to reporters (for example, GFP) which do and do not contain the predicted
regulatory regions, and observing whether these reporters can be detected in axons by
immunohistochemistry or in situ hybridisation.
It is possible that the small RNA molecules known as microRNAs are involved
in axonal RNA regulation. MicroRNAs are known to bind to the 3’UTRs of mRNAs
and repress their translation; they are also known to bind to mRNAs contained and
transported in protein complexes (Wu and Belasco, 2008). MicroRNAs have also
been shown to regulate mRNA translation in dendritic spines, where the gene Limk1
is upregulated when the microRNA miR-134 is repressed, causing the widths of the
dendritic spines where Limk1 is expressed to increase (Schratt et al., 2006).
The study of microRNAs is appealing, particularly for bioinformaticians, as
microRNA-mRNA bindings can be predicted computationally and the small size of
the binding (perhaps as little as 8bp) makes accurate prediction very challenging.
However, despite several years of speculation in a number of papers (see, for example,
Wu et al. (2005) and Hengst and Jaffrey (2007)), no axonal microRNA has been
reported to date. This may be because the technical difficulties of doing so are severe;
it took many years longer for mRNAs to be identified in axons compared to their
identification in dendrites, and the same may happen with microRNAs. It may also
be because microRNAs are not, in fact, present in axons; while the hypothesis that
they regulate multiple mRNAs is attractive, there is no reason in principle why a
sufficiently complex set of switches in the 3’UTR which bind to various regulatory
proteins couldn’t account for the regulation of hundreds of mRNAs in axons.
However, there is no doubt that, if hundreds of mRNAs are indeed present in axons
of various systems, and if these mRNAs vary from system to system, there is a great
deal of work left to be done to unravel the precise regulatory networks controlling the
targeting and expression of these mRNAs in axons.
7.3.2 Translation at the growth cone in the thalamocortical system
The results presented here demonstrating the presence of multiple RNAs in thalamic
axons raise many questions about the development of the thalamocortical system. How
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does the presence or absence of these RNAs affect the response of thalamocortical
axons to their environment? Is translation at the growth cone required for thalamo-
cortical axons to respond to guidance cues such as netrin-1, Slits 1 and 2 and ephrin-
A5? Is local translation involved in the interaction of thalamocortical axons with the
axons of cells from the internal capsule and the lateral ganglionic eminence, and with
corticothalamic axons? And does local translation have a role to play in the targeting
of thalamocortical axons from particular thalamic nuclei to their appropriate cortical
target areas?
These questions can be addressed using combinations of the in vitro techniques
encountered in Chapter 1; thalamic axons can be grown in culture either with tissue
from the hypothalamus, ventral telencephalon or cortex, or with gradients of specific
guidance cues, and the axons can be treated with protein synthesis inhibitors such
as cycloheximide or anisomycin to see if turning effects are abolished as they are
for retinal or commissural axons, for example. Co-cultures will pose more technical
challenges than treatment with guidance cues as it will be necessary to shield target
tissue sources from the protein synthesis inhibitors; this could be done by the use of
Campenot chambers, where membranes which permit the growth of axons but prevent
free flow of medium could be used to isolate thalamic tissue from target tissue (Eng
et al., 1999; Roche et al., 2009). Alternatively, specific antisense morpholinos could
be used against particular mRNAs, as has been done for β-actin (see Section 1.5.5).
It is possible that variants of the qRT-PCR technique presented in this thesis could
be developed which would enable quantities of mRNAs in the presence or absence
of guidance cues or target tissues to be examined, although once again the co-culture
experiments would be complicated by the need to isolate the thalamic axons away
from any other tissue. Also, the difficulty in growing sufficient quantities of axons for
detection by qRT-PCR may make testing of multiple guidance cues prohibitive.
Indeed, while it is easy to generate many tens of hypotheses about the interactions
of mRNAs, guidance cues and other axonal tracts given the large number of each which
are involved in thalamocortical development, it may prove very difficult to accurately
test these hypotheses. Firstly, the explant cultures used for the qRT-PCR experiments
used here only flourished with the addition of fetal calf serum; as it is very likely that
this serum contains growth factors and probably guidance cues as well, treating serum-
fed axons with guidance cues may not have an effect, as the axons may already be
saturated in their response to the cue. Secondly, the sheer number of factors involved
in thalamocortical development make it difficult to draw strong conclusions about in
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vitro results, as it is virtually impossible to simulate the in vivo environment of thalamic
axons in culture, and factors which have effects that are dependent on several other
factors may not influence axons directly in vitro.
Nevertheless, the in vitro approach should be pursued, particularly as no cor-
responding in vivo approach is available at present for the study of axonal RNAs.
While the expression of particular guidance cues and the disruption of axon growth
can be examined in vivo by generating genetic mutants, it is as yet unclear how to
generate mutants which will lack axonal RNA alone without disrupting cellular RNA
expression; it is even less clear how this might be done for thalamocortical axons alone,
without interfering with the other axonal systems with which the thalamocortical axons
must interact. It is hoped that this will become clearer as the structure and function of
the 3’UTRs of axonal RNAs is investigated, as it may be possible to identify regions
of the 3’UTR which are crucial for axonal targeting but no other function, which could
be excised from the gene in mutant animals.
In summary, multiple RNAs have been identified in thalamic axons, using gene-
specific qRT-PCR and in situ hybridisation experiments, including the mRNA for the
cell adhesion and signalling-related molecule β-catenin. This lays the foundation for
a thorough investigation of the role of local translation in thalamic axons, which it is
hoped will throw light on the development of the thalamocortical system and axonal
systems in general.
Appendix A
Source code for in situ image analysis
Below is the source code for the analysis of axonal in situs presented in Section 5.3.5,
written in the statistical programming language R (R Development Core Team (2008)).
1 # I n p u t : t r a c e s o f axon p i x e l i n t e n s i t i e s i n s e p a r a t e
2 # f i l e s w i th t h e e x t e n s i o n p l o t . t x t i n t h e f o r m a t :
3 # p o s i t i o n 1 i n t e n s i t y 1
4 # p o s i t i o n 2 i n t e n s i t y 2
5 # . . .
6 #
7 # Outpu t : PDF images compar ing s p e c i f i e d p a i r s o f p r o b e s
8 # and CSV f o r m a t l i s t o f images , p i x e l s , b i n means and
9 # s t a n d a r d d e v i a t i o n s f o r each probe
10
11 # Get maximum p i x e l i n t e n s i t y f o r a l l l ong / o l i g o p r o b e s f o r
12 # c o n v e r s i o n o f i n t e n s i t i e s t o p e r c e n t a g e s
13 g e t h i g h e s t i n t e n s i t y <−f u n c t i o n ( p r o b e s ) {
14 h i g h e s t i n t e n s i t y <−0
15 a x o n f i l e s <− l i s t . f i l e s ( p a t h = ” . ” , p a t t e r n = p r o b e s )
16 f o r ( i i n 1 : l e n g t h ( a x o n f i l e s ) ) {
17 a x o n f i l e n a m e <− a x o n f i l e s [ i ]
18 a x o n f i l e <−r e a d . t a b l e ( a x o n f i l e n a m e )
19 h i g h e s t i n t e n s i t y <−
20 max ( c ( h i g h e s t i n t e n s i t y , max ( a x o n f i l e $ V 2 ) ) )
21 }
22 r e t u r n ( h i g h e s t i n t e n s i t y )
23 }
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24 # Get a l l t h e a v e r a g e p i x e l i n t e n s i t i e s i n a b i n
25 # f o r a l l b i n s f o r a l l t h e f i l e s f o r s i n g l e p robe
26 g e t a v p i x i n t s <−f u n c t i o n ( p r o b e i d , b i n s ) {
27 a x o n f i l e s <− l i s t . f i l e s ( p a t h = ” . ” , p a t t e r n = p r o b e i d )
28 p r o b e p i x i n t s <−a r r a y (−1 , c ( l e n g t h ( b i n s ) , 1 5 ) )
29
30 f o r ( i i n 1 : l e n g t h ( a x o n f i l e s ) ) {
31 # Read i n t r a c e f i l e f o r one axon f o r t h e p robe
32 a x o n f i l e n a m e <− a x o n f i l e s [ i ]
33 a x o n f i l e <−r e a d . t a b l e ( a x o n f i l e n a m e )
34 n u m p i x e l s <− l e n g t h ( a x o n f i l e $ V 1 )
35
36 # Conve r t p o s i t i o n a l o n g axon t o p e r c e n t a g e
37 f o r ( j i n 1 : n u m p i x e l s ) {
38 a x o n f i l e $ V 1 [ j ] <− ( a x o n f i l e $ V 1 [ j ] / n u m p i x e l s )∗100
39 }
40
41 # Get p i x e l s f o r each b i n
42 f o r ( j i n 1 : l e n g t h ( b i n s ) ) {
43 b i n p i x e l s <− a x o n f i l e $ V 2 [ a x o n f i l e $ V 1 >=
44 ( b i n s [ j ]− b i n s [ 1 ] + 0 . 0 0 0 0 0 0 0 0 1 )
45 & a x o n f i l e $ V 1 <b i n s [ j ] ]
46 # Conve r t p i x e l s t o p e r c e n t a g e o f maximum i n t e n s i t y
47 # and i n v e r t p e r c e n t a g e
48 # ( so i n c r e a s i n g s t a i n i n g i n c r e a s e s v a l u e )
49 f o r ( l i n 1 : l e n g t h ( b i n p i x e l s ) ) {
50 b i n p i x e l s [ l ] <− 100 −
51 ( ( b i n p i x e l s [ l ] / h i g h e s t i n t e n s i t y ) ∗ 100)
52 }
53 # C a l c u l a t e mean p i x e l i n t e n s i t y f o r t h i s image
54 p r o b e p i x i n t s [ j , i ] <− mean ( b i n p i x e l s )
55 }
56 }
57 r e t u r n ( l i s t ( p r o b e p i x i n t s = p r o b e p i x i n t s ,
58 n u m f i l e s = l e n g t h ( a x o n f i l e s ) ) )
59 }
60
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61 # P l o t e r r o r b a r s f o r p i x e l s i n each b i n f o r two p r o b e s
62 p r i n t p l o t <−f u n c t i o n
63 ( p robe 1 , p robe 2 , p r o b e b i n m e a n s , p r o b e b i n s t d e r r s ,
64 b i n p v a l u e s , b in s , c o l o u r 1 , c o l o u r 2 ) {
65
66 # Open PDF f i l e f o r p l o t
67 p d f f i l e <−p a s t e ( ” . . / a x o n t r a c e f i g s / ” , p robe 1 , ” ” ,
68 probe 2 , ” . pdf ” , sep = ’ ’ )
69 pdf ( p d f f i l e )
70
71 # C r e a t e e r r o r b a r s f o r second ( low e x p r e s s i o n ) p robe
72 e r r b a r ( b ins , p r o b e b i n m e a n s [ 2 , ] ,
73 p r o b e b i n m e a n s [ 2 , ] + p r o b e b i n s t d e r r s [ 2 , ] ,
74 p r o b e b i n m e a n s [ 2 , ] − p r o b e b i n s t d e r r s [ 2 , ] ,
75 yl im =c ( 0 , 1 0 5 ) , c o l = c o l o u r 2 , t y p e =”o ” , pch =22 ,
76 x l a b =” D i s t a n c e a l o n g axon (%)” ,
77 y l a b =” I n t e n s i t y o f s t a i n i n g (%)” , add = FALSE)
78
79 # C r e a t e e r r o r b a r f o r f i r s t ( h igh e x p r e s s i o n ) p robe
80 # on t o p o f second probe
81 e r r b a r ( b ins , p r o b e b i n m e a n s [ 1 , ] ,
82 p r o b e b i n m e a n s [ 1 , ] + p r o b e b i n s t d e r r s [ 1 , ] ,
83 p r o b e b i n m e a n s [ 1 , ] − p r o b e b i n s t d e r r s [ 1 , ] ,
84 yl im =c ( 0 , 1 0 5 ) , c o l = c o l o u r 1 , t y p e =”o ” , pch =20 ,
85 add = TRUE)
86
87 l e g e n d ( 6 5 , 100 , c ( p robe 1 , p r o b e 2 ) ,
88 pch=c ( 2 0 , 2 2 ) , c o l =c ( c o l o u r 1 , c o l o u r 2 ) )
89
90 # Add s i g n i f i c a n c e s t a r s wi th p v a l u e s
91 f o r ( k i n 1 : l e n g t h ( b i n p v a l u e s ) ) {
92 i f ( b i n p v a l u e s [ k ] < 0 . 0 5 ) {
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98 compare p robes <−f u n c t i o n
99 ( p robe 1 , p robe 2 , h i g h e s t i n t e n s i t y ,
100 c o l o u r 1 , c o l o u r 2 , b i n s ) {
101
102 p r o b e l i s t <−c ( p robe 1 , p r o b e 2 )
103 a l l p r o b e b i n s <−
104 a r r a y (−1 , c ( l e n g t h ( p r o b e l i s t ) , l e n g t h ( b i n s ) , 1 5 ) )
105 p r o b e f i l e s <− a r r a y ( 0 , l e n g t h ( p r o b e l i s t ) )
106 p r o b e p r i n t o u t <− a r r a y ( ” ” , l e n g t h ( p r o b e l i s t ) )
107
108 # Get a v e r a g e p i x e l i n t e n s i t i e s f o r each probe
109 f o r ( k i n 1 : l e n g t h ( p r o b e l i s t ) ) {
110 p r o b e i d <− p r o b e l i s t [ k ]
111 p r o b e a v p i x i n t s <− g e t a v p i x i n t s ( p r o b e i d , b i n s )
112 a l l p r o b e b i n s [ k , , ] <−
113 p r o b e a v p i x i n t s $ p r o b e p i x i n t s
114 p r o b e f i l e s [ k ] <− p r o b e a v p i x i n t s $ n u m f i l e s
115 p r o b e p r i n t o u t [ k ∗2] <−
116 p a s t e ( p r o b e i d , ’ , ’ , p r o b e f i l e s [ k ] , sep = ’ ’ )
117 p r o b e p r i n t o u t [ k ∗2+1] <− ” , , S . E .M. , ”
118 }
119
120 # I n i t i a l i s e mean , s t a n d a r d e r r o r and p−v a l u e a r r a y s
121 p r o b e b i n m e a n s <− a r r a y ( 0 ,
122 c ( l e n g t h ( p r o b e l i s t ) , l e n g t h ( b i n s ) ) )
123 p r o b e b i n s t d e r r s <− p r o b e b i n m e a n s
124 b i n p v a l u e s <−v e c t o r ( )
125 # For each bin ,
126 # c a l c u l a t e means and s t a n d a r d e r r o r s f o r bo th p r o b e s
127 # and c a l c u l a t e p−v a l u e f o r compar i son o f p r o b e s
128 f o r ( j i n 1 : l e n g t h ( b i n s ) ) {
129 f o r ( k i n 1 : l e n g t h ( p r o b e l i s t ) ) {
130
131 # Get p i x e l s f o r t h i s b i n and probe
132 b i n p i x i n t s <− v e c t o r ( )
133 f o r ( i i n 1 : l e n g t h ( a l l p r o b e b i n s [ k , j , ] ) ) {
134 i f ( a l l p r o b e b i n s [ k , j , i ] >= 0) {
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135 b i n p i x i n t s <−
136 c ( b i n p i x i n t s , a l l p r o b e b i n s [ k , j , i ] )
137 }
138 }
139 i f ( j ==1) {
140 p r o b e p r i n t o u t [ k ∗2] <−
141 p a s t e ( p r o b e p r i n t o u t [ k ∗2 ] ,
142 ’ , Mean , ’ , sep = ’ ’ )
143 }
144
145 p r o b e b i n m e a n s [ k , j ] <−mean ( b i n p i x i n t s )
146 p r o b e b i n s t d e r r s [ k , j ]<−sd ( b i n p i x i n t s ) /
147 s q r t ( l e n g t h ( b i n p i x i n t s ) )
148
149 p r o b e p r i n t o u t [ k ∗2] <−
150 p a s t e ( p r o b e p r i n t o u t [ k ∗2 ] ,
151 p r o b e b i n m e a n s [ k , j ] , ” , ” , sep =”” )
152 p r o b e p r i n t o u t [ k ∗2+1] <−
153 p a s t e ( p r o b e p r i n t o u t [ k ∗2+1] ,
154 p r o b e b i n s t d e r r s [ k , j ] , ” , ” , sep =”” )
155 i f ( k ==1) { o n e b i n p i x i n t s <−b i n p i x i n t s }
156 e l s e { t w o b i n p i x i n t s <−b i n p i x i n t s }
157 }
158 # C a l c u l a t e one− t a i l e d Wilcoxon rank sum t e s t f o r b i n
159 # and add t o l i s t o f p−v a l u e s f o r p r o b e s
160 w i l c o x o u t <− wi l c ox . t e s t ( o n e b i n p i x i n t s ,
161 t w o b i n p i x i n t s , p a i r e d =FALSE ,
162 a l t e r n a t i v e =” g r e a t e r ” , )
163 b i n p v a l u e s <− c ( b i n p v a l u e s , w i l c o x o u t $ p . v a l u e )
164 }
165
166 # A d j u s t p−v a l u e s f o r m u l t i p l e t e s t s (20 b i n s )
167 b i n p v a l u e s <−p . a d j u s t ( b i n p v a l u e s , method = ” b o n f e r r o n i ” )
168
169 p r i n t p l o t ( p robe 1 , p robe 2 ,
170 p r o b e b i n m e a n s , p r o b e b i n s t d e r r s ,
171 b i n p v a l u e s , b in s , c o l o u r 1 , c o l o u r 2 )
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172 f o r ( i i n 2 : 5 ) {




177 l i b r a r y ( Hmisc ) # For e r r b a r f u n c t i o n
178 sys tem ( ” rm a x o n t r a c e f i g s / ∗ . pd f ” )
179 d i r e c t o r y <−”a x o n p l o t s ”
180 se twd ( d i r e c t o r y )
181
182 # I n i t i a l i s e 5% b i n s and c r e a t e an empty a r r a y
183 # t o ho ld p i x e l s f o r each probe f o r each b i n
184 b ins <−c ( 5 , 10 , 15 , 20 , 25 , 30 , 35 , 40 , 45 , 50 ,
185 55 , 60 , 65 , 70 , 75 , 80 , 85 , 90 , 95 , 100)
186
187 c s v h e a d e r <−”Probe , P i c t u r e s , ”
188 f o r ( i i n 1 : ( l e n g t h ( b i n s ) ) ) {
189 b i n s t a r t <− b i n s [ i ]− b i n s [ 1 ] + 1
190 i f ( i ==1) { b i n s t a r t <−b i n s t a r t −1}
191 c s v h e a d e r <−p a s t e ( c s v h e a d e r , b i n s t a r t , ’− ’ ,
192 b i n s [ i ] , ’% , ’ , sep =”” )
193 }
194 c a t ( c s v h e a d e r , ”\n ” , sep = ’ ’ )
195 # Compare long p r o b e s
196 h i g h e s t i n t e n s i t y <−g e t h i g h e s t i n t e n s i t y ( ” long . p l o t . t x t ” )
197 c o m p a r e p r o b e s ( ” BCatL2−A n t i s e n s e ” , ” BCatL2−Sense ” ,
198 h i g h e s t i n t e n s i t y , ” r e d ” , ” g r e e n ” , b i n s )
199 c o m p a r e p r o b e s ( ” BActL ” , ” BCatL2−Sense ” ,
200 h i g h e s t i n t e n s i t y , ” b l u e ” , ” g r e e n ” , b i n s )
201 c o m p a r e p r o b e s ( ” BCatL2−A n t i s e n s e ” , ”No−Probe ” ,
202 h i g h e s t i n t e n s i t y , ” r e d ” , ” ye l l ow ” , b i n s )
203 c o m p a r e p r o b e s ( ” BActL ” , ”No−Probe ” ,
204 h i g h e s t i n t e n s i t y , ” b l u e ” , ” ye l l ow ” , b i n s )
205 c o m p a r e p r o b e s ( ” BCatL2−Sense ” , ”No−Probe ” ,
206 h i g h e s t i n t e n s i t y , ” g r e e n ” , ” ye l l ow ” , b i n s )
207 c o m p a r e p r o b e s ( ” BActL ” , ” BCatL2−A n t i s e n s e ” ,
208 h i g h e s t i n t e n s i t y , ” b l u e ” , ” r e d ” , b i n s )
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209 # Compare o l i g o p r o b e s
210 h i g h e s t i n t e n s i t y <−g e t h i g h e s t i n t e n s i t y ( ” o l i g o . p l o t . t x t ” )
211 c o m p a r e p r o b e s ( ” Beta−Caten in−Ol igo ” , ” Scrambled ” ,
212 h i g h e s t i n t e n s i t y , ” r e d ” , ” ye l l ow ” , b i n s )
213 c o m p a r e p r o b e s ( ” Beta−Act in−Ol igo ” , ” Scrambled ” ,
214 h i g h e s t i n t e n s i t y , ” b l u e ” , ” ye l l ow ” , b i n s )
215 c o m p a r e p r o b e s ( ”18 S ” , ” Scrambled ” ,




Abdel-Mannan, O., Cheung, A. F., and Molnár, Z. (2008). Evolution of cortical
neurogenesis. Brain Research Bulletin, 75(2-4):398–404.
Abramoff, M. D., Magelhaes, P. J., and Ram, S. J. (2004). Image processing with
ImageJ. Biophotonics International, 11(7):36–42.
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Bagnard, D., Thomasset, N., Lohrum, M., Püschel, A. W., and Bolz, J. (2000). Spatial
distributions of guidance molecules regulate chemorepulsion and chemoattraction
of growth cones. Journal of Neuroscience, 20(3):1030–1035.
Bagri, A., Marı́n, O., Plump, A. S., Mak, J., Pleasure, S. J., Rubenstein, J. L. R., and
Tessier-Lavigne, M. (2002). Slit proteins prevent midline crossing and determine
the dorsoventral position of major axonal pathways in the mammalian forebrain.
Neuron, 33(2):233–248.
Barallobre, M. J., Pascual, M., Del Rio, J. A., and Soriano, E. (2005). The Netrin
family of guidance factors: emphasis on Netrin-1 signalling. Brain Research
Reviews, 49(1):22–47.
Barbe, M. F. and Levitt, P. (1992). Attraction of specific thalamic input by cerebral
grafts depends on the molecular identity of the implant. Proceedings of the National
Academy of Sciences, 89(9):3706–3710.
Bibliography 225
Bas, A., Forsberg, G., Hammarström, S., and Hammarstroöm, M.-L. (2004). Utility
of the housekeeping genes 18S rRNA, β-actin and glyceraldehyde-3-phosphate-
dehydrogenase for normalization in real-time quantitative reverse transcriptase-
polymerase chain reaction analysis of gene expression in human T lymphocytes.
Scandinavian Journal of Immunology, 59(6):566–573.
Bassell, G. J., Zhang, H., Byrd, A. L., Femino, A. M., Singer, R. H., Taneja, K. L.,
Lifshitz, L. M., Herman, I. M., and Kosik, K. S. (1998). Sorting of β-Actin mRNA
and protein to neurites and growth cones in culture. Journal of Neuroscience,
18(1):251–265.
Basyuk, E., Bertrand, E., and Journot, L. (2000). Alkaline fixation drastically improves
the signal of in situ hybridization. Nucleic Acids Research, 28(10):e46–e48.
Bayatti, N., Sarma, S., Shaw, C., Eyre, J. A., Vouyiouklis, D. A., Lindsay, S., and
Clowry, G. J. (2008). Progressive loss of PAX6, TBR2, NEUROD and TBR1 mRNA
gradients correlates with translocation of EMX2 to the cortical plate during human
cortical development. European Journal of Neuroscience, 28(8):1449–1456.
Bellion, A. and Métin, C. (2005). Early regionalisation of the neocortex and the medial
ganglionic eminence. Brain Research Bulletin, 66(4-6):402–409.
Bertrand, N. and Dahmane, N. (2006). Sonic hedgehog signaling in forebrain
development and its interactions with pathways that modify its effects. Trends in
Cell Biology, 16(11):597–605.
Besse, F. and Ephrussi, A. (2008). Translational control of localized mRNAs:
restricting protein synthesis in space and time. Nature Reviews Molecular Cell
Biology, 9(12):971–980.
Bhanot, P., Brink, M., Samos, C. H., Hsieh, J.-C., Wang, Y., Macke, J. P., Andrew,
D., Nathans, J., and Nusse, R. (1996). A new member of the frizzled family from
Drosophila functions as a Wingless receptor. Nature, 382:225–230.
Bienz, M. (2005). β-Catenin: A pivot between cell adhesion and Wnt signalling.
Current Biology, 15(2):R64–R67.
Binz, S. K., Sheehan, A. M., and Wold, M. S. (2004). Replication protein A
phosphorylation and the cellular response to DNA damage. DNA Repair, 3:1015–
1024.
Birnbacher, D. and Albus, K. (1987). Divergence of single axons in afferent projections
to the cat’s visual cortical areas 17, 18, and 19: A parametric study. Journal of
Comparative Neurology, 261(4):543–561.
Bishop, K. M., Goudreau, G., and O’Leary, D. D. M. (2000). Regulation of area
identity in the mammalian neocortex by Emx2 and Pax6. Science, 288(5464):344–
349.
Bibliography 226
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Lübke, J. and Feldmeyer, D. (2007). Excitatory signal flow and connectivity in a
cortical column: focus on barrel cortex. Brain Structure and Function, 212(1):3–17.
Lumsden, A. (1990). The cellular basis of segmentation in the developing hindbrain.
Trends in Neurosciences, 13(8):329–335.
Lundquist, E. A. (2006). Small GTPases. WormBook, 17:1–18.
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Uziel, D., Mühlfriedel, S., Zarbalis, K., Wurst, W., Levitt, P., and Bolz, J. (2002).
Miswiring of limbic thalamocortical projections in the absence of Ephrin-A5.
Journal of Neuroscience, 22(21):9352–9357.
Vanderhaeghen, P., Lu, Q., Prakash, N., Frisén, J., Walsh, C. A., Frostig, R. D.,
and Flanagan, J. G. (2000). A mapping label required for normal scale of body
representation in the cortex. Nature Neuroscience, 3(4):358–365.
Vanderhaeghen, P. and Polleux, F. (2004). Developmental mechanisms patterning
thalamocortical projections: intrinsic, extrinsic and in between. Trends in
Neurosciences, 27(7):384–391.
Vieira, C. and Martinez, S. (2006). Sonic hedgehog from the basal plate and the
zona limitans intrathalamica exhibits differential activity on diencephalic molecular
regionalization and nuclear structure. Neuroscience, 143(1):129–140.
Vitalis, T., Cases, O., Gillies, K., Hanoun, N., Hamon, M., Seif, I., Gaspar, P., Kind, P.,
and Price, D. J. (2002). Interactions between TrkB signaling and serotonin excess
in the developing murine somatosensory cortex: A role in tangential and radial
organization of thalamocortical axons. Journal of Neuroscience, 22(12):4987–5000.
Votin, V., Nelson, W. J., and Barth, A. I. M. (2005). Neurite outgrowth involves
adenomatous polyposis coli protein and β-catenin. Journal of Cell Science,
118(24):5699–5708.
Vue, T. Y., Aaker, J., Taniguchi, A., Kazemzadeh, C., Skidmore, J. M., Martin, D. M.,
Martin, J. F., Treier, M., and Nakagawa, Y. (2007). Characterization of progenitor
domains in the developing mouse thalamus. Journal of Comparative Neurology,
505(1):73–91.
Wacker, M. J. and Godard, M. P. (2005). Analysis of one-step and two-step real-time
RT-PCR using SuperScript III. Journal of Biomolecular Techniques, 16(3):266–271.
Wandell, B. A., Dumoulin, S. O., and Brewer, A. A. (2007). Visual field maps in
human cortex. Neuron, 56(2):366–383.
Wang, Y., Thekdi, N., Smallwood, P. M., Macke, J. P., and Nathans, J. (2002). Frizzled-
3 is required for the development of major fiber tracts in the rostral CNS. Journal of
Neuroscience, 22(19):8563–8573.
Wang, Y., Zhang, J., Mori, S., and Nathans, J. (2006). Axonal growth and guidance
defects in Frizzled3 knock-out mice: A comparion of diffusion tensor magnetic
resonance imaging, neurofilament staining, and genetically directed cell labelling.
Journal of Neuroscience, 26(2):355–364.
Bibliography 250
Wen, Z. and Zheng, J. Q. (2006). Directional guidance of nerve growth cones. Current
Opinion in Neurobiology, 16(1):52–58.
Wigle, J. T. and Eisenstat, D. D. (2008). Homeobox genes in vertebrate forebrain
development and disease. Clinical Genetics, 73(3):212–226.
Wilkie, G. S., Dickson, K. S., and Gray, N. K. (2003). Regulation of mRNA translation
by 5’- and 3’UTR-binding factors. Trends in Biochemical Sciences, 28(4):182–188.
Wilkinson, D. G. (2001). Multiple roles of Eph receptors and Ephrins in neural
development. Nature Reviews Neuroscience, 2(3):155–164.
Wilkinson, D. G., Bhatt, S., Cook, M., Boncinelli, E., and Krumlauf, R. (1989).
Segmental expression of Hox-2 homeobox-containing genes in the developing
mouse hindbrain. Nature, 341:405–409.
Willis, D., Li, K. W., Zheng, J.-Q., Chang, J. H., Smit, A., Kelly, T., Merianda, T. T.,
Sylvester, J., van Minnen, J., and Twiss, J. L. (2005). Differential transport and local
translation of cytoskeletal, injury-response, and neurodegeneration protein mRNAs
in axons. Journal of Neuroscience, 25(4):778–791.
Willis, D. E., van Niekerk, E. A., Sasaki, Y., Mesngon, M., Merianda, T. T., Williams,
G. G., Kendall, M., Smith, D. S., Bassell, G. J., and Twiss, J. L. (2007). Extracellular
stimuli specifically regulate localized levels of individual neuronal mRNAs. Journal
of Cell Biology, 178(6):965–980.
Windrem, M. S. and Finlay, B. L. (1991). Thalamic ablations and neocortical
development: Alterations of cortical cytoarchitecture and cell number. Cerebral
Cortex, 1(3):230–240.
Winer, J. A. and Lee, C. C. (2007). The distributed auditory cortex. Hearing Research,
229(1-2):3–13.
Winning, R. S., Wyman, T. L., and Walker, G. K. (2001). EphA4 activity causes cell
shape change and a loss of cell polarity in xenopus laevis embryos. Differentiation,
68(2-3):126–132.
Wolf, L. V., Yeung, J. M., Doucette, J. R., and Nazarali, A. J. (2001). Coordinated
expression of Hoxa2, Hoxd1 and Pax6 in the developing diencephalon. Neuroreport,
12(2):329–333.
Wong, M. L. and Medrano, J. F. (2005). Real-time PCR for mRNA quantitation.
Biotechniques, 39(1):75–85.
Woodhead, G. J., Mutch, C. A., Olson, E. C., and Chenn, A. (2006). Cell-
autonomous β-catenin signaling regulates cortical precursor proliferation. Journal
of Neuroscience, 26(48):12620–12630.
Wright, A. G., Demyanenko, G. P., Powell, A., Schachner, M., Enriquez-Barreto,
L., Tran, T. S., Polleux, F., and Maness, P. F. (2007). Close homolog of L1 and
neuropilin 1 mediate guidance of thalamocortical axons at the ventral telencephalon.
Journal of Neuroscience, 27(50):13667–13679.
Bibliography 251
Wu, K. Y., Hengst, U., Cox, L. J., Macosko, E. Z., Jeromin, A., Urquhart, E. R., and
Jaffrey, S. R. (2005). Local translation of RhoA regulates growth cone collapse.
Nature, 438(7053):1020–1024.
Wu, L. and Belasco, J. G. (2008). Let me count the ways: Mechanisms of gene
regulation by miRNAs and siRNAs. Molecular Cell, 29(1):1–7.
Xing, Y., Takemaru, K.-I., Liu, J., Berndt, J. D., Zheng, J. J., Moon, R. T., and Xu, W.
(2008). Crystal structure of a full-length β-catenin. Structure, 16:478–487.
Yamada, K. M., Spooner, B. S., and Wessells, N. K. (1971). Ultrastructure and
function of growth cones and axons of cultured nerve cells. Journal of Cell Biology,
49(3):614–635.
Yang, Y. S. and Strittmatter, S. M. (2007). The reticulons: a family of proteins with
diverse functions. Genome Biology, 8(12):234.
Yao, J., Sasaki, Y., Wen, Z., Bassell, G. J., and Zheng, J. Q. (2006). An essential
role for β-actin mRNA localization and translation in ca2+-dependent growth cone
guidance. Nature Neuroscience, 9(10):1265–1273.
Young-Pearse, T. L., Chen, A. C., Chang, R., Marquez, C., and Selkoe, D. J. (2008).
Secreted APP regulates the function of full-length APP in neurite outgrowth through
interaction with integrin beta I. Neural Development, 3(15).
Yuan, J. S., Wang, D., and Jr., C. N. S. (2008). Statistical methods for efficiency
adjusted real-time PCR quantification. Biotechnology Journal, 3(1):112–123.
Yun, M. E., Johnson, R. R., Antic, A., and Donoghue, M. J. (2003). EphA family gene
expression in the developing mouse neocortex: Regional patterns reveal intrinsic
programs and extrinsic influence. Journal of Comparative Neurology, 456(3):203–
216.
Zarei, M., Johansen-Berg, H., Jenkinson, M., Ciccarelli, O., Thompson, A. J., and
Matthews, P. M. (2007). Two-dimensional population map of cortical connections
in the human internal capsule. Journal of Magnetic Resonance Imaging, 25(1):48–
54.
Zeltser, L. M. (2005). Shh-dependent formation of the ZLI is opposed by signals from
the dorsal diencephalon. Development, 132(9):2023–2033.
Zhang, G., Fenyo, D., and Neubert, T. A. (2008). Screening for EphB signaling
effectors using SILAC with a linear ion trap-orbitrap mass spectrometer. Journal
of Proteome Research, 7(11):4715–4726.
Zhang, H. L., Eom, T., Oleynikov, Y., Shenoy, S. M., Liebelt, D. A., Dictenberg, J. B.,
Singer, R. H., and Bassell, G. J. (2001). Neurotrophin-induced transport of a β-
actin mRNP complex increases β-actin levels and stimulates growth cone motility.
Neuron, 31(2):261–275.
Bibliography 252
Zhang, H. L., Singer, R. H., and Bassell, G. J. (1999). Neurotrophin regulation of β-
actin mRNA and protein localization within growth cones. Journal of Cell Biology,
147(1):59–70.
Zhou, C., Qiu, Y., Pereira, F. A., Crair, M. C., Tsai, S. Y., and Tsai, M.-J. (1999).
The nuclear orphan receptor COUP-TFI is required for differentiation of subplate
neurons and guidance of thalamocortical axons. Neuron, 24(4):847–859.
Zhou, C.-J., Pinson, K. I., and Pleasure, S. J. (2004a). Severe defects in
dorsal thalamic development in low-density Lipoprotein Receptor-Related Protein-6
mutants. Journal of Neuroscience, 24(35):7632–7639.
Zhou, F.-Q. and Cohan, C. S. (2004). How actin filaments and microtubules steer
growth cones to their targets. Journal of Neurobiology, 58(1):84–91.
Zhou, F.-Q., Zhou, J., Dedhar, S., Wu, Y.-H., and Snider, W. D. (2004b). NGF-induced
axon growth is mediated by localized inactivation of GSK-3β and functions of the
microtubule plus end binding protein APC. Neuron, 42(6):897–912.
Zhou, L., Bar, I., Achouri, Y., Campbell, K., Backer, O. D., Hebert, J. M., Jones, K.,
Kessaris, N., de Rouvroit, C. L., O’Leary, D., Richardson, W. D., Goffinet, A. M.,
and Tissir, F. (2008). Early forebrain wiring: Genetic dissection using conditional
Celsr3 mutant mice. Science, 320(5878):946–949.
Zipper, H., Brunner, H., Bernhagen, J., and Vitzthum, F. (2004). Investigations on
DNA intercalation and surface binding by SYBR Green I, its structure determination
and methodological implications. Nucleic Acids Research, 32(12):e103.
Zou, Y. (2004). Wnt signaling in axon guidance. Trends in Neurosciences, 27(9):528–
532.
Zuker, M. (2003). Mfold web server for nucleic acid folding and hybridization
prediction. Nucleic Acids Research, 31(13):3406–3415.
